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ABSTRACT
NVCTALOPIN IS REQUIRED FOR LOCALIZATION OF THE TRPMl CHANNEL TO THE RETINAL
DEPOLARIZING BIPOLAR CELL DENDRITES

Jillian N Pearring
August 2, 2010
Mutations in the NYX gene, encoding the novel protein nyctalopin, cause human
congenital stationary night blindness type 1 (eSNB1). eSNB1 is an X-linked recessive condition
and is identified by a loss of the electroretinogram (ERG) b-wave while the a-wave remains
intact (Miyake et 01., 1986). The b-wave in normal patients is generated by the depolarization of
one class of bipolar cells, which receive signals from the photoreceptors. This indicates that
eSNB1 is a loss of signaling from the photo receptors to the depolarizing bipolar cells. Normal
stimulation of photoreceptors by light causes the photoreceptors to hyperpolarize and reduce
the amount of neurotransmitter, glutamate, released into the synaptic cleft. The decrease in
glutamate causes Grm6, a metabotropic glutamate receptor, at the postsynaptic depolarizing
bipolar cell dendrites to reduce its activity. This signal is relayed by a second messenger system
to result in the opening of a non-selective cation channel, which depolarizes one class of bipolar
cells. The signaling to the non-selective cation channel in depolarizing bipolar cells is disrupted
when nyctalopin is absent. Recent data shows that the non-selective cation channel is the
transient receptor potential subfamily M member 1 (TRPM1) channel (Shen et 01., 2009;
Morgans et 01., 2009; Koike et 01., 2009). The focus of my studies has been to understand the
function of nyctalopin in the depolarizing bipolar cells. I characterized TRPM1 expression in the
retina, investigated the interdependence between nyctalopin, Grm6 and TRPM1 and
determined the interactions between nyctalopin and Grm6 or TRPM1. There are five retinal
splice variants of TRPM1. Variants containing all six transmembrane domains have a
developmental expression profile similar to bipolar cells. Immunohistochemical analysis shows
TRPM1 is localized to Be somas and dendritic tips where it co-localizes with YFP-nyctalopin.
Nyctalopin interacts with the TRPMl channel is required for proper localization of the TRPMl
channel to the bipolar cell dendritic tips.
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CHAPTER I. INTRODUCTION
Retina Organization and Function

The retina is a part of the central nervous system and is designed to processes complex
visual signals. One way the retina processes visual information is via multiple types of retinal
neurons and their connections (Dowling & Boycott, 1966; Boycott & Dowling, 1969; Wassle &
Boycott 1991; MacNeil & Masland, 1998). In 1892, Santiago Ramon y Cajal published the first
anatomical description of retinal cells using a Golgi silver nitrate stained retina (Cajal, 1892;
Figure 1).
The retina is divided into three nuclear layers, that contain cell bodies, and two
plexiform layers that contain synapses (Cajal, 1892). The outer retina is composed of the
photoreceptor outer segments (OS) and inner segments (IS), their somas comprise the outer
nuclear layer (ONl) and their axon terminals extend into the outer plexiform layer (OPl). The
inner retina is divided into the inner nuclear layer (INl), inner plexiform layer (IPl), ganglion cell
layer (GCl) and inner limiting membrane (llM) (Figure 1). The terminals of the photoreceptors
(PRs) form synapses in the OPl with bipolar cells (BC) and horizontal cells (HC). There are two
types of PRs, the cones and rods (Figure lA, B). The INl contains the BCs, HCs and amacrine cells
(ACs) (Figure lB, C, D). BCs send their axons into the IPl to synapse with AC and/or ganglion cell
(RGC) dendrites. The innermost nuclear layer, the GCl, contains RGC and displaced AC somas.
The RGCs are the output cells of the retina, whose axons form the optic nerve and transmit the
visual signal to rest of the brain. In most mammalian retinas, the optic nerve also contains
incoming blood vessels that vascularize the retinal layers. In addition, the retina contains radial
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Muller glial cells that span the retina (Figure iF). Muller cells send out processes that surround
every neuronal cell body as well as form the OLM and ILM that serve as a barrier between the
retina and the rest of the eye.
The visual signal initiated in the photoreceptors travels through the retina via vertical
excitatory pathways, from the PRs to BCs then to RGCs. This pathway employs glutamate as its
primary neurotransmitter and is divided into two parallel, ON and OFF pathways. ON and OFF
responses are created by the type of glutamate postsynaptic receptors expressed on BCs
dendrites. ON BCs express metabotropic glutamate receptor 6, Grm6, and depolarize to light
increments. These will be referred to as depolarizing bipolar cells (DBCs). OFF BCs express
ionotropic glutamate receptors, AMPA/Kainate, and depolarize in response to light decrements.
These will be referred to as hyperpolarizing bipolar cells (HBCs). The ON and OFF pathways are
conserved at the next synapse in the retina where BCs synapse with ACs and RGCs. The IPL is
divided into two functionally discrete sublaminae. This functional segregation is mirrored by a
structured difference in the IPL. In sublaminae A, the most distal part of the IPL, OFF BCs axon
terminals form synapses with OFF RGC dendrites (Figure lG). In sublaminae B, the proximal part
of the IPL, ON BCs axon terminals form synapses with ON RGC dendrites (Figure lH). RGCs that
stratify in both sublaminae they are called bi-stratified (Figure 11).
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Figure 1: Schematic of the mammalian retina . (A) Cone Photoreceptor (B) Rod Photoreceptor (Ci) Rod
Bipolar Cell (Cii) Cone Bipolar Cell (D) Horizontal Cell (E) Muller Glial Cells (F) All Amacrine Cell (G)
Amacrine Cell (H) Bi-stratified RGC (I) ON-center RGC (J) OFF-center RGC. The laminated nomenclature
is depicted on the right side of the figure . Modified from "Structure of the Mammalian Retina" c.1900
By Santiago Ramon y Cajal.
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Each synapse in this vertical pathway is modulated by lateral inhibitory pathways. In the
outer retina, the inhibitory neurons are HCs (Mills & Massey, 1994) and are electrically coupled
to each other and provide negative feedback to the PRs and negative feed forward to BCs
(Dowling, 1970; Baylor et aI., 1971; Mangel, 1991; Vigh & Witkovsky, 1999). Glutamate release
from PRs binds AMPA/Kainate receptors on HCs to elicit a depolarization (Lasater & Dowling,
1982; Tachibana, 1985). Whether the HC employs a neurotransmitter or utilizes hemi-channel
gap junctions to feedback onto PRs or feed forward to BCs remains unclear. The inner retina
contains ACs that form inhibitory synapses with BC axon terminals and RGC dendrites. In
mammals, there are as many as 25 types of ACs, which are classified based on their dendritic
morphology, stratification in the IPL, and the neurotransmitter they use, primarily GABA or
Glycine.
Converging vertical and lateral inputs generate receptive fields (RFs), which are
characterized

by classic center/surround organization. Center/surround organization is

fundamental to encoding contrast between images and their background and spatial activity. In
the OPL, PR input is believed to form the center response of the BC (Werblin & Dowling, 1969).
If this signal was directly transmitted to the RGCs, without information from the surround, it
would be blurry. However, the electrically coupled HCs with wide receptive fields add an
inhibitory surround component to the BC Signal. The surround response could reflect the
negative feedback pathway from HCs to PRs and/or direct inhibitory input from the HCs to BCs.
Importantly, the HC contribution is thought to depict the background intensity and help to fine
tune the BC response.
Visual processing begins with the conversion of light into an electrical signal in the PRs.
PRs consist of an outer segment filled with stacks of membranes containing a visual pigment,
opsin, an inner segment containing a connection cilium, mitochondria and endoplasmic
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reticulum, a cell body containing the nucleus and a synaptic terminal where neurotransmission
to second order neurons occurs. Humans have three types of cones, which are responsible for
color vision and operate under normal daylight levels. There is only one type of rod PRs that
functions in dim light. Cone PRs are distinguished by the type of opsin they express. L-cones are
known to be maximally sensitive to wavelengths peaking at 564 nm (red), M-cones at 533 nm
(green) and $-cones at 437 nm (blue) (Gouras, 1984). Rod PRs contain only one type of visual
pigment, called rhodopsin, with peak sensitivity at 500 nm (blue-green).
In the primate as well as some mammals, rod and cone photoreceptors are differentially
distributed across the retina. In the fovea cone PRs are concentrated at maximum density, with
exclusion of the rods (Yamada, 1969; Curcio et 01., 1987). The fovea is responsible for high acuity
central vision. In the parafoveal region, the rods break up the dense hexagonal packing of the
cones but still maintain an organized architecture with evenly spaced cones surrounded by rings
of rods. The peripheral retina is rod-dominated, with exclusion of cones.
Phototransduction begins when light stimulates a retinal chromophore, which is derived
from vitamin A and covalently bound to the transmembrane protein rhodopsin (Koutalos &
Ebrey, 1986). Rhodopsin is a G-protein coupled receptor that is linked to the heterotrimeric Gprotein, transducin. Transducin contains an a-,

~-,

and y-subunit. Upon absorption of a photon

of light, the retinal chromophore isomerizes from the ll-cis form to an all-trans form that
changes the conformation of rhodopsin to meta rhodopsin II, the active form of rhodopsin.
Metarhodopsin II exchanges GDP for GTP on transducin. The active GTP bound form of
transducin causes the Gat subunit to dissociate from the G~y subunits. The Gat subunit then
activates a cGMP-phosphodiesterase (PDE). PDE is a heterotetramer consisting for two catalytic
subunits (a~ in rod, aa in cones) and two identical regulatory y subunits (Beavo, 1995).
Activation of PDE occurs by binding of GacGTP to the PDEy subunit, which induces a structural
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change and activation of the catalytic subunit. Activated PDE then hydrolyzes cGMP to 5' -GMP,
reducing cytoplasmic levels of cGMP (Dizhoor, 2000). The decrease in cGMP results in closure of
a cGMP-gated cation (CNG) channel, preventing influx of sodium that results in PR
hyperpolarization (Haynes et 01., 1986). The hyperpolarization results in closure of an L-type
voltage-dependent calcium channels (L-VDCCs) at the PR axon terminals. As the local calcium
concentration in the axon terminals decreases, the glutamate released by the PR into the
synaptic cleft also decreases.
The VDCCs in PRS are regulated by graded changes in membrane potential, which
transmits information over a wide range of light intensities. One way this dynamic range is
achieved is by using a unique chemical synapse at the PR terminal called the synaptic ribbon
(Dowling, 1987). The ribbon is part of a specialized type of presynaptic active zone. It is
composed of electron-dense processes that extends from the site of release into the cytoplasm
of the axon terminal and is covered with hundreds of synaptic vesicles (Rao-Mirotznik et 01.,
1995; von Gersdorff, 2001). The ribbon synapse is found in the CNS at synapses where there is
continuous release of neurotransmitter. It is thought to be designed to sustain high, long-lasting
rates of neurotransmitter release that are modulated by small changes in membrane potential
(DeVries & Baylor, 1993; Rieke & Schwartz, 1996; von Gersdorff et 01., 1996; Parsons & Sterling,
2003; Heidelberger et 01., 2002). In the retina, this specialized synapse is also found in the
second order neurons, the BCs (von Gersdorff et 01., 1996).
Two types of bipolar cells, the DBC and HBC, monitor the change in synaptic glutamate
released by PRs and are named based on their response to a light increment (Nawy & Jahr,
1991; Masu et 01., 1995; Saito & Kaneko, 1983; Attwell et 01., 1987). DBCs express metabotropic
glutamate receptors, Grm6, at their dendrites (Nakajima et 01., 1993). The DBC synapse is signinverting, so light induced hyperpolarization of PRs decreases glutamate release and causes DBC
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depolarization and creates an excitatory response correlated with light onset. HBCs express
ionotropic glutamate receptors of the AMPA/Kainate family at their dendrites (Gilbertson et 01.,
1991; DeVries & Schwartz, 1999; DeVries, 2000). The HBC synapse is sign-conserving, so light
induced hyperpolarization of PRs leads to decreased glutamate release and causes HBC
hyperpolarization. At light offset, the increased glutamate concentration binds to AMPA/Kainate
receptors and depolarizes the HBCs and creates an excitatory response correlated with light
offset. The opposing DBC and HBC responses establish the ON and OFF parallel pathways,
respectively in the retina.
There are 8-12 types of cone BCs in the vertebrate retina and 6-8 are DBCs (Boycott &
Wassle, 1991; Euler & Wassle, 1995; Ghosh et 01., 2004). There is only a single morphological
type of rod DBC (Dacheux & Raviola, 1986). DBC dendrites make invaginating synapses with
cone and rod PRs (Kolb, 1970). In the dark, glutamate concentration in the OPL is high and the
ligand binding site of the Grm6 receptor is predominately occupied. This keeps a G-protein
cascade active, a non-specific cation channel closed, and the DBC hyperpolarized (Slaughter &
Miller, 1981). Recently the non-selective cation channel in the DBCs was identified as the
transient receptor potential subfamily M member 1 (TRPM1) (Bellone et 01., 2008; Shen et 01.,
2009; Morgans et 01., 2009; Koike et 01., 2009). When illumination increases, PRs hyperpolarize
decreasing glutamate release, which in turn decreases the activity of the DBC Grm6 receptor
and its G-protein cascade opening the TRPM1 channel. Influx of calcium and sodium through
TRPM1 depolarizes the DBC.
In addition to invaginating synapses, HBC also form basal junctions with cone PRs. When
glutamate binds AMPA/Kainate receptors on HBCs, they open directly to cause depolarization.
This response is transient because the AMPA/Kainate receptor rapidly moves into a
desensitized, poorly conducting state (Jonas et 01., 1993; Paternain et 01., 1998). Therefore, in
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prolonged darkness when synaptic glutamate remains high the AMPA/Kainate receptors on
HBCs are desensitized. When

light increases, synaptic glutamate decreases and the

AMPA/Kainate receptors recover from desensitization. This system enables the HBCs to signal
decrements in illumination, but respond poorly to an increase in light intensity.
The ON and OFF parallel pathways developed in the cone BCs are transmitted to ACs
and RGCs in the IPL. The synapse between BCs and RGCs in the IPL is sign conserving so the
primary signal transmitted to the RGC is determined by the type of BC providing the input
(Raviola & Raviola, 1982). The RGC response is made up of the light evoked activity from the
excitatory parallel pathways shaped by the integrative inhibitory networks. RGC responses are
sent to the brain via action potentials that propagate down axons that form the optic nerve,
optic chiasm, and optic tract.
Rod Pathways

The human visual system has the ability to detect a single quantum of light (Hecht et al.,
1942). This high level of performance is accomplished using the rod PRs, which transmit signals
to the inner retina by three known pathways (Figure 2). The primary rod pathway is used under
the dimmest light conditions and utilizes rod OBCs (Field & Rieke, 2002). In this pathway rod
OBCs do not synapse directly onto RGCs, but instead the excitatory signal is transmitted via a
narrow-field bistratified AC, the All (Kolb, 1977; Strettoi et al., 1990, 1992). All ACs form
electrical synapses with cone OBCs and inhibitory synapses with HBCs (Pourcho & Goebel, 1985).
Release of glutamate from rod BCs activates AMPA/Kainate receptors on the All ACs causing
depolarization (Oacheux & Raviola, 1986). The All AC depolarization is transferred through the
sign conserving gap junction causing the cone OBCs to depolarize. The depolarization also
causes the All AC to release glycine that inhibits HBCs (Figure 2, Sassoe-Pognetto et al., 1994,
Wassle et al., 2009). All ACs receive input from many rod OBCs that convergence before synaptic
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output to RGCs. This provides pooling and amplification of the rod signal so our visual system is
very sensitive.
The secondary rod pathway uses electrical coupling between rod and cone PRs (Deans
et 01., 2002; Zhang & Wu, 2005). The rod signal is then transmitted through the cone pathway
(Figure 2, Nelson, 1977). A single rod spherule contains between three and five gap junctions,
which originate from either M- or L-cones (Ahnelt et 01., 1990). Rod-cone coupling functions
under mesopic conditions when rod DBC signals begin to saturate, so are transmitted to the
cones via rod-cone gap junctions (Smith et 01., 1986). This pathway is faster than the primary rod
pathway (Sharpe et 01., 1989; Stockman et 01., 1995).
The tertiary rod pathway involves synaptic connections between rods and a subset of
HBCs (Figure 2, West, 1978; Hack et 01., 1999; Tsukamoto et 01., 2001). When light increases,
rods hyperpolarize causing a subset of HBCs to hyperpolarize due to decreased glutamate bound
to the AMPA/Kainate receptors. When light decreases and rods depolarize, the HBCs then
depolarize. Therefore, the synapse between a rod and the HBCs can respond to light-off in a
mammalian retina. Though the function of this pathway remains unclear, it was recently shown
to be the fastest rod pathway and respond to decreased illumination (U et 01., 2010). The
presence of mUltiple rod pathways optimize signaling under a broad range of low light
intensities and expands the range of rod mediated vision.
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Figure 2: Rod signaling in the mammalian retina travels via three routes. The primary rod pathway (pink,
rod-7DBC-7AII AC-7HBC) . During light onset rods stop releasing glutamate onto rod DBCs, which provide
an excitatory input to All amacrine cells, wh ich stimulate ON RGC through cone DBCs and inhibit OFF RGCs
through HBCs. Signaling in this pathway depends on the Grm6 signaling at the DBC. The secondary rod
pathway (blue, rod-7cone-7BC) . The electrical coupling between rods and cones sends the rod signals to
into the cones, signaling both cone DBCs and HBCs and their respective RGCs. The tertiary rod pathway
(green, rod-7HBCs) provides a direct glutamatergic input via AMPA/Kainate receptors to a subset of cone
HBCs and consequently OFF RGCs.
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Congenital Stationary Night Blindness
Congenital stationary night blindness (CSNB) is a group of genetic retinal disorders that
cause profound loss of rod-mediated function without evidence of retinal degeneration (Ripps,
1982). Individuals with CSNB can be diagnosed using an electroretinogram (ERG). The ERG is a
non-invasive, gross potential recording from the corneal surface that reflects light evoked retinal
activity. A flash ERG records the gross potential from the retina to a single flash of light. Upon a
flash of light the retina first responds with a cornea-negative ERG a-wave, reflecting the lightinduced closure of CNG channels along the PR outer segment membrane (Lamb, 1996; Robson &
Frishman, 1998; Xu et 01., 2003). This is followed by a cornea-positive ERG b-wave, reflecting the
subsequent depolarization of the BCs (Robson & Frishman, 1998; Sharma et 01., 2005). The flash
ERG can be used to discriminate the two major forms of CSNB; Schubert-Bornschein and Riggs.
Schubert and Bornschein (1952) described the ERG phenotype of one form of CSNB in which
there was a normal ERG a-wave, while the ERG b-wave amplitude was greatly decreased. The
normal amplitude and kinetics of the ERG a-wave with abnormal ERG b-wave suggests that
while the PR response is normal there is a failure of synaptic transmission to the DBCs. The
second type of CSNB was described by Riggs (1954) in which both the ERG a-wave and b-wave
amplitudes were drastically reduced suggesting abnormalities in the PR signal transduction
cascade.
X-linked, autosomal recessive and dominant pedigrees of Schubert-Bornschein CSNB
have been identified (Carr et 01., 1966; Miyake et 01., 1986; Kabanarou et 01., 2004; Abramowicz
et 01.,2005). The X-linked form of the Schubert-Bornschein type CSNB has been divided into two
separate types, complete and incomplete (Miyake et 01., 1986). The complete form of CSNB is
characterized by no recordable ERG b-wave, while patients with incomplete CSNB have a
recordable ERG b-wave although it is subnormal in amplitude. The complete and incomplete
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forms are now referred to as CSNBl and CSNB2, respectively. Molecular cloning has identified
the underlying genes in both X-linked CSNBl and CSNB2. CSNBl is caused by mutations in the
NYX gene encoding the novel protein nyctalopin (Bech-Hansen et 01., 2000; Pusch et 01., 2000).
In humans, more than 30 mutations have been mapped in the NYX gene (Bech-Hansen et 01.,
2000; Pusch et 01., 2000; Jacobi et 01., 2002; Zeitz et 01., 2005b). CSNB2 is caused by mutations in
the CACNA1F gene, encoding an al subunit of voltage-dependent Cal.4 channel {L-VDCq (BechHansen et 01., 1998; Strom et 01., 1998). More than 40 mutations have been identified in
CACNA1F pedigrees (Bech-Hansen et 01., 1998; Strom et 01., 1998; Wutz et 01., 2002; Jacobi et
01.,2003; Zeitz et 01., 2005b).
Autosomal recessive Schubert-Bornschein CSNB (arCSNB) have also been classified into
the complete (arCSNB1) and incomplete (arCSNB2) forms depending on the severity of the ERG
b-wave reduction. Patients with arCSNBl have no recordable ERG b-wave, where as individuals
with arCSNB2 have a very small ERG b-wave. arCSNBl is caused by mutations in the GRM6 gene
encoding the metabotropic glutamate receptor 6 (Grm6) (Dryja et 01., 2005; Zeitz et 01., 2005a)
and in the TRPMl gene encoding the transient receptor potential channel subfamily Ml
(TRPM1) (Li et 01., 2009; van Genderen et 01., 2009; Audo et 01., 2009; Nakamura et 01., 2010).
Both genes are integral members of the DBC transduction cascade. Individuals with arCSNB2
have mutations in the CABP4 gene encoding the calcium binding protein 4. CABP4 is localized in
the PR synaptic terminals and modulates calcium influx through the L-VDCC (Zeitz et 01.,2006).
As the mutations underlying the CSNBl and CSNB2 were identified, it became clear that
where the genes are located within the PR-BC synapse is important in understanding the
phenotype. CSNBl involves mutations in genes expressed

post~synaptically,

in the DBCs

dendrites that are essential to the transduction cascade. CSNB2 is caused by mutations in genes
expressed pre-synaptically, in the PR terminals that control glutamate release.
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Autosomal dominant mutations of CSNB (adCSNB) in human patients have a no ERG awave phenotype. Mutations have been identified in the RHO gene encoding rhodopsin, the

GNAT gene

encoding

rod

transducin,

and

the

PDE68

gene

encoding

rod

cGMP

phosphodiesterase beta-subunit (Dryja et 01., 1993; Rao et 01., 1994; Gal et 01., 1994; Dryja et 01.,
1996; al Jandal et 01., 1999; Zeitz et 01., 2008). Many mutations in RHO lead to retinitis
pigmentosa (RP), which initially resembles CSNB but gradually leads to death of rods in the
periphery of the retina. However, four mutations in the RHO gene cause non-progressive
adCSNB. These mutations are believed to cause constitutive activation of rhodopsin and its
downstream target, transducin, which causes a loss of the ERG a-wave and consequently a loss
of the b-wave (Dryja et 01., 1993; Rao et 01., 1994; al Jandal et 01., 1999; Zeitz et 01.,2008).
CSNBl individuals with mutations in the different genes expressed in the DBCs can be
further distinguished using a is-Hz flicker ERG, which discriminate the slow and fast rod
pathways. At low scotopic luminance levels, the is-Hz flicker is dominated by the slow, sensitive
rod pathway (rod ~ rod DBC ~ All AC) and at high scotopic levels by the faster (rod ~ cone ~
HBC) pathway. These rod pathways are separated by a delay of approximately 33ms, or half of
the is-Hz period. When they are used equally by the retina, at about -0.56 log scot td·s, there is
destructive interference between the two signals causing a null ERG (Sharpe et 01., 1989; Sharpe
et 01., 1993). The is-Hz flicker ERG in normal individuals starts with a measurable amplitude at
low light. The ERG amplitude decreases as luminance increases, reaches a null at about -0.56 log
scot td·s, before increasing in amplitude at higher luminances (Figure 3A).
Patients with X-linked CSNBl have no slow rod signals and the faster rod signals have
reduced amplitudes, which is consistent with an altered ON pathway (Scholl et 01., 2001; Figure
3C). The is-Hz ERG amplitude is reduced at light levels below -0.56 log scot td·s, but is normal at
light levels above -0.56 log scot td·s. This 15-Hz phenotype was also identified in arCSNB
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patients with TRPMl mutations (Figure 3D, van Genderen

et 01.,

2009) . In contrast, arCSNB

patients with mutations in GRM6 have a complicated profile with normal responses at low and

et 01.,

high scotopic levels and very large responses in between these light levels (Figure 3B, Zeitz
200Sa; van Genderen

et 01., 2009). This

distinctive GRM6 ERG phenotype is suggested to be due

to the interaction between the secondary and the tertiary rod pathway (rod

7

OFF-HBCs). The

is-Hz flicker ERG can be used to distinguish patients with mutations in GRM6 from Nyx or

TRPMl (Zeitz et 01., 200Sa; van Genderen et 01., 2009).
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Figure 3: 15 Hz flicker ERG responses from representative (A) normal healthy subjects and probands
with (B) GRM6, (e) NYX and (D) TRPMl mutations. ERG responses are from the right eye (Grey) and
the left eye (Black). Scotopic 15Hz flicker ERG responses to a series of 11 stimuli of increasing
intensities starting at -1.72 log scot td ·s (top trace) to 0.44 log scot td ·s (bottom trace) . Between -1.72
and -0.56 log scot td ·s rod signals in the normal retina uses the primary (rod -7 ON bipolar -7 All
amacrine cell) pathway. At mesopic levels (-0.56 log scot td ·s and up) the secondary (rod -7cone -7
bipolar) pathway is used . At approximately -0.56 log scot td ·s, the signals transferred through the
primary and secondary pathways are equal in amplitude, but lag one another by half a phase, causing
destructive interference and a null response, see normal subject (A). In probands with NYX (e) or
TRPMl (D) mutations, ERG responses from the primary rod pathway are not present, where as
responses from the secondary rod pathway are within normal limits, causing reduced amplitudes. In
the proband with GRM6 mutation (B), ERG responses could be measured at all intensities, but the
responses had abnormal phase behavior. Modified from van Genderen et 01., 2009 .
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Mouse Models of CSNB

In the past decade, several mouse models for CSNB have been identified or generated
and these mutations provide both functional and molecular comparisons to the human disease.
Mouse-based studies have provided insights into the underlying mechanism of the CSNB group
of retinal disorders and are generally classified into two main groups: pre-synaptic mutations
(CSNB2) and post-synaptic mutations (CSNB1).
CSNB2 Mouse Models

Mouse models of CSNB2, like the human counterparts, have mutations in genes
expressed on PR terminals. These mutations disrupt glutamate release to the second order
neurons. Glutamate from PR terminals is initiated by calcium influx through L-VDCC. Cone PRs
express L-VDCCs that are comprised of alF and aiD subunits, while rod PRs contain L-VDCCs
with only the alF subunit (Morgans et 01.,2001; Morgans et 01.,2005).
To study the contribution of the L-VDCC alF subunit to PR signal transmission a
CACNA1F knockout mouse, CACNAlpmlTbh, was generated (Mansergh et 01., 2005). In addition, a
spontaneous mouse mutant was identified, CACNA1F"°b2 (Chang et 01.,2006). Retina morphology
in the two CACNA1F mutant mice is very similar. The synapses between PRs and BCs in both
mutants are disrupted, resulting in an abnormally thin OPL. In addition, dendrites of both the
DBCs and HCs extend into and across the ONL (Mansergh et 01., 2005; Chang et 01., 2006).
Functionally, both CACNA1F mutant mice display a normal ERG a-wave with significantly
reduced ERG b-wave at both light and dark adapted conditions (Mansergh et 01., 2005; Chang et
01.,2006). However, though the ERG phenotype is similar, the underlying visual responses were

drastically different. The CACNAlpmlTbh mouse has no visually evoked responses in the superior
colliculus, implying absence of activity through RGCs (Mansergh et 01., 2005). The RGCs in
CACNA1F"°b2 mice, however, retain near normal RF organization and sensitivity to light under
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photopic conditions and have relatively normal visual performance, as measured by the
optokinetic response, when compared to wildtype (Chang et 01.,2006; Doering et 01.,2008).
The conflicting phenotypes between the two CACNA1F mutant mice led to further
analysis of their gene expression by Doering and colleagues (2008). The CACNA1F"°b2 mice
contain a transposable element (Mus musculus transposon ETn) inserted in exon 2 of the
CACNA1F gene. Analysis of the CACNA1F mRNA identified alternative splicing in which the ETn

element was removed in approximately 10% of the transcripts (Doering et 01., 2008). This
alternately spliced transcript produces a functional L-VDCC protein that differs from wild type LVDCC protein by 22 amino acids at the N-terminal (Doering et 01., 2008). The altered N-terminus
in CACNA1F"°b2 cannot interact with filamin (Doering et 01., 2008). Filamin is a protein that binds
the actin cytoskeleton and participates in anchoring membrane proteins, such as L-VDCCs. This
suggests that the mutant L-VDCC in CACNA1F"°b2 mice might not be properly anchored in the PR
terminals. The additional residues at the N-terminus in the CACNA1F"°b2 mice did not alter the
function of the L-VDCC, which could explain the relatively normal visual responses measured in
CACNA1F"°b2 mice.

Mice with the targeted deletion of the a1D subunit, which is shown to be expressed in
cone PRs, have a normal ERG phenotype (Wu et 01.,2007). In addition, a CACNAl F"ob2/ CACNA 1 0/- double knockout had a similar dark adapted ERG as the CACNA1F"°b2 mouse (McCall et 01.,
2008). This suggests that though the cone terminals express both the alF and a1D subunits of LVDCC the a1D subunit is not a major contributor to the ERG b-wave. What the a1D subunit of
the L-VDCC is dOing in the cone PR terminals remains to be determined.
Mutations in five other genes involved in release of neurotransmitter from PRs have
been reported to cause decreased ERG b-waves. These pre-synaptic mutations disrupt calcium
signaling and prevent neurotransmitter release, which is consistent with the reduced b-wave
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phenotypes. Mutations in two auxiliary subunits to the L-VDCC,

~2

and a204, result in abnormal

or absent ribbon synapses in rod PRs and thinning of the OPL (Ball et 01., 2002; Ruether et 01.,
2000; Wycisk et 01., 2006a). Mutations in bassoon, a component of the ribbon synapse (Dick et

01., 2003), CABP4, which encodes calcium binding protein 4 (Haeseleer et 01., 2004) and
dystrophin, a component of the extracellular matrix (Pillers et 01., 1999), all have reduced ERG bwaves and abnormal BC and HC dendritic morphology.
The functional and morphological abnormalities in the CSNB2 mutants all produce
alterations in calcium entry or glutamate release. In addition, these mutants have disrupted OPL
architecture, which indicates the underlying genes may be involved in synapse formation
between PR and BCs. Calcium influx can activate intracellular pathways directly at the synapse
or mediate changes in nuclear gene transcription (Rosen et 01., 1994; Ghosh & Greenberg, 1995;
Curtis & Finkbeiner, 1999). These intracellular processes have the potential to alter cell surface
molecules that may be critical to normal synapse formation. In vitro studies have described links
between L-VDCCs and PR development. Blocking the influx of ions through the VDCCs inhibited
axon outgrowth, varicosity formation and vesicle protein synthesis in developing rods (Zhang &
Townes-Anderson, 2002; Nachman-Clewner et 01., 1999). These results suggest that the
presence or activity of L-VDCCs is required for normal development and synapse formation in
the outer retina. Defects in calcium entry may explain the altered synaptic architecture of the
OPL in pre-synaptic mutant mice. However, glutamate release may also be a key component
guiding BC and HC neurites to synapse with PR terminals. Glutamate has been shown to playa
role in synaptic motility (Engert & Bonhoeffer, 1999; Maletic-Savatic et 01., 1999; Wong et 01.,
2000; Wong & Wong, 2001). In the IPL, glutamate release from BCs regulates the formation of
synapses between BCs and RGCs (Kerschensteiner et 01., 2009). Though the mechanism remains
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unknown, pre-synaptic signals either regulate synaptogenesis or help maintain synaptic
structures.

CSNBl Mouse Models
Mutations in seven genes expressed by the DBCs have helped identify proteins critical to
DBC signal transduction. In some cases, mice were identified by their ERG no b-wave phenotype
and positional cloning subsequently identified mutations in the underlying genes (Nyx"°b, Pardue

et 01., 2003; Grm6

nob3

, Maddox et 01., 2008; Grm6nob4 , Pinto et 01., 2007). Other mice were

produced by gene targeting of genes known to be expressed in BCs (Grm6tmlNa\ Masu et 01.,

1995; Gnaol tmlLib , Dhingra et 01.,2000; GnbS tmCk, Rao et 01., 2007; TRPMl"I.; Koike et aI., 2009) or
identified in knockout mice generated by Lexicon Genetics (TRPMltmlLex, Shen et 01., 2009).
There are three alleles that disrupt the Grm6 gene; Grm6TmlNak (Masu et 01., 1995); Grm6nob3

nob4 (Pinto et 01., 2007), two alleles that disrupt G-proteins in the
(Maddox et 01., 2008); Grm6
Grm6 cascade, Gaa and G135 (GnaoltmlLbi and GnbS tmck ) (Dhingra et 01., 2000; Dhingra et 01.,
2002; Rao et 01., 2007), one allele that disrupts nyctalopin, Nyx"ob (Pardue et 01., 1998, Gregg et

01., 2003) and two alleles that disrupt the TRPMl gene, TRPM1TmLex and TRPMl"I- (Shen et 01.,
2009; Koike et 01., 2009). With the exception of GnbS

tmCk mice whose OPL thickness is abnormal,

the gross morphology of the retina in these mutants is normal (Tagawa et 01., 1999; Pinto et 01.,
2007; Dhingra et 01., 2000; Pardue et 01., 1998; Morgans et 01., 2009). The decrease in OPL
thickness could be explained by the existence of two GnbS retinal splice variants. A short form
of GnbS (GnbS-S) is expressed in the BCs and a long form of GnbS (GnbS-L) is expressed in PRs.
Thus, the pre-synaptic mutation of the GnbS-L isoform would be consistent with other presynaptic mutations with altered OPL morphology. To determine the postsynaptic contribution of

GnbS-S alone a GnbS-L transgene was introduced into the rods of GnbS tmCk mice (Rao et 01.,
2007). Transgenic expression of GnbS-L failed to rescue the b-wave or the OPL defects
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suggesting Gnb5-S is involved in OPL synaptic development (Rao et 01., 2007). The synaptic
connections between PRs and BCs are formed between Pl0 to P14 (Takada et 01., 2004). Gnb5-S
is present during this critical period, so could be playing a developmental role (Rao et 01.,2007).
Immunohistochemical and electron microscopic studies of Nyx"°b and GnaoltmlLbi mice
show that the OPL architecture is normal (Pardue et 01., 2001; Dhingra et 01., 2000). However,
electron microscopic studies of Grm6TmlNak mice found a subset of DBC that contained ectopic
ribbon synapses in their dendrites (Ishii et 01., 2009). In Grm6-deficient mice the ectopic
dendritic ribbons might be due to alteration in DBC activity that increases intracellular trafficking
of synaptic proteins resulting in an overload and mislocalization of synaptic proteins (Ishii et 01.,
2009).
The functional impact of the deficits in DBC signaling on RGC function has been reported
for several CSNBl mutants. RGC responses of Nyx"ob and Grm6 mutant mice are the best
characterized and indicate that mutations in the same cascade can produce drastically different
outcomes on downstream cellular function. In Grm6 mutants the number of ON-responsive
RGCs is reduced, while the OFF-center RGCs are relatively normal compared to wildtype mice.
When an ON RGC response was elicited the response was delayed and the firing rate reduced
compared to wildtype (Pinto et 01., 2007; Renteria et 01., 2006; Maddox et 01., 2008). These
delayed ON responses are initiated by the OFF pathway (Renteria et 01,. 2006). Taken together
these results indicate that the absence of signaling through the Grm6 receptor results in an
abnormal ON pathway. Interestingly, Nyx"°b mice lack RF organization in both ON and OFF RGCs
(Demas et 01.,2006, Gregg et 01.,2007; Heflin et 01.,2010). This suggests that the Grm6 mutation
is restricted to the ON pathway, where as the lack of nyctalopin expression causes global RGC
abnormalities. This variation may result from differences in the state of the TRPMl channel,
which will affect the DBC resting state and subsequent downstream visual processing. Patch
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clamp recordings from DBCs in Nyx"°b mice lack holding currents compared to an average inward
holding current of 40pA in wildtype DBCs (Gregg et 01., 2007). Further, variance analysis and
determination of open probability suggests that the TRPM1 channel is absent or closed in Nyx"ob
DBCs (Gregg et 01., 2007). Supporting this conclusion are studies of RGC response properties
from TRPMltmlLex mice, which exhibit a RGC phenotype similar to Nyx"°b mice (Heflin et 01.,
2010). While the status of the TRPM1 channel in the Grm6 mutants is unknown, the difference
in RGC phenotypes in Nyx"°b and TRPMltmlLex verse Grm6 mutants suggests the state of the DBCs
is different.

Grm6 Cascade in Depolarizing Bipolar Cell
Synaptic transmission from PRs to BCs initiates the ON and OFF signaling pathways in
the retina. This divergence is due to the receptor composition expressed on the dendrites of
BCs. The OFF pathway is mediated through the HBCs ionotropic AMPA/Kainate glutamate
receptors, while the ON pathway is mediated through the DBCs metabotropic glutamate
receptor, Grm6 (Nawy & Jahr, 1990; Shiells & Falk, 1990; Nakajima et 01., 1993; Nomura et 01.,
1994; Vardi et a11998, 2000, 2002).
Grm6 is coupled to the heterotrimeric G-proteins Gao, G~5 and Gy, which were
originally identified in the cascade by physiology and gene expression profiling of DBCs (Nawy,
1999; Dhingra et 01., 2000, 2002; Watson et 01., 1996, Nakajima et 01., 2009). The TRPM1
channel is the transduction channel in the DBCs and when signaled to open, de polarizes the
DBC. The G-protein second messengers are believed to act directly or indirectly to regulate the
TRPM1 channel (Snellman et 01., 2008). Although aspects of the transduction cascade remain
elusive, significant progress has been made in characterizing many of the modulatory proteins.
A schematic representation of the DBC G-protein cascade is depicted in Figure 4. The
DBC cascade is broken down into four key steps required for the cell's normal response to
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increases or decreases in glutamate. First, glutamate released into the synaptic cleft binds to
Grm6 transforming it from an inactive to an active state (Nawy & Jahr, 1990; Nakajima et al.,
1993). This initiates signal transduction by exchanging a GOP for a GTP on Gao. Activated GaoGTP is released from the

G~V

complex. GTP exchange is believed to be critical to initiate the

second stage in OBC signaling cascade, closure of the TRPM1 channel. It is unknown whether
Gao and/or G~V directly act to close the TRPM1 channel or whether they act through another
pathway (Snellman et al., 2008). When luminance increases, glutamate decreases and Grm6
inactivates. Inactive Grm6 stops the exchange of GOP for GTP on Gao and the intrinsic GTPase
activity of Gao hydrolyzes GTP to GOP. Inactivation of the Grm6 cascade leads to opening of the
TRPM1 and the OBC depolarizes. The molecular mechanism regulating this process remains
enigmatic. The cascade is initiated again when the luminance decreases and initiates the Grm6
cascade to close TRPM1 and hyperpolarize the OBC until the next light-evoked response. Each
step of the OBC transduction cascade and the proteins regulating the kinetics of the response
are discussed in more detail below.
Grm6 is a G-protein coupled receptor (GPCRs) that is predicted to have seven
transmembrane spanning a-helices (Filipek et al., 2003) and a large extracellular ligand binding
domain that binds glutamate (O'Hara et al., 1993; Kunishima et al., 2000). The glutamate signal
is transmitted across the membrane to a heterotrimeric G protein coupled on the cytoplasmic
surface. The activation and inactivation of Grm6 has been modeled after the crystal structure of
rhodopsin (Palczewski et al., 2000; Park et al., 2008). The transmembrane domains of GPCRs are
held in the basal state by non-covalent interactions between their side chains (Schone berg et

al., 1995; Kobilka et al., 1998). Upon agonist binding intramolecular interactions are altered to
favor an active conformation (Balmforth et al., 1997; Groblewski et al., 1997). Agonist binding is
a complex process involving kinetically distinct stages resulting in activation, exchange of GOP
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for GTP on Gao, and release of the heterotrimeric G-protein (Swaminath et 01., 2004, 2005;
Liapakis et 01., 2004, Yao et 01., 2006; Weis & Kobilka, 2008).
Glutamate binding activates Grm6, which propagates the signal by exchanging GOP for
GTP on Gao. The GTP exchange is facilitated by a retina variant of Purkinje cell protein-2 (RetPCP2), which was identified as a guanine exchange factor (GEF) in OBCs (Xu et 01., 2008). RetPCP2 contains a Goloco motif that interacts with Gao and accelerates the exchange of GTP for
GOP (luo & Oenker, 1999; Zhang et 01., 2002; Xu et 01., 2008). Interestingly, Ret-PCP2 facilitates
TRPM1 closure in OBCs not by directly acting on the channel, but by altering the G-protein
kinetics.
The termination phase of the Grm6 cascade is also assisted by a regulator of G-protein
signaling (RGS) protein. Though Gao has intrinsic GTPase activity, its hydrolysis is facilitated by a
RGS protein. RGSll and RGS7, members of the R7 family of RGCs proteins, are expressed in
OBCs (Song et 01., 2007; Morgans et 01., 2007; Rao et 01., 2007; Mojumder et 01., 2009) and
accelerate GTP hydrolysis of Gao (Hooks & Harben, 2004). Recently, RGS7 and RGSll knockout
mice were shown to have a delayed ERG b-wave, which reflect slower inactivation of the Gproteins and subsequent opening of TRPM1 in OBCs (Mojumder et 01., 2009; Chen et 01., 2009;
Zhang et 01., 2010). Interestingly, in RGS7/RGSll double knockout mice the b-wave delay was
even greater suggesting a parallel involvement for RGS7 and RGSll in regulating the shut off
phase of the OBC response (Mojumder et 01., 2009; Chen et 01., 2009; Zhang et 01., 2010). The
time course of the ERG b-wave in RGS7/RGSll knockout mice is still faster than intrinsic GTP
turnover on Gao, so it is likely that another protein is serving as the RGS for Gao (Bourne &
Stryer, 1992; Mojumder et 01., 2009; Chen et 01., 2009; Zhang et 01., 2010).
Termination of the G-protein signaling cascade results in the depolarization of the OBC.
In 2009, Shen et 01 identified TRPM1 as the transduction channel responsible for the
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depolarizing light response in DBCs. Identifying the TRPMl channel as the nonselective cation
channel signified a major breakthrough. The key question remaining is how TRPMl is gated by
the DBC signaling cascade .

Dark

Light

Dark

Glutamate Relea se

DBC Voltage Response

Figure 4: Schematic representation of the Grm6 signaling cascade in depolarizing bipolar cells (DSC) .
The top trace represents glutamate release over time, and the bottom t race represents voltage
response of the DSC. Step 1: In darkness, continuous release of glutamate from PRs activates Grm6
receptors located at the dendritic tips of the DSC. Step 2: Activation of Grm6 leads to an exchange of
GDP with GTP on Gao, which is facilitated by a GEF, and dissociation of G~y from Ga-GTP. As a result,
Ga-GTP and G~y are in their active forms, either of which could lead to closure of TRPM1 and
membrane hyperpolarization. Step 3: When light intensity increases, glutamate release decreases, and
GAP activity of Gao hydrolyzes Ga-GTP to Ga-GDP. This hydrolysis in DBCs is likely facilitated by an
RGS protein. Step 4: Ga-GDP rebinds G~y forming the inactive heterotrimer. Thus, TRPM1 channels
are opened and calcium influx depolarizes the membrane. Step 1: When the luminance decreases,
glutamate release increases again and Grm6 is activated, re initiating the cascade. Protein structures
were adapted from Cheever et 01., 2008; Maruyama et 01., 2007; Muto et 01., 2007.
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Nyctalopin

Biochemical and genetic approaches have identified many regulatory proteins of the
Grm6 signaling cascade. One such protein, nyctalopin, was identified by positional cloning of the
gene responsible for X-linked CSNB1 in humans and mice (Candille et 01., 1999; Gregg et 01.,
2003; Bech-Hansen et 01., 2000; Pusch et 01., 2000). Nyctalopin is a member of the leucine rich
repeat protein (LRR) superfamily (Bech-Hansen et 01., 2000; Pusch et 01., 2000). These proteins
contain a repeated 11-amino acid motif LxxLxLxxNxL (x being any amino acid) that is considered
an excellent motif for protein-protein interactions. The first crystal structure of a LRR protein,
porcine ribonuclease inhibitor (RNI), helped define the prototypic LRR fold that is characterized
by a right-handed solenoid-like morphology (Kobe & Deisenhofer 1993). Each LRR contributes
one ~-strand to the parallel ~-sheet on the inner face of the solenoid. A molecular structure of
nyctalopin using the Modbase Modeller System is depicted in Figure SA. Nyctalopin contains a
core 11 leucine-rich repeat region that is flanked by cysteine rich "cap" regions suggesting it is a
member of the small leucine-rich repeat proteoglycans (SLRP) (Bech-Hansen et 01., 2000; Pusch

et 01., 2000; Gregg et 01., 2003). However, nyctalopin has distinct N-and C-terminal cap motifs.
The N-terminal cap contains extra cysteine residues, which are predicted to form an additional
disulfide bond. The C-terminal capping motif is not the prototypical ear-repeat as seen in other
SLRP proteins, but contains two disulfide bonds that adopt a similar structure as the broader
class of LRR proteins. These unique structures have caused speculation that nyctalopin does not
belong in the SLRP family (Bella et 01., 2006). Another unique feature downstream of the LRR
domain is an evolutionarily conserved region with unknown function. In addition, nyctalopin is
predicted to be attached to the membrane with the N-terminus extending into the extracellular
matrix (Morgans et 01., 2005; Zeitz et 01., 2005; O'Conner et 01., 2005). In humans, nyctalopin is
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attached to the membrane by a GPI anchor, while the mouse protein is predicted to have a
single transmembrane domain (Gregg et 01.,2003; O'Conner et 01.,2005).
The function of nyctalopin in the retina remains enigmatic. In Nyx"ob mice, absence of
the b-wave in the ERG places the functional deficits in transmission of signals between PRs and
DBCs (Pardue et 01., 1998). Patch clamp recordings from Nyx"ob mice show DBCs do not respond
to glutamate suggesting nyctalopin is involved in generating the DBC response (Gregg et 01.,
2007). However, conflicting reports have shown nyctalopin expression in the murine retina at
the GCl, DBC and INl, which has caused some debate as to the potential function of nyctalopin
(Pesch et 01., 2003; Gregg et 01., 2003; Morgans et 01., 2003). To address this question, Gregg et
al (2007) generated a transgenic mouse that expressed an YFP-nyctalopin fusion protein.
Immunohistochemistry for the YFP-nyctalopin fusion protein showed robust expression on the
dendrites of DBCs in the OPl (Figure 5B). localization with Grm6 and not Ribeye suggests
nyctalopin is postsynaptic (Figure 5B). Most importantly, crossing the TgYFPNYX mouse line with
the Nyx"°b mice rescued the no b-wave ERG phenotype of the Nyx"°b mice (Figure 5C). Therefore,
nyctalopin expression only on DBC dendrites is required for normal function of murine DBCs.
However, the mechanism of action of nyctalopin remains to be determined.
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Figure 5: Nyctalopin structure, function and expression in the retina. A. Molecular structure of

nyctalopin using the Modbase Modeller System. Nyctalopin is predicted to have a curved structure
with l3-sheets (arrows) line the concave side, with helices on the convex side. B. YFP-nyctalopin is
localized to the postsynaptic membrane of bipolar dendrites. Staining of TgYFPNyx retinal sections for
YFP-nyctalopin (green) and Grm6 (red) or ribeye (red) . The merged images show that YFP-nyctalopin is
only co-localized with Grm6, but is closely aligned with the presynaptic ribbon maker, ribeye. Scale bar
nob
is S~m. C. Transgenic expression of YFP-nyctalopin to BCs restores the ERG b-wave in Nyx
mice.
nob
Representative dark-adapted ERGs from control (black traces), Nyx
(blue traces) and TgYFPNYX
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TRPMl in Depolarizing Bipolar Cells
Significant progress had been made in characterizing the properties of the nonselective
cation channel in the DBCs. Measurements of the current-voltage relation associated with lightevoked responses showed that glutamate closed a DBC channel with a reversal potential near
OmV and had an inwardly rectifying current (Shiells et 01., 1981; Nawy & Copenhagen, 1987;
Nawy & Jahr, 1990). Furthermore, addition of intracellular GTP into DBCs demonstrated that the
DBC channel response was mediated by a G protein-coupled mechanism (Nawy & Jahr, 1990).
Key features of the DBC channel are that it is calcium permeable and the influx of calcium
triggers a negative-feedback pathway that desensitizes the channel (Sheills & Falk, 2000; Nawy
et 01., 2000). The calcium-triggered negative-feedback pathway is activated during PR

adaptation to steady illumination when synaptic glutamate levels fall and the number of open
DBC channels increases. Calcium entry through the channel closes the DBC channel, which
restores the membrane potential and input resistance of DBCs (Shiells & Falk, 1994; Nawy et 01.,
2000). This regulation by calcium provides the DBCs with the ability to adapt to changes in
ambient light. Though the DBC channel was shown to be potentiated by GTP and depressed by
calcium, the channel identity remained elusive until recently.
In 2008, Kim et al screened for retina DBC genes using microarray analysis from a single
DBC and identified TRPM1 channel mRNA. In situ hybridization, showed TRPMl mRNA was
expressed in BCs and its developmental expression pattern correlated with other BC specific
genes (Kim et 01., 2008). The first report that the TRPM1 channel may be involved in regulating
PR to DBC responses came from studies of night blind appaloosa horses. Appaloosa horses carry
the leopard complex (LP) gene, which is responsible for distinct coat color patterns (Sandmeyer
et 01., 2007). Horses homozygous for the LP gene have an ERG consistent with CSNB1

(Sandmeyer et 01., 2007). Mapping LP localized the gene to a 6 cM region on equine
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chromosome 1 (ECA1), which contains the TRPMl gene (Terry et 01., 2004). Quantitative RT-PCR
analysis of mRNA from the retina of appaloosa horses homozygous for LP had an 1800 fold
decrease in TRPM1 expression compared to controls (Bellone et 01., 2008). This suggested that
TRPM1 is involved in DBC signal transduction. The requirement for TRPM1 in generating the bwave of the ERG was confirmed in TRPM1 knockout mice (Shen et 01., 2009). Further studies in
mice and non-human primates localized TRPM1 expression to the DBCs (Morgans et 01., 2009;
Koike et 01., 2009; van Genderen et 01., 2009). Patch clamp recordings showed the absence of
normal light responses in DBCs from TRPMr/ - further suggesting TRPM1 is the DBC cation
channel (Koike et 01., 2009). When expressed in a heterologous system along with Grm6 and
Gao, TRPM1 activity could be negatively regulated by glutamate (Koike et 01.,2009). Collectively,
these studies demonstrate that TRPM1 is a required component of the nonselective cation
channel critical for DBC function.
The TRPM1 channel is a member of a large family known as transient receptor potential
(TRP) channels, which have diverse roles including sensory cell function, thermosensation and
cellular redox. There are 7 related families of TRP channels (TRPM, TRPV, TRPC, TRPML, TRPA,
TRPN and TRPP) all of which contain a conserved TRP domain. They contain six transmembrane
domains and can function as homo- or hetero-tetramers (see review by Venkatachalam &
Montell, 2007). TRPM1 was the initial member of the melastatin TRP family and was identified
in a differential display screen analyzing mRNA in malignant verse benign melanocytes (Duncan
et 01., 1998; Hunter et 01., 1998). TRPM1 mRNA is absent in malignant melanoma cells, so has
become a prognostic marker for patients with localized melanoma (Duncan et 01., 2001). TRPM1
mRNA is present in all stages of embryonal development and is restricted to the skin, brain, ear
and eye in adults (Duncan et 01., 1998; Takumida et 01., 2008; Harteneck et 01., 2005). Primary
human neonatal epidermal melanocytes have a splice variant for TRPM1, which contains only
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the first SOOaa. The short variant does not form an ion channel, but is reported to interact
directly with and suppress calcium entry though full-length TRPM1 (Xu et 01., 2001). In addition,
four N-terminal splice variants of TRPM1 were identified in human melanocytes, brain, and
retina (Oancea et 01., 2009). The TRPM1 variants were named based on the number of amino
acids found at the N-terminal that were different from full length TRPM1, which are 17-TRPM1,
70+TRPM1, 92+TRPM1 and 109+TRPMl. All of the variants are predicted to be ion-channel
forming isoforms and two (92+ TRPM1 and 109+TRPM1) generated ionic currents similar to
endogenous TRPM1 when expressed in human melanoma cells. Interestingly, the five splice
variants are differentially expressed in primary and transformed melanocytes, suggesting they
may have separate biological functions (Oancea et 01.,2009).
The physiology of the TRPM1 channel has been described in melanoma cells, DBCs and
heterologous systems. Endogenous TRPM1 currents recorded from mouse melanoma cells
display an inward rectifying current with a reversal potential of OmV (Oancea et 01., 2009), which
is consistent with the DBC cation channel currents (Shen et 01., 2009). In HEK293T cells, fulllength TRPM1 mediates calcium entry that can be blocked by lanthanum (Xu et 01., 2001).
Though TRPM1 was localized to the plasma membrane it is predominantly intracellularly
localized when expressed in HEK293T cell lines (Xu et 01., 2001; Oancea et 01., 2009).
Additionally, TRPM1 currents in melanoma cells are small, which raises the possibility that their
primary function in these cells is intracellular or restricted to specific regions of the plasma
membrane. Intracellular vesicles containing TRPM1 could be stimulated to insert more TRPM1
into the plasma membrane in response to particular signals, as shown for TRPM7 and TRPCS ion
channels (Oancea et 01.,2006; Bezzerides et 01.,2004). Aspects of TRPM1 ion channel trafficking,
properties and cellular function remain to be explored.
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Protein Trafficking
Cells communicate with their surroundings through integral membrane proteins.
Expression of membrane proteins on distinct cellular regions is important for cellular function.
This is especially evident in neurons, which require very different compositions of membrane
receptors and/or channels on their dendrites and axons.
Eukaryotes process membrane proteins through the ER and Golgi apparatus before
vesicular translocation to the membrane. Translational targeting of membrane proteins to the
eukaryotic endoplasmic reticulum (ER) is mediated by a ribonucleoprotein complex, the signal
recognition particle (SRP), and its membrane-associated receptor, the translocon. Secretory or
membrane proteins contain a signal sequence, which is recognized by the SRP and used to
target the protein to the ER. A typical signal sequence consists of a 9-12 hydrophobic residues
at the N-terminus of the protein (Valent et 01., 1995; Lee & Bernstein, 2001; Adams et 01., 2002).
Proteins that lack a signal sequence can also be transported into the ER by the SRP. They contain
a polypeptide with the critical level of hydrophobicity that is flanked by basic residues (Lee et 01.,

2002; Peterson et 01., 2003). For integral membrane proteins anyone of their transmembrane
domains can serve this function.
SRP-mediated translocation begins as the nascent polypeptide exits the ribosome and
the signal sequence is recognized by and binds the SRP, halting translational elongation. The SRP
bound to ribosome and nascent polypeptide is transported to the ER membrane. Once at the
membrane the SRP forms a complex with the translocon. Following docking with the translocon,
the signal sequence is released from the SRP and inserted through the aqueous pore of the
translocon into the lumen of the ER. The signal sequence is either cleaved or can remain as a
transmembrane region of the protein. After docking of the ribosome onto the translocon, the
SRP is released from the translocon in a GTP-dependent manner and free SRP is recycled for
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subsequent rounds of protein targeting (Bourne, 1986; Freymann et al., 1999). When elongation
of the peptide resumes, the newly synthesized protein is inserted through the translocon into
the lumen of the ER. If a protein contains a highly hydrophobic region, such as an internal
transmembrane domain, translational elongation is halted. The hydrophobic transmembrane
domain is transferred into the lipid bilayer by a lateral gating mechanism in the translocon
where it remains as a single a-helical membrane spanning segment. Once inserted into the ER
membrane, translational elongation resumes. This stop and transfer mechanism will occur for
each transmembrane domain in the polypeptide. Once the entire polypeptide has been
translated the ribosome is released from the translocon.
Post-translational glycosylation of proteins is believed to participate in many biological
functions such as protein folding, intracellular targeting, immune response, cell adhesion and
protease resistance. Glycosylation is initiated in the ER when a precursor oligosaccharide,
composed of 14 sugars, is transferred to the amino group on asparagines of newly translated
proteins. This action is performed by the membrane-bound enzyme oligosaccharyl transferase.
Three glucoses and one mannose are removed from the precursor oligosaccharide while still in
the ER. Continued trimming and modifying of the N-linked oligosaccharide occurs in the Golgi
apparatus.
The biosynthetic-secretory pathway is involved in the delivery of newly synthesized
proteins to the plasma membrane. This pathway utilizes exocytosis and endocytosis of vesicles
to deliver secretory and membrane proteins from the ER to the Glogi and on to secretory
vesicles that are targeted to the cells exterior. After translation at the ER, proteins are
transported to the Golgi apparatus. The Golgi apparatus is a major site of carbohydrate
synthesis and is involved in sorting the proteins from the ER. It consists of an ordered series of
compartments from the cis Golgi, the site of entry, through the medial Goigi to the trans Golgi,
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the exit site. The exact mechanism of transport between each Golgi compartment is unknown,
but is thought to be either by vesicle transport or maturation of the compartments. What is
known

is that oligosaccharide

processing is

organized

into separate

compartments.

Oligosaccharides that are linked to the hydroxyl group of serine, threonine or hydroxylysine are
formed in the Golgi apparatus by unknown mechanisms. Another important process of the Golgi
apparatus is to separate plasma membrane proteins from the membrane proteins with
functions in the ER and Golgi apparatus. The lipid bilayer of the plasma membrane is thicker
because it is rich in cholesterol. The rigid sterol ring of cholesterol forces neighboring
hydrocarbon chains into more extended conformations, increasing membrane thickness (GarciaSaez et al., 2007). Membrane proteins destined for the plasma membrane have longer
transmembrane segments (20-25aa) to span the thickness, while proteins with shorter
transmembrane segments (15aa) are excluded. Once membrane proteins are packaged into
vesicles they are transported to the membrane through constitutive or regulated mechanisms.
In the plasma membrane it is imperative that certain proteins be restricted to specific
regions of the cell. In neurons that have polarized morphologies this is taken to an extreme. In
order for electrical signals to be correctly processed by the neuron they must be received by its
dendritic processes, relayed to the cell body where the output is then conveyed to the next cell
via the axon terminal. Functional specializations require a high degree of molecular
compartmentalization. To establish and maintain polarity, membrane proteins are sorted into
distinct vesicles for proper transport. Most studies of vesicle packaging come from the apical
and basolateral division of epithelial cells (Folsch, 2008). Proteins in polarized epithelial cells
contain sorting signals in their cytoplasmic tails, which ensures they are packaged into vesicles
destined for either the apical or basolateral plasma membrane (Ang et al., 2004; Bonifacino &
Traub, 2003; Luton et al., 2009). In neurons, a few channels, for example the shaker Kvl voltage-
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gated potassium channel, have been shown to contain amino acid motifs that direct their axonal
or dendritic targeting; however, the mechanism is unknown (Gu et 01., 2003; Rivera et 01., 2003;
Kanaani et 01., 2002). Though neuronal sorting of proteins remains enigmatic, the molecular
trafficking of vesicles between axons and dendrites displays distinct mechanisms.
In axons and dendrites microtubules serve as scaffolds along which vesicles and
macromolecular complexes can be transported. Microtubules are highly dynamic, polar
cylinders made from a polymer of a- and

~-tubulins.

In axons and distal dendrites the positive

end of the microtubule points away from the cell body, while proximal dendrites contain
microtubules of mixed polarity (Burton & Paige, 1981; Bass et 01., 1988). Microtubule-associated
proteins (MAPs) associate with microtubules to control their dynamics. Axons and dendrites
express different MAPs, which determine the spacing between microtubules (Chen et 01., 1982).
Axonal microtubules express the MAP, tau, and are typically 20 nm apart, where as dendritic
microtubules express MAP2 and are typically 65 nm apart (Chen et 01., 1992; Kanai & Hirokawa,
1995). Stable microtubules undergo detyrosination of the C-terminal tyrosine of a-tubulin,
which is removed through the action of tubulin carboxypeptidase (Ersfeld et 01., 1993).
Microtubules in the axon are highly stable and tend to be detyrosinated, while dendritic
microtubules are more dynamic and remain tyrosinated (Khawaja et 01., 1988; Witte et 01.,2008;
Konishi et 01., 2009).
Vesicle trafficking is mediated by motor proteins, which distinguish different
microtubules and leads to transport to either the axonal or dendritic compartment (Burack et

01., 2000; Setou et 01., 2000; Hirokawa & Takemura, 2005). Certain kinesin motors (KIF17 and
KIFC2) interact specifically with dendritic proteins and are confined to the dendrites (Setou et

01., 2000; Saito et 01., 1997). However, the motor domains of these kinesins do not appear to
have a preference for dendritic versus axonal microtubules, suggesting that vesicular targeting
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may depend on additional cues (Nakata & Hirokawa 2003). Recent evidence suggests that this
cue is the cytoskeletal structure of the axon which acts as a molecular sieve. A network of
polarized actin filaments in the initial segment of the axon prevents dendritic vesicles from
passing into axonal areas (Song et 01., 2009; Lewis et 01., 2009). Dendritic vesicles associate with
both Kinesin and Myosin Va motors. The Kinesin motors move vesicles along microtubules;
however, when Myosin Va interacts with the actin filaments in the proximal axon the vesicle is
retargeted back to the cell body for proper trafficking to the dendrite. Vesicles targeted to the
axon do not contain Myosin Va. In addition, the ability of a vesicle to pass through the axon filter
depends on which kinesin isoform is propelling it along with the identity of the protein (Song et

01., 2009). This new hypothesis of an axonal filter has advanced our understanding of neuronal
transport of vesicles; however, many questions regarding vesicle packaging remain.
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CHAPTER II. DETERMINE THE EXPRESSION PROFILE OF TRPMllN THE RETINA
Hypothesis The TRPM1 channel is expressed at the tips of the dendrites of DBCs and co-localizes

with nyctalopin.
Introduction

Synaptic transmission from photoreceptors (PRs) to depolarizing bipolar cells (DBC) is
mediated by the metabotropic glutamate receptor 6, Grm6 (Nakajima 5., 1993; Nomura et 01.,
1994). Tonic activation of Grm6 in the dark results in closure of a non-specific cation channel,
which keeps DBCs hyperpolarized (Shiells et 01., 1981; Slaughter & Miller, 1981). There is a sign
reversal at the PR to DBC synapse, which inverts light-activated hyperpolarization of PRs into a
depolarization in DBCs.
The Grm6 receptor is a member of the group III family of metabotropic glutamate
receptors, which include: Grm4, Grm7 and Grm8 (Conn & Pinn, 1997). In general these group III
receptors are coupled to the inhibition of adenylyl cyclase and decrease in cAMP (Okamoto et

01., 1994). The mechanism by which Grm6 modulates the non-selective cation channel in DBCs
remains unknown (see review by Snellman et 01., 2008).
Until recently, the molecular identity of the DBC cation channel was unknown. Two
general candidates were postulated: a cyclic-nucleotide-gated (CNG) channel or a transient
receptor potential (TRP) channel (Nawy & Jahr, 1990; Snell man & Nawy, 2004). A CNG channel
was proposed because exogenous cGMP potentiated the Grm6 responses to glutamate and light
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(Nawy & Jahr, 1990; Shiells & Falk, 1990, 2002; de la Villa et 01., 1995). This is a similar cascade
to phototransduction, so the theory gained rapid acceptance in the literature. Though CNG
channel mRNA was detected in goldfish OBCs by single cell RT-PCR and in situ hybridization,
immunocytochemical identification in mammalian OBCs was negative (Wassle et 01., 1992;
Henry et 01., 2003). Additionally, dialysis of OBCs with poorly hydrolyzed analogs of cGMP did
not alter the glutamate response and addition of cGMP in the presence of glutamate had no
effect on the cells holding current (Nawy, 1999; Snell man & Nawy, 2004). These results indicate
that cGMP alone cannot gate the channel. The lack of evidence for a CNG channel turned the
focus to the TRP channels.
TRP channels are a large family of nonselective cation channels. TRP channels were
proposed to be the transduction channel in OBCs because they are desensitized by calcium, can
be

modulated

by G-protein signaling and the transduction

currents

had a similar

pharmacological profile to several classes of TRP channels (Snellman et 01., 2008). Initial
candidates from the TRP channel super-family were TRPV1 and TRPMl. TRPV1 is expressed
predominantly in the peripheral nervous system and mediates heat sensation. It was selected as
a candidate because it had several properties in common with the OBC channel, including
permeability to and desensitization by calcium (Liu & Simon, 1996; Caterina et 01., 1997; Koplas

et 01., 1997; Nawy, 2000; Shiells & Falk, 1999; Berntson et 01., 2004; Nawy, 2004). In addition,
the OBC transduction channel could be activated by both capsaicin and anandamide,
compounds known to activate TRPV1 (Shen et 01., 2009; Caterina et 01., 1997; Piper et 01., 1999).
Interest in TRPM1 as a candidate arose when TRPM1 mRNA was identified in a subset of OBCs
(Kim et 01., 2008). Additionally, decreased expression of TRPM1 mRNA was proposed as the
cause of congenital stationary night blindness (CSNB) in Appaloosa horses (Bellone et 01.,2008).
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TRPVl and TRPMl knockout mice were examined to determine if inactivation of these
genes impacted DBC function (Shen

et 0/./ 2009). The DBC transduction channel is required for

proper signal transmission and its loss would be expected to result in a no b-wave ERG
phenotype. TRPVrl - mice had a normal ERG suggesting they retained the DBC transduction
current (Shen

et 01., 2009) . In contrast, TRPMrl - mice lacked an ERG b-wave indicating the

TRPMl channel is required for normal function of DBCs (Figure 6A and B, Shen

et 01., 2009). The

ERG recordings suggested TRPM1, not TRPV1, is playing a critical role in DBC signaling.
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Figure 6: Analysis of TRPM1 and TRPV1 knockout mouse ERGs. (A) Left, dark-adapted ERGs from a wild 2
type (WT) and a TRPVr/- mouse. Flash intensities are -3.6, -2.4, -1.2, 0.0 and 1.4 log cd s/m • Right,
summary of the b-wave and a-wave amplitudes as a function of light intensity in WT (n=8) and TRPV1 -/(n=6) mice. (B) Left, dark-adapted ERGs from a WT and a TRPMr/- mouse. Flash intensities are -2.6, -1.7, 2
0.8, 0.1 and 1.0 log cd s/m • Right, summary of the b-wave and a-wave amplitudes as a function of light
intensity in WT (n=3) and TRPMri- (n=4) mice. For TRPMrl -, only the a-wave data are plotted, as there was
no measurable positive-going response. Adapted from Shen et al., 2009.
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Individuals with CSNBl have a defect in signaling from PR to DBCs, which is
characterized by an absent b-wave and normal a-wave in the ERG. CSNBl is caused by
postsynaptic defects in DBC signaling. Mutations in NYX and GRM6 have been shown to be
causative of CSNBl in many individuals (Bech-Hansen et 01., 2000; Pusch et 01., 2000; Jacobi et
01., 2002; Zeitz et 01., 2005a, 2005b; Dryja et 01., 2005). However, several CSNBl individuals did
not have mutations in these genes. Three groups simultaneously investigated if mutations in
TRPMl might be responsible. The majority (~50%) of autosomal recessive CSNBl (arCSNB1)
probands contain mutations in TRPMl (van Genderen et 01., 2009; Ando et 01., 2009; Li et 01.,
2009). Patch clamp recordings from TRPMr/ - mice also show the lack of a light-evoked
response, confirming the defect is in DBC signaling (Koike et 01., 2009). Additionally,
immunohistochemistry localized TRPMl to the DBC dendritic tips in human, mouse and monkey
retina sections (van Genderen et 01., 2009; Morgans et 01., 2009; Koike et 01., 2009). Collectively,
these studies established that the TRPMl channel is required for the transduction current in
DBCs.
The current murine Ensembl database (www.ensembl.org) contains twenty splice
variants of TRPM1, with thirteen predicted to be protein coding. The high number of TRPMl
splice variants raises questions about their expression profile and function. TRP channels are
known to form hetero-tetramers, so alternative isoforms could come together to form novel
channels. Additionally, studies in HEK293T cells have shown that a short TRPMl splice variant,
containing no transmembrane domains, suppresses function of the long channel forming variant
(Xu et 01., 2002). Whether a single or multiple TRPMl splice variants are required for DBC
signaling is currently unknown.
The idea that DBC isoform specific gene expression occurs is expected. Gao is part of the
heterotrimeric G-protein complex that is activated by glutamate binding to the Grm6 receptor
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(Dhingra et 01., 2000). The Gao subunit has two splice variants in the retina, referred to as Gaol
and Gao2. Targeted deletion of Gaol causes a no b-wave ERG phenotype, while Gao2 knockout
mice have a normal ERG response. Therefore, only Gaol is believed to be involved in signal
transduction from Grm6 in the DBCs (Dhingra et 01., 2002). One goal of my studies was to
characterize the TRPMl isoforms expressed in the retina.
Retinal genes have a well-defined temporal expression profile during development that
correlates with cell differentiation and the formation of synapses (Cepko et 01., 1996). In the
vertebrate retina there are five major neuronal cell classes and one glial cell type that develop in
an overlapping and well-defined temporal pattern (Cepko et 01., 1996). In mice, ganglion cells,
cone PRs, ACs, and HCs are specified embryonically, and BCs and Muller glia specified
postnatally (Sidman 1961; Young 1985a, 1985b). Rod PRs, the most abundant cell type in the
retina, are born both pre- and postnatally, with the peak coinciding with the day of birth (Cepko

et 01., 1996). Birthdating studies have given rise to the competence model of retinal
development, in which the ability of a retinal progenitor cell to produce a particular cell type
changes through out development (Cepko et 01., 1996). Retinal progenitors have the potential to
produce all the retinal cell types during retinal development. However, they only produce a
single cell, or a subset of cells, at anyone time. This has provided a means to correlate
developmental gene expression with individual cell type expression.
When I joined the Gregg lab the identity of the DBC cation channel remained unknown.
As my dissertation progressed TRPMl was identified as the non-selective cation channel. This
chapter describes my work to characterize TRPMl expression in the retina.
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Results
Molecular Cloning of TRPMl from Retina

To determine if TRPMl and/or TRPVl was expressed in the retina I used reverse
transcriptase PCR (RT-PCR) to amplify cDNAs from C57BL/6J retina RNA. The Ensembl database
indicated that full-length mouse TRPMl has a 4,869 base pair (bp) open reading frame (ORF)
and a 142bp 5' untranslated region (UTR) (TRPM1; ENSMUST00000085222). The TRPVl cDNA
has 3,252bp ORF with a 109bp 5'UTR (TRPV1; ENSMUSTOOOOO102526). Primers were designed
that would amplify the full length cDNA representing each gene's ORF (Table 1). RT-PCR for fulllength TRPMl from retinal cDNA yielded fragments of approximately 4,800bp (Figure 7A).
Multiple primer sets were tested for TRPVl (Table i), but I was unable to obtain any evidence it
was expressed in murine retina. Molecular cloning of TRPMl from retinal cDNA identified
several splice variants. I characterized the mRNA expression profile of these TRPMl splice
variants in the retina to determine which variant(s) would likely be essential to DBC function.

Table 1. peR primer sets for TRPMl and TRPVl in murine retina
PCRName

forward Primer·

Reverse Primer·

TRPMl

CCCATGGGGTCCATGAGGAA

TCAGCACTCAGTTTCCGCGC

TRPMI-005

GAGGAGGCTGAAGGAGGCTA

GCGCGGAAACTGAGTGCTGA

TRPMI-007

GAGGAGGCTGAAGGAGGCTA

TCAGGGCAGAGGTGGGGTGA

TRPMI-008

GAGGAGGCTGAAGGAGGCTA

GTGTGTTCACTTCAATGTAG

FL-TRPVl

CCCATGGAGAAATGGGCTAGCTTAG

TCATTTCTCCCCTGGGGCCATGGAAT

5'-TRPVl

CCCATGGAGAAATGGGCTAGCTTAG

GTGTCACTACGGCTGTGGAA

3'-TRPVl

TGTACTTCAGCCATCGCAAG

TCATTTCTCCCCTGGGGCCATGGAAT

"All primers are listed from 5' to 3'.
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PCR products from two RT-PCR reactions were cloned into the pCR-Blunt II-Tapa
plasmid. 9 and 13 clones from the two cloning reactions, respectively, were analyzed further.
Sequence analysis of the 22 clones identified four splice variants: TRPM1, TRPM1-LF, TRPM1-N
and TRPM1-SV, shown schematically in Figure 7B. Table 2 summarizes the retinal variants and
describes their insertions or deletions compared to the full length TRPM1 (Accession,
NM_018752). TRPM1-SS and TRPM1-LF matched variants reported in the mouse Ensembl
database. However, TRPM1-SV and TRPM1-N are novel variants.
A full length TRPM1 variant, TRPM1-N, was cloned from a CH3/HeJ strain of mouse. This
variant was identified during a screen to determine the gene responsible for a spontaneous
mutant CH3/HeJ mouse with a no b-wave ERG phenotype, now called nobS. Whether the
TRPM1-N variant is expressed in CS7BL/6J retina remains to be determined.
In addition to full length TRPM1 isoforms, short forms lacking the transmembrane
domains have been reported and are represented in the mouse Ensembl database. Most of the
short variants of TRPM1 contain a different 5' untranslated region (UTR) and alternative
downstream start sites. Primers also were generated to amplify these variants. Only one short
isoform, TRPM1-007, was amplified from the retinal cDNA (Figure 7A, ENSMUSTOOOOO107516,
Table 2).

Table 2:

TRPMl retinal splice variants,

BP

ORF

AA

TRPM1-003

5013

4869

1622

None

TRPM1-LF

TRPM1-001

5076

4887

1628

RKTRIH inserted at 1065aa between Exon l3 & 24

TRPM1-SV

NONE

4481

4737

1578

Deleted Exon 20

TRPM1-N

NONE

5040

4896

1631

VSIPGGRVE inserted at 549aa between Exon 13 & 14

TRPM1-007

TRPMI-007

2765

1629

547

5'UTR missing Ex on 1. but contains Exon 2, ATG start site in Exon 4
VELSRHTVSCA SQSN MWF LDVLPQl(PTCAECN SSPHLSQTDITPPLP.
inserted at 611aa between Exon 15 & 16

Name

Ensembl

TRPM1-SS

Insertions/Deletiom
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Figure 7: Analysis of TRPMl in retinal cDNA. (A) Cloning for full length TRPMI-003 and TRPMI-007 from
retinal cDNA library. (8) Schematic of the exons, depicted with red boxes, used for each retinal TRPMl
splice variant. Intronic add itions are shown for TRPMI-LF in green, TRPMI-N in pink and TRPMI-007 in
purple.

Multiple TRPMl Splice Variants Expressed in Murine Retina
I identified five retinal TRPMl splice variants that all could produce a funct ional TRPMl
channel. To determine which isoform(s) are likely to form a functional channel in the OBC
dendrites I examined the expression profile of each during development. Ideally this would also
be corroborated using isoform specific antibodies to show protein distribution; however, the
only available antibodies recognize all full length variants (Morgans

et 01., 2009; Koike et 01.,

2009).
Many genes expressed in BCs have been shown to exhibit a specific expression profile
during development (Kim

et 01., 2008). This BC profile shows low expression levels at PO with

expression gradually increasing and peaking at P13-21, after which expression declines (Kim

et

01., 2008) . This developmental expression pattern correlates with the terminal differentiation of
BCs and synaptogenesis between PR axons and BC dendrites in the OPL. The BC specific genes
used to generate the expression profile were from different BC cell subtypes, so specific BC
types (even differences between OBCs and HBCs) cannot be identified. However, determining
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gene expression can be used to differentiate BC-enriched genes from genes enriched in the PRs,
ACs or GCs.
The temporal expression pattern of TRPM1 was first described after microarray analyses
of retina cDNA (Kim et 01., 2008). Its expression follows a BC developmental pattern and in situ
hybridization confirmed its expression was restricted to BCs (Kim et 01., 2008). The isoform
analyzed in these studies was not identified. To determine the temporal expression pattern of
TRPM1 isoforms during development I used isoform specific quantitative real-time PCR (qRTPCR).
Specific Taqman assays were designed to distinguish the different TRPM1 splice
variants that are predicted to contain transmembrane domains, TRPM1-SS, TRPM1-LF, TRPM1-N
and TRPM1-SV. To quantify total TRPM1 expression I designed a Taqman assay, TRPM1-T,
targeting the exon 3 and 4 junction, which is present in all isoforms. Taqman primers to
discriminate TRPM1-LF and TRPM1-N could not be designed within the small intronic insertions.
I designed Taqman assays specific to TRPM1-SV and the TRPM1-SS, TRPM1-LF and TRPM1-N
variants (TRPM1-LF). The TRPM1-SV assay flanks the exon 19-21 junction that is present only in
TRPM1-SV. The TRPM1-LF Taqman assay was designed to flank the exon 20-21 junction, which is
absent in TRPM1-SV and present in TRPM1-SS, TRPM1-SV and TRPM1-N. The location of these
Taqman assays is shown schematically on the TRPM1 transcript in Figure 8A.
Initial experiments were performed to check the specificity of the Taqman assays for
their respective TRPM1 transcripts. To quantify the absolute amount of each transcript I
generated a standard curve using known concentrations of plasmid DNA representing each
isoform. Plasm ids containing cDNA clones of TRPM1-LF or TRPM1-SV were serially diluted over a
9-log range. To increase the complexity of the cDNA pool I added SOng of cDNA synthesized
from HEK293T cells, which do not express TRPM1. Figure 8B shows the standard curves for each
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Taqman assay, plotted as log of the concentration of each isoform (log[pg]) verse cycle number
(Ct). TRPM1-T assay identified both the TOPO-TRPM1-LF (red, Figure 8A) and TOPO-TRPM1-SV
(blue, Figure 8A) plasmids with similar efficiency, as indicated by the overlap between the
templates at each concentration. The TRPM1-LF assay detected TOPO-TRPM1-SV plasmid, but
64 fold less efficiently. The TRPM1-SV assay amplified products from TOPO-TRPM1-LF plasmid,
but only at concentrations close to lng, which is not biologically relevant (Figure 8B). These data
show that the TRPMl Taqman assays can be used to distinguish TRPMl variants; TRPM-SS,
TRPM1-LF and TRPM1-N from TRPM1-SV. Once I established the utility of these assays I used
them to determine the developmental profile of the TRPMl splice variants in the retina. In
addition, the total amount of TRPMl cDNA and the amount of each variant in the retina was
quantified using calculated standard curves.
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Figure 8: Analysis of TRPMl Taqman assays. (A) Schematic showing the location of TRPMl Taqman
assays on TRPMI-lF and TRPMl-SV templates . Total TRPMl (green, TRPMI-T), long forms of TRPMl
(purple, TRPMI-lF) and the splice variant of TRPMl (orange, TRPM1-SV) . (8) Standard curves
generated for each the Taqman assays over a 9-log dilution series of a TOPO plasmid containing either
TRPMI-lF (red) or TRPM1-SV (blue). The TRPMI-T assay was able to detect both plasm ids with similar
accuracy. TRPM1-SV assay was able to reliably detect TOPO-TRPM1-SV at low concentrations, but not
TOPO-TRPMI-LF . TRPMI-LF assay was only able to detect TOPO-TRPMI-LF in the normal range.
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The expression level of the TRPMl variants was quantified at seven developmental time
points (Pi, P7, P13, P21, P26 and 3 Months). To correct for variation in mRNA isolation and
cDNA synthesis all samples were normalized to 185 and expressed as pg/input RNA.
The results show that TRPM1-LF (red) has a similar developmental expression profile as
TRPM1-T (green). Both have low expression between Pi and P7 then peak during
synaptogenesis between P13-21 before declining in adults, 3 months (Figure 9) . This temporal
expression profile is distinctive to BC genes (Kim et 01., 2008). The TRPMl-5V expression was
lower than TRPM1-T or TRPM1-LF had and reached a plateau by P21. This temporal profile is
similar to that seen for PR specific genes (Rho, Gnat1, and Gucala; Kim et 01., 2008). The
temporal profile of the long forms of TRPMl (TRPMl-55, TRPM1-LF, and TRPM1-N) mRNA
expression is consistent with the expression established for BC specific genes.
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Figure 9: TRPMl splice variant mRNA expression profile in the developing C57BL/6J retina . Total
TRPMl (green, TRPM1-T) has a BC expression profile with peak expression between P13 and P26. Long
form TRPMl variants, which contain all six transmembrane domains, also follow a BC profile (red ,
TRPM1-LFl . TRPMl variants lacking exon 20 have a late expressing PR profile (blue . TRPMl-5VI.
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TRPMl Expression Profile in Wildtype vs. Nyx"°b Retina
In Nyx"ob mice, electrophysiological recordings from DBCs are consistent with the
absence the TRPM1 channel or its presence in a constitutively closed state (Gregg

et 01.

2007).

To determ ine the consequences of the absence of nyctalopin on TRPM1 transcription I
compared the developmental mRNA expression pattern of TRPM1 in C578L/6) and Nyx"°b retina.
I used the TRPM1-T Taqman assay to quantify total transcript levels at six time points
(P1, P7, P13, P21, P26 and 3 months). Expression of TRPM1 in the C57BI/6J wildtype mice
follows a BC developmental pattern that peaks at P13-21 (grey, Figure 10). In contrast the
TRPM1 transcript levels are reduced in the Nyx"°b mutant at late stages of development as well
as in adult retinas (black, Figure 9) . TRPM1-T qRT-PCR results between C5681/6) and Nyx"°b were
analyzed by a Student t Test and showed no significant differences between any developmental
time point (Table 3).
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Figure 10: Total TRPMl mRNA expression levels in C57BI/6J versus Nyxnob mice. In C57BI/6J mice
TRPM1-T expression follows a BC expression profile, with peak expression at P21 (grey). In Nyxnob
mice, the TRPM1-T mRNA levels are significantly reduced (black). Scale bars represent standard errors
from fou r biologi cal replicates per developmental time point.
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Table 5: C57BI/6Jverse Nyx" oD TRPM1-T qRT-PCR Statistics

Age

T Value

T Probability

PI

-1.013

0.350

P7

-1.640

0.152

P13
P21

-1.421
-0.784

0.204
0.462

P26
3M

0.844
0.612

0.430
0.562

Screening TRPMl Antibodies

To localize expression of the TRPM1 channel in the retina I tested six commercial TRPM1
antibodies (Table 4). These antibodies were made against human or mouse peptides. Each
antibody was screened at three antibody dilutions (1:300, 1:1000 and 1:3000) on normal human
and C57BL/6J or TRPMr/- mouse transverse retinal sections.
Table 4: Commercial TRPMl antibodies screened for expression in the human and murine retina

Lab #

Company

Species

Antieen

84

Santa Cruz (SC-l6999)

Goat

Synthetic peptide from N-Terminus of human TRPMl

85

Novus (NBllG-7500s)

Sheep

Synthetic peptide from rat. mouse, dogand monkeyTRPMl (1066-107laa)

86

Novus (NBllG-74963)

Rabbit

Synthetic peptide from mouse TRPMl (189-107 Baa)

88

Novus (NBllG-74925)

Rabbit

Synthetic peptide from rat, mouse, dogand monkeyTRPM1 (1066-1071aa)

89

Novus (NBUG-74972)

Sheep

Synthetic peptide from mouse TRPM1 (189-107Baa)

92

Sigma (HPA014785)

Rabbit

Synthetic peptide from C-terminal d human TRPM1

Along with TRPM1, retinal sections were stained with the OPL marker peanut agglutinin
(PNA). PNA is a lectin with high affinity for galactose-galactosamine disaccharide residues. In the
vertebrate retina, PNA labels cone PRs, specifically labeling their inner and outer segments and
synaptic pedicles (Blanks & Johnson, 1983, 1984). Cone synaptic pedicles make synapses with
several hundred postsynaptic dendrites from BCs and HCs, so staining of the cone pedicle with
PNA provides a marker for these synapses (Missotten, 1965; Chun et aI., 1996; Haverkamp et 01.,
2000, Figure 11). Postsynaptic DBC proteins, such as Grm6 and nyctalopin, co-localize with PNA
in the OPL at the light microscope level. Therefore, I expected TRPM1 to be expressed in DBCs
and be restricted to the DBC dendritic tips and co-localize with the PNA marker.
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Figure 11: Immunohistochemical markers used to identify outer plexiform layer (OPL) of the retina .
Vertical section of a creysl violet stained retina shows lamination of nuclear and plexiform layers.
Enlarged cartoon image of the OPL where cone and rod PRs contact Horizontal (H) and Bipolar (B) cell
dendrites. The PNA lectin, orange, labels the synaptic cleft in cone synaptic pedicles. RIBEYE
antibodies, purple, label the ribbon synapse found in all PR axon terminals. Grm6 antibodies, blue,
label the dendritic terminals of DBCs.

A representative image of each TRPM1 antibody tested in a C57BL/6J mouse retina at a
1:1000 dilution is shown in Figure 12A. Only the 92-TRPM1 antibody co-localized with PNA in the
human and C57BL/6J mouse retinal sections. In addition, staining was absent in the TRPMr/ retina suggesting it is specific for TRPM1 (Figure 12B). The 92-TRPM1 antibody is made to a
peptide from the (-terminus of the human TRPM1. Alignment of the human and murine amino
acid sequences from this region shows the human peptide has 57.5% homology (69/120
conserved residues) with the mouse TRPM1 (conserved residues shown in red, Figure 12C).
Though the antibody labeled TRPM1 in mouse retina I also evaluated whether this antibody
could be used on western blots. Extracts from C57BL/6J and TRPMr/ - mouse retina were
isolated and analyzed . I was unable detect a specific band at the predicted size (180Kd). This
antibody will be used for further immunohistochemical analysis ofTRPM1 in the retina.
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Figure 12: Immunohistochemical analysis of TRPM1 antibodies in C5781/6) retina . (A) Representative
images for each TRPM1 antibody (84-86, 88, 89, 92, green) performed on C5761/6J transverse retinal
sections. The cone terminals in the OPL were localized using PNA (red). Antibodies were used at 1:1000
dilution of. Each image is a maximum projection of a 91lm z-stack. Scale bar is lOllm. (6)
Immunohistochemistry on C5781/6) and TRPMrl · retinal sections. 92-TRPM1 shows staining in the OPL of
sections from C5781/6). There is no staining in sections from TRPMrl - mice. Scale bar is 51lm. (C) Alignment
of the human and mouse TRPM1 protein sequences in the region used to make the 92-TRPM1 antibody.
Red are conserved sequences.
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TRPMl Expression in Human Retina

Individuals with mutations in TRPMl are night blind and have a CSNBI ERG no b-wave
phenotype, indicating disrupted PR to DBC signal transmission (van Genderen et 01., 2009; Aldo

et 01., 2009; Li et 01., 2009). In the previous section, I identified a TRPMl specific antibody that
identified expression of TRPMl in the BC somas and the OPL. To further refine the expression
pattern of TRPMl I reacted transverse sections of normal human retina with antibodies to
TRPMl and either PNA or RIBEYE (Figure 13).
Peanut Agglutinin (PNA) stains the cone pedicles in the OPL and is known to co-localize
with dendritic DBC proteins, such as Grm6 and nyctalopin (Nomura et 01., 1994; Vardi et 01.,
2000; Gregg et 01., 2007). Immunohistochemistry with TRPMl antibodies and PNA show dense
TRPMl puncta in the OPL of normal human retina (Figure 13A). Large puncta co-localize with
PNA and represent staining of the cone pedicles. To assess the co-localization quantitatively
fluorescence intensity of green and red pixels was determined across a 211m line placed at PNApositive puncta. These data show complete co-localization of TRPMl and PNA (Figure Be).
DBC dendrites form invaginating synapses with PR axon terminals. RIBEYE is a major
component of retina synaptic ribbons found in the PRs axon terminals adjacent to the OPL
synapse (Schmitz et 01., 2000). Synaptic ribbons are important for the physiological properties of
these tonically active synapses and it is thought that RIBEYE acts as a scaffold protein to build
the entire ribbon (Magupalli et 01., 2008). Staining for TRPMl and RIBEYE show they are closely
associated, but not overlapping, in both cone and rod terminals (Figure 13B). The cone terminals
contain 30-40 DBC dendritic tips making them large puncta, while a single DBC dendrite contact
one rod terminal so are smaller puncta. The RIBEYE staining surrounds the large and small
TRPMl puncta in the OPL (Figure 13B). The pixel fluorescence intensity for TRPMl was
determined across a 2.5um line placed at RIBEYE-positive puncta. The distribution of the pixel
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intensities across that line show that TRPMl fluorescence does not co-localize with RIBEYE
fluorescence but is restricted to the DBC dendrites (Figure 13e).
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Figure 13: TRPMl expression in human retina. (A) Immunohistochemical staining of human retinal sections
for TRPMl (green) and PNA (red). The merged images show that TRPMl is co-localized with PNA. Scale bar
is 5~m. (B) TRPMl sta ining is closely aligned with RIBEYE (red). Scale bar is 5~m . (e) Quantitative analysis
of pixel intensity for TRPMl (green) and PNA (red). A line of 2~m (white bar) was drawn through the center
of the distinct PNA-positive synapses. The distribution of the fluorescence intensity along this line was
determined to generate fluorescent profiles corresponding to PNA (red) fluorescence and TRPMl (green).
(0) For quantification with RIBEYE a 2 . 5~m line was drawn through the center of the distinct RIBEYEpositive synapses. The distribution of the fluorescence intensity along this line was scanned to generate
intensity profiles for TRPMl (green) and RIBEYE (red) . Shown traces are the average of 10 intensity
measurements from different puncta within a single image.
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TRPMl Expression in Murine Retina

To evaluate whether TRPM1 was similarly expressed in DBC dendrites at PR invaginating
synapse, I reacted retinal sections with antibodies to both TRPM1 and PNA or RIBEYE. Figure
14A, shows representative expression patterns of TRPM1 and PNA in transverse retinal sections
from C57BL/6J mice. In the confocal merged image, co-localization of TRPM1 and PNA is evident
and the pattern is consistent with alignment of the cone terminal with invaginating BC dendrites
within the OPL. This co-localization as shown for human retinal sections also was quantified and
I found that TRPM1 fluorescence overlaps with PNA fluorescence in the murine retina (Figure
14B). TRPM1 expression in the OPL was also examined in a whole mount retinal preparation
(Figure 14C). For these experiments 41lm confocal stacks were taken of the OPL. PNA positive
cone pedicles co-localize with TRPM1 staining. I also examined transverse retinal sections for coexpression of TRPM1 and RIBEYE (Figure 14D). The merged images show that RIBEYE and TRPM1
do not co-localize, rather they are closely associated as in the human synapse. Quantification of
the co-localization confirmed that TRPM1 does not co-localize with the RIBEYE-positive ribbon
synapse (Figure 14E). TRPM1 expression in murine retina is consistent with human retina at the
immunohistochemical level.
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Figure 14: TRPMl channel expression in murine retina . (A) Immunohistochemistry of transverse retinal
sections in wildtype mice using a TRPMl antibody. Expression is seen in the OPL (arrows) as well as on Be
somas (arrowhead) . Scale Bar is 20~m (B) A 2~m line (white bar) was drawn across the PNA-positive
synapses. Fluorescence intensity for TRPMl (green) and PNA (red) was determined and normalized to the
peak value . (e) Whole mount retina showing co-localization of TRPMl (green) and PNA (red). Scale bar is
5~m . D. TRPMl (green) expression in the OPL is closely aligned with RIBEYE (red). Scale bar is 5~m. (E) A
2 . 5~m line was drawn through the RIBEYE-positive synapses. Fluorescence intensity for TRPMl and RIBEYE
was analyzed and normalized to the peak. Data show TRPMl expression in murine retina is postsynaptic.

54

Nyctalopin has been shown to be critical for DBC function (Gregg et 01., 2003; 2007).
However, there is no antibody to nyctalopin in mouse retina. As a consequence I used a
transgenic mouse line in which a functional YFP-nyctalopin fusion protein was expressed in the
DBC dendritic tips (Gregg et 01./ 2007). GFP antibodies were used to examine the localization of
nyctalopin relative to TRPMl. Figure 15 shows the expression of TRPMl and YFP-nyctalopin. As
demonstrated previously, YFP-nyctalopin is restricted to dendritic terminals of DBCs in the OPL
in murine retina (Gregg et 01., 2007). Figure 15A shows that TRPMl expression co-localizes with
the nyctalopin puncta in the OPL. In addition, TRPMl also stains BC somas within the ONL
(Figure 15A). Higher magnification images of the OPL shows staining of TRPMl and YFPnyctalopin consistent with the terminals of rods, small puncta, and larger cone DBC dendrites
(Figure 15B). In the whole mount preparation, the large clusters of puncta are DBC dendrites on
cone terminals and single puncta represent rod terminals (Figure 15C). These data suggest that
TRPMl is localized on the dendritic tips of DBCs in close association with YFP-nyctalopin.
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Figure 15: The TRPMl channel co-localizes with nyctalopin in DBC dendrites. (A)
Immunohistochemistry of retinal sections in TgYFPNyx mice using a TRPMl antibody show expression
in the OPL co-localizes with the YFP-nyctalopin fusion protein. Scale Bar is 20llm. (B) A selected region
of the OPL has been enlarged for closer analysis. (C) Images from whole mount TgYFPNyx retina also
show co-localization of TRPMl and YFP-nyctalopin in the OPl. Scale bar is Sllm. This indicates the
TRPMl channel is localized to the DBC dendrites in the retina.
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Discussion
Research over the last several decades had pieced together important physiological and
functional aspects of the DBC transduction channel; however, its identity remained unknown
until 2008-2009. My dissertation work played a role in identifying the transduction channel as
TRPM1.
I showed that full length TRPMl could be amplified and cloned from murine retina
cDNA. These experiments identified five retinal TRPMl splice variants in mouse retina. Other
TRPM family members also have multiple splice variants, but little is known about the functional
roles. 50me might act as either alternative isoforms of the channel or function in combination
with full-length versions with modified properties. Recently, two novel human TRPMl splice
variants were identified from mRNA of primary human neonatal epidermal melanocytes
(Oancea et 01., 2009). These novel TRPMl variants contained all six transmembrane domains
and when expressed in 5K-Me119 melanoma cells generated an ionic current similar to
endogenous TRPMl current. These results suggest that the TRPMl isoforms could form novel
channels that conduct current and are biologically relevant.
An interesting aspect of the TPRMl variants identified in melanoma cells was that each
variant had a different expression pattern in melanocytes, retina and brain (Oancea et 01., 2009).
Expression of specific TRPMl variants in the retina may be critical to DBC physiology. My studies
of the developmental gene expression of TRPMl isoforms determined that TRPM1, TRPM1-LF
and TRPM1-N are likely expressed in DBCs. These variants were amplified by the qRT-PCR
TRPM1-LF assay and had an expression profile consistent with those of other genes expressed in
BCs (Kim et 01.,2008). The TRPM1, TRPM1-LF and TRPM1-N variants contain the characteristic 6
transmembrane domains of TRP channels. On the other hand, the TRPMl-5V assay amplified
only the TRPMl-5V variant, which is missing transmembrane domain 2 (52). This splice variant
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displayed a temporal gene expression profile that is similar to genes expressed in PRs. Overall,
the transcript profile of the TRPM1-LF and TRPMl-5V assays was consistent with the hypothesis
that only the TRPM1 variants containing all six transmembrane domains would be expressed in
the BCs.
Expression of TRPM1, TRPM1-LF and TRPM1-N variants could have a physiological role
in BCs. TRPM1 is the full-length version, while the TRPM1-LF and TRPM1-N isoforms contain
short intronic insertions (Table 2). Though small, these insertions could have drastic
consequences on channel function. For example the TRPM1-LF variant has 6 amino acids
(RKTRIH) inserted between transmembrane domains 54 and 55. The addition of 3 positive
residues (2 arginines and 1 lysine) in the 54-55 linker region could potentially impact TRPM1
channel function. Positive residues in the 54 domain and 54-55 linker form the gating charge in
the TRPM8 channel as well as in Shaker K+ channels (Aggarwal & MacKinnon, 1996; 5eoh et 01.,
1996; Voet et 01., 2007). The gating charge is part of the voltage-sensor. When the channel is
closed the gating charge is positioned near the intracellular surface and then moves into the
membrane when the channel opens (Jiang et 01., 2003). Mutating the positive arginines to
neutral ala nines in this region resulted in reduced TRPM8 gating charge (Voets et 01.,2007). Fulllength TRPM1 does not display voltage dependent properties; however, the additional positive
residues in the TRPM1-LF isoform may lead to voltage sensing capabilities.
The TRPM1-N isoform has an additional 9 amino acids (V5IPGGRVE) inserted in the
TRPM homology domain (MHD). The MHD is found in all TRPMs members and consists of four
regions of sequence homology just downstream of the N-terminus. Though the sequence is
similar between the four regions they do not represent any known structural motifs. The MHD is
suggested to playa role in multimeric assembly and/or normal surface trafficking of assembled
multimeric channels, though the exact function remains to be established (Perraud et 01., 2003,
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2004). Insertion of additional residues in the MHD region may affect the multimeric interactions
between TRPMl isoforms and could lead to novel TRPMl heterotetrameic combinations.
Though sequence analysis of the two BC splice variants raises many possibilities, the
exact function of these TRPMl isoforms in the retina remains to be determined. Future studies
on the TRPMl variants could include: in situ hybridization analysis of the splice variants in tissue
to confirm the expression pattern observed by qRT-PCR, generating antibodies to determine
protein expression of the different TRPMl variants and/or recapitulating each TRPMl variant in
a heterologous system and using patch clamp or calcium imaging to determine if they form a
functional cation channel.
Transcriptional regulation and post-transcriptional mRNA processing are hardly
predictable from genomic information. Two major aspects have to be considered: First,
comparative analysis of the variants can help us understand structure-function relationships of
TRPMl proteins. Second, TRPMl variants have been shown to be differentially expressed and
might serve particular functions in different cell types (Oancea et 01.,2009). Thus, to understand
the physiological role and the molecular identity of native TRPMl channels it is necessary to
determine the subset of TRPMl variants expressed in a specific kind of cell. In addition, though I
identified some TRPMl retinal variants there are presumably more; however, whether they
form functional channels remains to be determined.
In Nyx"ob mice, DBC holding currents have decreased variance suggesting the TRPMl
channel is closed or absent from the membrane (Gregg et 01.,2007). Interestingly, TRPMl mRNA
levels are reduced in Nyx"°b mice compared to C57BL/6J mice. This reduction was observed only
in late developmental time points; however, was not shown to be statistically significant.
Whether the loss of nyctalopin is directly causes a reduction of TRPMl transcripts remains to be
determined. PR genes, such as those encoding calcium channels, also have decreased mRNA
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expression in the Nyx"°b mice (Bojang & Gregg, 2008). These results suggest the altered activity
in the Nyx"°b mice cause global decreases in mRNA transcription. However, the BC gene, Grm6,
showed a 4-fold increase in mRNA levels at P13 (Bojang & Gregg, 2008), so the mRNA reduction
of TRPMl may be a direct consequence of lack of nyctalopin.
Analysis of the temporal mRNA expression of TRPMl and comparison with other genes
expressed

in

BCs

suggests

it

is expressed

in

BCs.

This

result

was

confirmed

by

immunohistochemistry using a commercial TRPMl antibody. TRPMl expression in human and
murine retina is localized to the OPL and to BC somas in the INL. TRPMl in the OPL was assessed
by co-expression with the markers, RIBEYE or PNA, which showed expression was consistent
with the OBC dendritic tips. The TRPMl expression pattern in the retinal OBCs supports the ERG
data that shows TRPMl mutations in both humans and mice cause disrupted signal transmission
from PRs to OBCs (Shen et 01., 2009; Morgans et 01., 2009; van Genderen et 01., 2009; Aldo et 01.,
2009; Li et 01., 2009).
In addition, my studies show that at the dendritic tips of OBCs, TRPMl expression colocalizes with YFP-nyctalopin. Previously, YFP-nyctalopin was reported to co-localize with Grm6
and the absence of nyctalopin specifically prevented glutamate responses in OBCs (Gregg et 01.,
2007). The molecular function of nyctalopin is yet to be established, so co-localization with
TRPMl is intriguing. In my next chapter I examine whether the membrane proteins, nyctalopin,
Grm6, and TRPM1, are required for each others expression at the OBC dendritic tips. This
approach helps to elucidate their structural and functional interactions in vivo.
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CHAPTER III: DETERMINE THE INTERDEPENDENCE OF NYCTALOPIN, TRPMl AND GRM6
EXPRESSION IN DEPOLARIZING BIPOLAR CELLS IN THE MURINE RETINA
Hypothesis Nyctalopin and TRPM1 expression in DBC dendrites is interdependent, while Grm6

expression is independent of either nyctalopin or TRPMl.
Introduction

The Grm6 signaling cascade is essential for light responses in retinal DBCs. Its disruption
results in a loss of DBC mediated signaling, which can be characterized by using the
electroretinogram (ERG) (see review by McCall & Gregg, 2008). Congenital stationary night
blindness type 1 (CSNB1) can be caused by mutations in GRM6, TRPMl or NYX, which result in a
no b-wave ERG phenotype and in Nyx"ob BC in a lack of glutamate mediated depolarization
(Pardue et 01., 2003; Maddox et 01., 2008; Pinto et 01., 2007; Masu et 01., 1995; Shen et 01.,
2009). Grm6 monitors changes in the concentration of synaptic glutamate released from PR
terminals and relays that information via an intracellular G-protein cascade to regulate TRPM1
channels. TRPM1 is the nonselective cation channel that generates the DBC voltage response to
light onset (Bellone et 01., 2008, Shen et 01., 2009, Morgans et 01., 2009, Koike et 01., 2009).
Nyctalopin is an extracellular proteoglycan, and how it disrupts DBC signaling remains unknown
(Pardue et 01., 1998, Gregg et 01., 2007).
The Nyx"ob mouse contains an 85bp deletion in the Nyx gene, which encodes nyctalopin
(Gregg et 01. 2003). In the absence of nyctalopin, Grm6 and its second messenger, Gao, are
properly localized to DBCs dendrites (Ball et 01., 2003); however, glutamate application to DBC
dendrites does not mediate gating of TRPM1 through the Grm6 cascade (Gregg et 01., 2007).
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Analysis of Nyx"°b DBC activity using patch clamp recordings suggests that the TRPM1 channel is
closed or absent (Gregg et 01., 2007). These results imply that nyctalopin could be required for
expression of TRPM1 in the membrane or for regulation of TRPM1 by the Grm6 cascade.
Nyctalopin is predicted to be an extracellular protein, so it should only directly act on
membrane-bound protein such as TRPM1, Grm6 or an unknown adaptor protein.
Previous studies were performed to determine how mutations of Grm6 and TRPM1
affect protein expression and localization. Expression of Grm6 CSNB-associated mutants in
HEK293T cells leads to retention of the mutant Grm6 protein in the ER (Zeitz et 01., 2007). The
mutant protein was not trafficked to the plasma membrane, but when isolated and separated
on a non-denaturing gel exhibited normal dimerization compared to wildtype (Zeitz et 01., 2007).
These data suggest that Grm6 CSNB mutations did not affect the overall structure of the protein,
but did altered its localization.
Defects in trafficking of TRPM1 CSNB-associated mutants have been reported
(Nakamura et 01., 2010). In CSNB patients two TRPMl gene mutations were identified in amino
acids that are evolutionarily conserved, R624C (c.1870C>T) and F1075S (c.3224T>C). When these
mutant channels were transiently expressed in the retina they failed to be transported to the
tips of the DBC dendrites (Nakamura et 01., 2010). Since these amino acids are highly conserved
it suggests that they are most likely essential to the physiologic functions of TRPM1 channels.
Overall, these results show that trafficking of Grm6 and TRPM1 to the plasma membrane is
critical to generating normal DBC responses.
Membrane receptors and channels often form large complexes with multiple accessory
proteins. These macromolecular complexes can be required for proper trafficking, assembly and
stability of the receptor and/or channel. The first evidence for a TRP signaling complex
(signalplex) comes from studies of Drosophila photoreceptor cells, called rhabdomeres. TRP, the
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founding member of the TRP family, is required for phototransduction in Drosophila (Cosens &
Manning, 1969). A central player in the TRP signalplex is Inactivation No After Potential D
(INAD), a scaffold protein comprised of five PDZ protein interaction domains. The TRP signalplex
includes core proteins that are constitutively bound to INAD consisting of TRP, PLC and PKC. The
signalplex also contains non-core proteins that are not constitutively bound to INAD and include
TRPL, rhodopsin, calmodulin, myosin III and the immunophilin FKBP59 (Chevesich et 01. 1997; Xu

et 01. 1998; Wes et 01. 1999). Unlike the core proteins, non-core proteins differ from the
concentration of INAD and are believed to interact transiently with INAD. The TRP signalpex is
required to retain TRP in the rhabdomeres and mediate rapid termination of the photoresponse
(Chevesich et 01. 1997; Adamski et 01. 1998; Wes et 01. 1999). Loss of one member of a
macromolecular complex can have a deleterious effect on the entire complex.
In DBCs, there are several proteins that form a signalplex. G-protein cascades depend on
several proteins including RGS (regulator of G protein signaling) and RGS9-1 anchor protein
(R9AP). These proteins have been extensively studied in PRs. Recent studies have extended to
DBCs and suggests that RGSll, G~5S and R9AP form a heterotrimer, which increases the rate of
termination of the Grm6 cascade by facilitating GTP hydrolysis to GDP on the Gao subunit (Chen

et 01., 2003; Morgans et 01., 2007; Cao et 01., 2008, 2009).
RGS proteins, such as RGSll, RGS9 and RGS7, contain three functional domains, the
Dishevelled, EGL-10, Pleckstrin/DEP helical extension (DEP/DHEX), G-protein gamma subunit-like
(GGL) and RGS, and form complexes with two binding partners R9AP and G~5S. The N-terminal
DEP (Disheveled, EGL-10, Pleckstrin) and DHEX (DEP helical extension) domain form a single
functional domain that mediates binding to the membrane anchor R9AP (Anderson et 01., 2007;
Cheever et 01., 2008; Martemyanov et 01., 2003; Narayanan et 01., 2007). The central GGL
domain is structurally similar to the conventional v-subunits of G-proteins and forms a complex
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with

G~5

(Snow et 01., 1998; Witherow et 01., 2000; Makino et 01., 1999; Cabrera et 01., 1998).

The crystal structure of the

RGS9-G~5

complex revealed that their interaction has the same

orientation and association as those observed in the G~V complex (Cheever et 01., 2008). At the
C-terminus is the RGS domain that mediates conversion of active Ga-GTP species into inactive
Ga-GDP species (Martemyanov & Arshavsky, 2004). In addition, the crystal structure of the RGS
domain of RGS7 shows direct contacts with the switch region of the activated Ga subunit to
stabilize it in the transition state of GTP hydrolysis (Slep et 01.,2001; Soundararajan et 01.,2008).
Though the mechanism used to gate the TRPM1 channel in DBCs remains poorly
understood, regulation through Gao is required (Dhingra et 01., 2000, 2002). Therefore, the
kinetics of the DBC response depend on how quickly Gao inactivates. RGS proteins control the
timing of this inactivation, so playa critical role in shaping the magnitude and duration of the
DBC response. For a complete review on RGS proteins see Anderson et 01 (2009).
Disrupting one of the proteins in the RGSll,

G~5S

and R9AP heterotrimer, such as in

G65-1- mice, results in loss of the other two proteins (Cao et 01., 2008,2009). In addition, stability

of the RGSll protein requires association not only with
Grm6

nob4

G~5S

and R9AP, but also with Grm6. In

mice, immunohistochemistry showed a lack of expression of RGSll, G~5S and R9AP in

the DBC dendrites (Cao et 01., 2009). Total protein levels in Grm6nob4 mice were maintained for
R9AP and G~5S, though RGSll levels were significantly reduced. These results suggest G~5S,
R9AP and Grm6 interact with RGSll, which protects RGSll from proteolytic degradation (Cao et
01., 2009). Grm6 interaction with RGSll was confirmed in a heterologous expression system

(Cao et 01., 2009). These results clearly show how individual components of macromolecular
complexes depend on other complex members for proper localization.
In this chapter, I investigate the interdependence of nyctalopin, Grm6 and TRPMl. All
three proteins are expressed on the dendritic tips of DBCs (Gregg et 01., 2007; Morgans et 01.,
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2009; Shen et 01., 2009). I expect that protein complexes in the DBC dendrites will require
protein-protein interactions to maintain stability; therefore, the loss of one member of the
complex may lead to mislocalization or proteolytic degradation of the other members.
Additionally, the expression requirements for each membrane protein may provide insight into
their in vivo interactions and help to determine the function of nyctalopin.
Results
Confocal microscopy shows that nyctalopin co-localizes with Grm6 and TRPM1 at the
tips of the DBC dendrites (Figure 16, Gregg et 01., 2007; Morgans et 01., 2009; Pearring et 01.,
2010). TgYFPNYX mice express a YFP-nyctalopin fusion protein in the DBC dendritic tips.

Immunohistochemistry with a GFP antibody for YFP-nyctalopin shows it co-localizes with both
TRPM1 (Figure 16A) and Grm6 (Figure 16B). In addition, electron microscopy has shown that
Grm6 and nyctalopin are restricted to the DBC dendritic tips (Gregg et 01., 2007). Since all three
of these proteins have a similar expression pattern and are critical to the G-protein transduction
cascade in DBCs I expect they will be closely associated and their expression may be
interdependent.
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be seen by an absence of TRPM1 puncta in the OPL of whole mount preparations of Nyx"°b
retina (Figure 17B). The decrease in TRPM1 expression in the OPL of Nyx"°b retina is similar to
images from TRPMr/ - retina (Figure 17B, Morgans et 01.,2009; Koike et 01.,2009).
To further examine the reduction in TRPM1 expression in the OPL of Nyx"°b retina, I
quantified the intensity of TRPM1 pixels to PNA pixels (see Methods for details). These data
show that in C57BI/6J mice the peak intensity for TRPM1 overlaps with the peak for PNA, though
TRPM1 intensity is not equal to PNA (Figure 18A). The difference in peak intensity between the
two channels is likely due to the quality of the TRPM1 #92 antibody. As described in Chapter II,
this antibody was made to a human TRPM1 peptide that only has 57.5% homology to murine
TRPM1. In Nyx"°b mice, the TRPM1 intensity was dramatically reduced and no TRPM1 staining
was observed within the PNA-positive puncta (Figure 18B). These results suggest that
localization of TRPM1 to the DBC dendritic tips requires expression of nyctalopin.
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Figure 17. TRPMl localization in the absence of nyctalopin (A) Immun
emistry for TRPMl
nob
(green) in C5781/6), Nyx and TRPMr/- transverse retinal sections. PNA (red) was used to stain the
cone terminals in the OPL that co-localize with TRPMl in C5781/6) mice (yellow, arrows Merge) .
TRPMl is also present in the INL (arrow heads). TRPMl channel expression is absent from the DBC
nob
term inals in Nyx
mice (red, Merge), which is similar to TRPMr/- mice (red, Merge). (B) Horizontal
sect ions show TRPMl (green) puncta co-localize with PNA (red) staining in t he OPL of C5781/6) retina .
nob
The TRPMl expression in t he OPL is absent in Nyx sections. Scale bars are Sllm.
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Figure 18. Quantitative analysis of the TRPM1 fluorescence in C5781/6) and Nyx mice. (A) Analysis of
TRPM1 fluorescent intensity in the OPL of C5781/6) retinal sections. A line of 211m (white bar) was
drawn through the center of distinct PNA-positive synapses. The fluorescence intensity along this line
nob
was scanned to generate profiles corresponding to PNA (red) and TRPM1 (green) . (6) In Nyx
retinal
sections TRPM1 pixel intensity is not above background within the PNA-positive punctate. Shown
traces are an average from two images with 10 intensity scans for each image.

Nyctalopin expression in the absence of TRPMl
TRPM1 requires nyctalopin for expression in the OPL. The next step was to determine if
this dependence was interchangeable and I examined nyctalopin expression in the absence of
TRPM1 using TRPM1-/- mice.
To detect nyctalopin expression I crossed TgYFPNYX mice onto the TRPMr/· background
to generate TgYFPNYX/TRPMr/' mice. Transverse sections and whole mounts were prepared for

TgYFPNYX/TRPMr/. and control (TgYFPNYX) retinas. Figure 19 shows the expression pattern of
YFP-nyctalopin stained with a GFP antibody and TRPMl. YFP-nyctalopin is present as puncta
located on the tips of rod Be dendritic terminals as well as adjacent to cone terminals in control
and TRPM1 ·1· retinas (Figure 19A). In transverse sections from TgYFPNYX/TRPMr/. mice, YFPnyctalopin expression in the OPL is indistinguishable from the control sections. This finding is
also apparent in the confocal optical sections at the level of the OPL obtained from whole
mounts (Figure 19B).
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To further refine the localization of nyctalopin in the absence of TRPM1, I examined
nyctalopin' s expression relative to PNA, Grm6 and RIBEYE . Grm6 is located at the dendritic tips
of OBCs and has been shown to be co-localized with nyctalopin (Masu et 01./ 1995; Vardi &
Morigiwa, 1997; Gregg et 01., 2007) . The staining pattern for YFP-nyctalopin expression relative
to Grm6 was indistinguishable between TgYFPNYX and TgYFPNYX/TRPMr/ - retinal sections
(Figure 20A) . Grm6 is expressed at the tips of the OBCs were it co-localizes with YFP-nyctalopin
(Gregg et 01./ 2007). The post-synaptic localization of nyctalopin in the OPL was confirmed by
expression relative to RIBEYE (red, Figure 20B) or PNA (red, Figure20q. YFP-nyctalopin did not
localize with the pre-synaptic marker, RIBEYE, but co-localized with the cone pedicle marker,
PNA. These results reveal that nyctalopin expression and localization to the dendritic tips of
OBCs is independent ofTRPM1 expression.

A TgYFPNyx

TgYfPNyx!TRPM1-1-

B TgYFPNyx

TgYfPNyx!TRPMr/ -

Figure 19: Nyctalopin expression in the absence of TRPM1. (A) In TgYFPNYX mice, YFP-nyctalopin
(green) is co-localized with TRPMl (red) as seen by the yellow in the merged image. In the
TgYFPNYX/TRPMrl - mice, there is no staining for TRPM1, but YFP-nyctalopin is normally expressed .
Scale bar is Sllm . (6) Horizontal optical sections through the OPL from TgYFPNYX and
TgYFPNYX/TRPM1 -1- whole mount preparations also show YFP-nyctalopin is localized to the OPL in the
absence of TRPM1. Scale bar is SIAm.
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Figure 20 . Nyct a lopin OPL lo calization in the ails ence ofTRPM1 . (A) Immunohistochemis try for YFP-nyctalopin (green) a nd Grm6 (red) s how they remain co-lo ca lized in
the DBC den driti c tip; in TgYFPNYX/7RPM1 / mice . (B) YFP-nyctalopln (green) express ion is posHynaptic as s hown by doubl e labe ling with the pre ~ ynaptic ribbon
marker, RIBEYE (red) in the TgYFPNYX/7RPM1 / ' mice . (C) YFP-nyctalopin (green) co -localizes with the PNA (red) in the OPL (yellow, Merge) eyen in the abs ence ofTRP Ml .
Sca le ba r is Sllm .

Nyctalopin expression pattern in the absence of Grm6

I examined the localization of nyctalopin in the absence of Grm6. The

Nyx"ob

mouse has

normal expression pattern of Grm6 at the dendritic tips of the DBCs. This indicates that Grm6
stability and targeting to the membrane is independent of nyctalopin expression (Ball et 01.,
2003). However, nyctalopin expression in a Grm6 mutant has not been determined.
Nyctalopin expression was examined in the absence of Grm6 expression by crossing

TgYFPNYX mice onto the Grm6

nob4

genetic background to generate TgYFPNYX/Grm6

nob4

mice.

Immunohistochemistry for YFP-nyctalopin using a GFP antibody was performed on sections from

TgYFPNYX/Grm6

nob4

retina. Figure 21A shows the expression pattern of YFP-nyctalopin and

Grm6 in sections from TgYFPNYX and TgYFPNYX/Grm6

n0b4

mice. In TgYFPNYX retinas, YFP-

nyctalopin was present at the tips of the DBC dendrites, where it co-localizes with Grm6 (Gregg

et 01., 2007). In the absence of Grm6, the staining pattern of YFP-nyctalopin appears
indistinguishable from controls (Figure 21A).
To further examine the expression pattern of YFP-nyctalopin in Grm6nob4 mice, I double
labeled with PNA, RIBEYE and PKCu. PNA is a lectin that binds the inner and outer segments as
well as the axon terminals of cone PRs. RIBEYE is a ribbon synapse protein that is expressed in
the axon terminals of PRs and BCs. PKCu is a protein kinase that is specifically expressed in the
cytosol of rod DBCs.
In retina sections from Grm6-/- mice, YFP-nyctalopin co-localized with the PNA (Figure
21B); however, YFP-nyctalopin did not overlap with RIBEYE (Figure 21C). This staining suggests
YFP-nyctalopin expression in the absence of Grm6 remains postsynaptic. PKCu (red) labels rod
BC bodies in the INL along with their dendrites that project into the OPL (Haverkamp & Wassle,
2000). Double labeling for YFP-nyctalopin and PKCu in TgYFPNYX/Grm6

nob4

showed that YFP-

nyctalopin is localized as puncta at the tips of rod BCs (arrowhead, Figure 21D). Large puncta
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representing staining of YFP-nyctalopin on cone terminals also can be seen at the inner part of
the OPL (arrows, Figure 21D). This immunohistochemistry demonstrates that nyctalopin is
properly restricted to the DBC dendritic tips in the absence of Grm6. Therefore, nyctalopin
localization and stability is independent of Grm6.
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Figure 21: Nyctalopin expression in the absence of Grm6. (A) YFP-nyctalopin (green) staining in
control, TgYFPNYX sections, co-localizes with Grm6 (red). In TgYFPNYX/Grm6'°b4 sections, Grm6
staining is absent, but YFP-nyctalopin remains expressed. YFP-nyctalopin staining is indistinguishable
between TgYFPNYX and TgYFPNYX/Grm6'ob4 mice as shown by double-labeling with PNA (B) and
RIBEYE (C) . (D) Staining of YFP-nyctalopin (green) and rod BC marker, PKCa (red) shows nyctalopin
puncta is localized to the tips of rod BCs (arrowheads) . Larger nyctalopin puncta represent localization
in cone BCs dendrites (arrows). Scale bar is 5~m for all images.

74

TRPMl Localization in the Absence of Grm6

Previous reports have shown that Grm6 localization to the DBC dendritic tips of DBCs is
independent of TRPMl (Morgans et 01., 2009; Koike et 01., 2009). To determine if TRPMl
expression depends on Grm6, I examined TRPMl expression pattern in a Grm6 mutant mouse.
Since the absence of Grm6 expression does not alter nyctalopin expression, YFP-nyctalopin was
used as a marker for the DBC dendritic tips in retinal sections from control, TgYFPNYX, and
mutant, TgYFPNYX/Grm6

nob4

•

Figure 22A shows TRPMl expression in the OPL and on DBC somas

in the INL of TgYFPNYX retinas. The staining pattern in the OPL is punctate, which is typical of
staining of DBC dendritic tips. TRPMl co-localizes with the punctate staining pattern of YFPnob4

nyctalopin (yellow in merged Figure 22A). In Grm6

sections, the punctate staining for TRPMl

is reduced in the OPL although it remains in the INL (Figure 22B). This absence of TRPMl from
the OPL is apparent in the merged image with nyctalopin, where there is no evidence of colocalization (green, arrow Figure 22B). TRPMl staining in the INL does not appear to be altered
in TgYFPNYX/Grm6

nob4

mice retinal sections (arrowhead, Figure 22B).

This reduction of TRPMl expression at the DBC dendritic tips in Grm6nob4 sections was
further examined by quantifying the pixel intensity of staining for TRPMl to YFP-nyctalopin. In
TgYFPNYX mice the TRPMl peak lies within the YFP-nyctalopin peak intensity. In the
TgYFPNYX/Grm6

nob4

mice, there is no evidence of TRPMl fluorescence in the average from 30

intensity profiles across nyctalopin-positive puncta (Figure 22C). These results suggest TRPMl
expression in the OPL depends on Grm6 expression.
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Figure 22: TRPM1 expression in the absence of Grm6. (A) Immunohistochemistry of YFP-nyctalopin
(green) and TRPM1 (red) in TgYFPNYX retinal sections. YFP-nyctalopin co-localizes with the TRPM1 in the
OPL (merge). (B) In TgYFPNYX/Grm6"°b4 sections, the expression of nyctalopin is unaffected; however,
TRPM1 expression is absent from the OPL (arrow). TRPM1 expressed in the INL is present in the absence
of Grm6 (arrowhead). Scale bar is Silm (C) Quantitative analysis of the TRPM1 and nyctalopin intensity. A
line of 211m (white bar) was drawn through the center of the distinct YFP-positive synapses. In
TgYFPNYX, the distribution profiles of YFP-nyctalopin (green) and TRPM1 (red) correspond; however,
TRPM1 pixel intensity no longer overlaps with nyctalopin puncta in the absence of Grm6. Shown traces
are an average from three images with 10 intensity scans for each image.
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There are three mutant alleles of Grm6: Grm6

nob4

,

Grm6

nob3

and Grm(il-. To confirm that

TRPMl is reduced in the DBC dendrites in all of these Grm6 mutant mice, I performed
immunohistochemistry for using the TRPMl antibody on retinal sections from Grm6nob3 and
Grm(il- mice. Figure 23 shows immunohistochemistry for TRPMl and PNA in C57BI/6J, Grm6

nob3

and Grm(ii- transverse retinal sections. TRPMl is expressed in the dendritic tips of the DBCs, and
co-localizes with PNA in retinas from C57BI/6J animals (yellow in merge, Figure 23A). However,
in both the Grm6 mutants TRPMl puncta are absent from the OPL although TRPMl staining
remains in the DBC soma. This is apparent in the merged images, which shows no evidence of
co-localization (Figure 23A). The average pixel intensity in the green and red channels was
determined by measuring the intensity across PNA-positive puncta (Figure 23B). Intensity peaks
for the TRPMl and PNA puncta overlap in the C57BI/6J OPL, but in the Grm6 mutants TRPMl
lacks a intensity peak within the PNA puncta. These results shows that regardless of the
alteration in Grm6 (knockout or spontaneous mutation) that TRPMl is not properly localized to
the dendritic tips of DBCs.
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Figure 23: Immunohistochemistry of TRPMl in Grm6 mutant mice. (A) C5781/6) transverse retinal
sections shows co-localization between TRPMl (green) and PNA (red) in the OPL (yellow, merge). In
Grm6·;' sections, expression of TRPMl in the OPL is reduced. TRPMl is no longer co-localized with
PNA. The absence of TRPMl from postsynaptic structures is also present in the Grm6'°b3 mutants.
Scale bar is Sllm (6) Quantification of the intensity of TRPMl fluorescence across the PNA-positive
puncta. TRPMl intensity is co-localized with PNA in controls, C5781/6), but is absent from PNA puncta
of Grm6 mutants.
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Discussion
Receptors and channels are known to form macromolecular complexes in the
membrane and disruption of one member can lead to disruption of the entire complex. Grm6,
nyctalopin and TRPM1 are three membrane proteins required for the normal DBC response to
light. I used several mutant mouse models to determine how loss of one DBC membrane protein
affected the expression of the other two proteins. As discussed in the introduction,
interdependence of proteins has also been reported for the RGS,

G~5S,

Grm6 and R9AP proteins

in the DBCs (Cao et al., 2009).
Studies of DBC activity in Nyx"°b mice suggest that without nyctalopin the TRPM1
channel is closed or absent (Gregg et al., 2007). My immunohistochemical results show TRPM1
expression is absent from the dendritic tips of DBCs in the Nyx"ob retina. Since the synaptic
architecture of the OPL is normal in Nyx"ob mice (Ball et al; Gregg et al., 2007) the reduction of
TRPM1 implies nyctalopin is required for the stability or trafficking of TRPM1 in the DBC
dendrites. The exact mechanism involved is unknown, but there are several possibilities.
Nyctalopin could playa role in maintaining TRPM1 integrity. Nyctalopin's LRR domain
structure is similar to ankyrin repeats, which folds into two anti-parallel helices followed by a
beta-hairpin (Mosavi et al., 2004; Sedgwick & Smerdon 1999). TRPA, TRPN, TRPV and TRPC
subfamilies contain ankyrin repeat domains in their N-terminus (Montell, 2005; Gaudet, 2008).
Deletion of the ankyrin domain impairs TRP channel assembly and trafficking to the cell
membrane (Jung et al., 2002; Chang et al., 2004; Erler et al., 2004). Nyctalopin could be acting as
an auxiliary ankyrin domain for TRPM1 by supporting subunit assembly in the DBCs. When
nyctalopin is absent the TRPM1 channel would not assemble and be unable to properly localize
to the DBC dendrites.
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Nyctalopin could be playing a role in trafficking the TRPMl channel to the plasma
membrane. In neurons, some channels contain amino acid motifs that direct their axonal or
dendritic targeting (Gu et 01., 2003; Rivera et 01., 2003; Kanaani et 01., 2002). Nyctalopin could
be acting as a target for TRPMl channel expression to the membrane. TRPMl in other cells,
such as melanocytes, is predominately localized to the endoplasmic reticulum (Oancea et 01.,
2009). In fact, many TRP channels play an intracellular role (Oancea et 01., 2006; Bezzerides et

01., 2004). Perhaps, nyctalopin is required to transport the TRPMl channel to the membrane, so
it is at the plasma membrane only in cells that also express nyctalopin.
Interestingly, my results show that nyctalopin transport and stability is not dependent
on either TRPMl or Grm6 postsynaptic expression. I hypothesized that if nyctalopin formed a
complex with these proteins it would be mis-localized or degraded in the absence of its
interacting partner. Positive nyctalopin expression suggests it could be interacting with multiple
proteins, so that loss of one does not affect the overall stability of all. Therefore, it would be
critical to determine if nyctalopin localizes in DBC dendritic tips in the double knockout mouse,
TRPMr//Grm6

nob4

•

Additionally, if nyctalopin is acting as an anchor to stabilize membrane

proteins in the synaptic site its localization may not depend on expression of its partners. It may
be acting solely as the glue that holds the complex together.
In contrast to my hypothesis that TRPMl would only require nyctalopin for proper
localization I found that Grm6 mutants showed reduced intensity of TRPMl staining in the OPL.
Elimination of Grm6 leads to the failure of the DBC to establish synaptic connections with the PR
terminals (Cao et 01., 2009). In addition, ectopic ribbon synapses in the DBC dendritic tips have
been identified in Grm6 mutants (Ishii et 01., 2009). These results suggest that signaling through
Grm6 is required for proper synaptic connectivity of the DBCs. Therefore, loss of TRPMl may be
due to disruption of the DBC synaptic architecture, not through direct interaction with Grm6.
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Alternatively, TRP channels are reported to have activity dependent trafficking. For
example, growth factor stimulation initiates rapid translocation of the TRPCS channel from
vesicles held in reserve near the plasma membrane (Bezzerides et 01., 2004). Rapid translocation
of TRPM1 channels into the postsynaptic membrane could be regulated by Grm6 activity. To
provide for spatio-temporally restricted cation entry through TRPM1 channels, the channels
may be sequestered into vesicles and inserted into the plasma membrane upon termination of
the Grm6 cascade. The rapid incorporation of TRPM1 maintained in readily available vesicles,
followed by Grm6 activated endocytosis would represent a secondary method to control
membrane levels of TRPM1, possibly during light adaptation, since it is likely not fast enough to
generate the millisecond response to glutamate. Light adaptation is the ability of PRs to respond
to a large range of light intensities. Protein translocation has been observed for the G-protein
signaling molecules present in PRs and contributes to light adaptation (for a complete review
see Calvert et 01., 2006).
Nyctalopin's role in the Grm6 cascade has remained elusive since it was first identified in
1998 (Bech-Henson et 01., 1998, Pardue et 01., 1998). My current results suggest nyctalopin is
involved in transport or stability of TRPM1 in the dendritic tips of DBCs. To date, no SLRP protein
has been implicated in trafficking or anchoring of a channel and this finding could be a novel
mechanism for SLRP proteins. In the next chapter, I will investigate the biochemical interactions
between Grm6, nyctalopin and TRPM1, which will shed light on the protein complex present in
the DBCs.
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CHAPTER IV. DETERMINE INTERACTIONS BETWEEN NYCTALOPIN, GRM6 AND/OR TRPMl
Hypothesis Nyctalopin will interact with TRPM1, but not Grm6.
Introduction Nyctalopin is a 476 amino acid member of the small leucine-rich repeat

proteoglycan family (SLRP). The SLRP family contains several extracellular matrix proteins that
are composed of leucine-rich repeats (LRRs) flanked by two conserved cysteine-rich regions
(McEwan et 01., 2006). Nyctalopin contains an N-terminal signal sequence, the LRR domain, a
highly conserved linker region and a domain that attaches to the membrane. Human nyctalopin
is predicated to use a glycosylphosphatidyl-inosital-anchor (GPI anchor) to attach to the
membrane, while murine nyctalopin contains a putative transmembrane domain at the Cterminus (Bech-Hansen et 01., 2000; Pusch et 01., 2000; O'Conner et 01., 2005). Nyctalopin is the
only member of the SLRP family that is attached to the plasma membrane.
The LRR domain is believed to be the functional region of the SLRP proteins (Buchanan
& Gay, 1996; Kobe & Kajava, 2001). LRR are tandem repeats that are found across functionally

diverse proteins and are involved in a variety of cellular process such as cell adhesion, signal
transduction, DNA repair and RNA processing (Kobe and Deisenhofer, 1994). One LRR
corresponds to a 20-29 amino acid sequence (LxxLxLxxNxL) that form a ~-strand parallel to an ahelix connected by loops (Hocking et aI., 1998; lozzo, 1999). These tandemly repeated structures
are arranged as a horseshoe-shaped molecule with a curved parallel

~-sheet

lining the concave

side and the a-helices forming its convex side (refer to Figure SA). The LRR domain of nyctalopin
is structurally distinct from the other SLRPs. It has 11 core LRRs that are flanked by an N- and C-
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terminal cysteine-rich LRR cap (CX 3 CXCX 6 C). The unique cysteine-rich caps have lead to
speculation that nyctalopin may not behave as other members of the SLRP family.
Biological roles for most SLRP proteins remain elusive, though several are reported to be
involved in forming the structure of the extracellular matrix, mediating cell adhesion and
regulating growth factor activity (Hocking et 01., 1998; Winnemoller et 01., 1991; Yamaguchi et
01., 1990; Hildebrand et aI., 1994). Nyx"°b mice lack nyctalopin and have a no b-wave ERG
phenotype indicating disrupted signaling between photoreceptors (PR) and depolarizing bipolar
cells (DBC) (Pardue et aI., 1998). Glutamate puffs in the OPL of Nyx"°b mice are unable to elicit a
DBC response (Gregg et 01., 2007), which suggests nyctalopin is directly involved in the Grm6
cascade that regulates the TRPMl channel. The Nyx"°b mouse has normal retinal morphology
and ultrastructure suggesting nyctalopin is not affecting the structure of the extracellular matrix
like many SLRP proteins (Pardue et 01., 1998, 2001; Ball et 01.,2003).
Nyctalopin is predicted to be extracellular, so interactions likely occur in the
extracellular matrix. In the DBCs, there are two known proteins with extracellular domains that
are involved in generating the light-evoked response, Grm6 and TRPMl. In the previous
chapters, I showed that accumulation of nyctalopin in the DBC dendritic tips co-localizes with
Grm6 and TRPMl (Gregg et 01., 2007; Pearring et 01., 2010). Since all three proteins are closely
associated in DBC dendrites and nyctalopin is required for proper signaling of TRPMl by Grm6, I
hypothesize that nyctalopin will interact with Grm6 or TRPMl.
Grm6 receptors form dimers to transmit external glutamate signals to an intracellular Gprotein signaling pathway. The Grm6 protein consists of three distinct regions: the extracellular
(EC), transmembrane (TM), and intracellular regions. The large EC region recognizes glutamate
and can be further divided into two parts: the N-terminal ligand binding region (LB) and the
cysteine-rich (CR) domain. The large LB region of Grm6 undergoes a ligand-induced
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conformational change when glutamate binds (Muto et 01., 2007). The neighboring CR domains
in the Grm6 dimer form lateral interactions, which are believed to promote clustering of the
receptor to the cell surface. If nyctalopin bound these extracellular regions of Grm6 it could
regulate ligand-binding or cluster the receptor to the DBC dendritic tips.
To date no structural information is available for the TRPM1 channel. Electron
microscopic reconstruction of three TRP members, TRPC3, TRPM1 and TRPV1 provides a general
structure for TRP channels (Maruyama et 01., 2007; Mio et 01., 2005; Moiseenkova-Bell et aI.,
2008). TRPM2 and TRPC3 channels have a bullet-shape with a dense putative transmembrane
domain and the majority of the protein occupying the cytosol (see review by Moiseenkova-Bell
& Wensel, 2009). However, the amino acid sequence variety among TRP channels suggests they

are likely to be a structurally diverse family.
Based on these TRP channel structures and transmembrane prediction programs,
TRPM1 is not predicted to have a large extracellular domain. Interactions with nyctalopin would
have to occur with the small extracellular domains or perhaps within the transmembrane
region, which could only be possible for the murine version of nyctalopin. Therefore, it is likely
that the extracellular domain of nyctalopin interacts with its binding partner. Interdependence
experiments reported in Chapter III show that nyctalopin is required for expression of TRPM1 to
the dendritic tips of DBCs. An example of TRP channel targeting to the membrane has been
described in Drosophila. INAD, Inactivation No After Potential D, regulates the subcellular
localization and stability of the TRP channel in the rhabdomere (Tsunoda et 01., 1997; Chevesich
et 01., 1997), which is critical to phototransduction. Interactions between nyctalopin and TRPM1
could playa role in regulation, subunit assembly or trafficking of the TRPM1 channel in the DBC
dendritic tips.
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In this chapter, I investigate the role of nyctalopin interactions with the Grm6 receptor
and the TRPM1 channel to further elucidate its function.

Results
Purification of YFP-nyctalopin from TgYFPNYX murine retina
To examine interacting partners of nyctalopin it is essential to be able to identify and
purify nyctalopin complexes from total retinal protein. Many attempts included several different
strategies to isolate YFP-nyctalopin from transgenic mouse retinas that expressed the YFPnyctalopin fusion protein (TgYFPNYX). None of these approaches were successful. Retinas were
subjected to a variety of methods such as deglycosylation to remove large glycans from the
nyctalopin protein (for a complete list, refer to Table 7 in the methods section), membrane
fractionation and a range of strong and weak detergents. Regardless of the approach I was
unable to detect YFP-nyctalopin on a western blot. Nyctalopin is predicted to be glycosylated,
therefore, it is possible its in vivo molecular weight was too large to enter the polyacrylamide
gel, or be transferred to the PVDF membrane. In an attempt to decrease the molecular mass of
nyctalopin I scanned the protein for protease cleavage sites. YFP-nyctalopin contains two
predicted thrombin cleavage sites that upon exposure to thrombin should liberate the YFP-tag.
However, these sites were not recognized by thrombin in my control experiments. Thrombin
experiments are described in more detail in Appendix I.
Figure 24 shows a representative western blot from control (C57BI/6J) and TgYFPNYX
retina lysate following membrane fractionation. Each fraction, total lysate (L), cytoplasmic (C)
and membrane (M) was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) then analyzed by immunoblot. Lysates from mock or transiently transfected
recombinant Strep-YFP-tagged nyctalopin HEK293T cells were loaded as negative and positive
controls, respectively (lanes 1-2, Figure 24A). Complete details ofthe generation, expression and
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purification of Strep-YFP-nyctalopin (SYFP-NYX) from HEK293T cells are discussed in detail in the
next section. Immunoblotting with a GFP antibody identified a band in the lane with
recombinant YFP-nyctalopin at the predicted size 90 kDa.
The next three lanes contain protein from the membrane fraction isolated from retinas
of C5781/6) mice. As expected, blotting with a GFP antibody did not detect any proteins in the
C5781/6) fractions (lane 3-5, Figure 24A). Lanes 6-8 contain membrane fractions from TgYFPNYX

retina. Surprisingly, we could not detect a band for YGP-nyctalopin in the TgYFPNYX total lysate
or membrane fraction (Figure 24A). To ensure the blot contained protein, it was stripped and reprobed with an antibody to the ribbon synapse protein, RIBEYE. The RIBEYE antibody recognizes
two protein bands (110 and 90 kDa, Figure 24B) in the mouse retina (tom Dieck & Brandstatter,
2005). The RIBEYE bands followed the expected pattern for membrane proteins by being
present in total lysate and enriched in the membrane fraction, but not present in the
cytoplasmic fraction. These results show isolation. and enrichment of membrane proteins from
the TgYFPNYX murine retina; however, I was unable to detect YFP-nyctalopin.
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Figure 24: Western blot for YFPnyctalopin. (A) GFP antibody
detects recombinant SYFP-NYX
expression from HEK293T cells
(lane 2), but not in C5781/6)
(lanes 3-5) or TgYFPNYX (lanes 68) retina fractions. (B) To confirm
the blot contained protein the
same blot was re-probed with an
antibody for the synaptic ribbon
protein, RIBEYE . Lysate (L),
cytosolic
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and
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Immunohistochemistry in TgYFPNYX retinal sections using a GFP antibody shows YFPnyctalopin expression is restricted to DBC dendritic t ips in the OPL (refer to Figure 16, Gregg et

01., 2007) . Therefore, the amount of YFP-nyctalopin expressed may be a small fraction of total
protein. I used an immunoprecipitation approach to enrich for YFP-nyctalopin from total

TgYFPNYX retinal lysate. Protein-G agarose beads (Roche, Basel, Schweiz) were added to the
pre-clear the lysate. This will identify YFP-nyctalopin if it was non-specifically bound to the
agarose beads. After the pre-clearing the supernatant, 11lg of GFP antibody was incubated with
the TgYFPNYX lysate. Then Protein-G agarose beads were added to precipitate the antibody and
any bound proteins. The GFP antibody was incubated with the protein lysate before adding the
Protein-G agarose beads to prevent the antigen site from being blocked. Finally, the beads with
attached antibody were washed to remove non-interacting proteins. Bound proteins were
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released and denatured by heating to 70

D

e in

sample loading buffer before separation by SDS-

PAGE.
Figure 25 shows a western blot using this immunoprecipitation approach. As a positive
control for the GFP antibody, lysate from SYFP-NYX expressing HEK293T cells was loaded in the
first lane of the gel and the GFP antibody detects the expected band for SYFP-NYX (lane 1, Figure
25A). In contrast, the GFP antibody did not detect YFP-nyctalopin in any fraction from the

TgYFPNYX immunoprecipitation (lane 2-5, Figure 25A). To ensure the protein lysate was not
degraded during immunoprecipitation, the membrane was stripped and re-probed with RIBEYE
antibody (Figure 25B). The presence of RIBEYE bands confirm protein was loaded onto the
polyacrylamide gel. Additionally, RIBEYE did not bind the elution fraction (E) off the GFP
antibody.
Expression of YFP-nyctalopin mRNA is highest during synaptogenesis, specifically at
post-natal day 13 (P13) (Bojang & Gregg, 2007). Immunoprecipitation experiments also were
performed on retinas collected from TgYFPNYX mice at P13 to optimize for the peak expression
of nyctalopin. Even at the peak of nyctalopin mRNA expression this approach produced negative
results (data not shown).
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Figure 25: Immunoprecipitation results
from TgYFPNYX retina lysate. Total
Iysates (L), pre-clearing off the ProteinG beads (pre), elution from the GFP
antibody (E) and flow-through fraction
that did not bind antibody (FT) were
loaded to track YFP-nyctalopin in the
immunoprecipitation experiment. (A) In
the first lane, YFP-nyctalopin from
HEK293T cells was loaded as a positive
control. The GFP antibody detected a
band at 90KDa. The GFP antibody did
not detect any bands for YFPnyctalopin. (B) Immunoblot with an
anti-RIBEYE antibody. Bands for RIBEYE
at 100 and 90 KDa were present in the
L, Pre and FT fractions. RIBEYE does not
interact with the GFP antibody, so is not
present in the E fraction.
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Buffer selection is important to maintain protein-protein interactions. To test the
efficiency of the immunoprecipitation procedure for YFP-nyctalopin I spiked a Nyx"°b retinal
membrane fraction with recombinant SYFP-NYX lysate. Retinas from five Nyx"°b and five

TgYFPNYX animals were isolated for membrane purification. 1.3mg of total membrane protein
was used in the GFP immunoprecipitation. In addition,

30~g

of HEK293T cell lysate, obtained

from cells transiently expressing recombinant SYFP-NYX was added to the Nyx"°b fraction. The
immunoprecipitation experiment was repeated and proteins from various fractions analyzed by
western blot (Figure 26). In lane 1,

30~g

of SYFP-NYX lysate from HEK293T cells was loaded as a

reference. Lanes 2-4, contain the Nyx"°b membrane fraction with SYFP-NYX. The GFP antibody
detected SYFP-NYX in the fraction eluted from the Protein-G beads (E) (lane 5, Figure 26).
However, this was at reduced levels compared to the concentration used to spike the Nyx"°b
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membranes (lane 1, Figure 26) . No SYFP-NYX band was identified in the flow-through fraction,
probably because SYFP-NYX lysate was diluted into the retinal membrane fraction . The GFP
antibody did not pull down all the spiked SYFP-NYX and did not detect any bands in any of the
fractions from the immunoprecipitation experiment on TgYFPNYX membranes (lane 5-7, Figure
26) . Recombinant SYFP-NYX was not completely purified from the retina, which could be due to
SYFP-NYX binding retinal proteins that prevent interactions with the GFP antibody. These data
clearly show that my procedures could pull down at least a fraction of YFP-nyctalopin . The
reason I am unable to enrich YFP-nyctalopin from the TgYFPNYX retina Iysates remains unclear.
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Figure 26: Western blot of protein fractions from GFP immunoprecipitation . Pre-clearing off Protein-G
beads (Pre), elution off GFP antibody (E), flow-through fraction not bound to antibody (FT). Lane 1, total
nOb
recombinant SYFP-NYX lysate (L) . Lane 2-4, Recombinant SYFP-NYX spiked into Nyx retina lysate. GFP
antibody detected SYFP-NYX in elution fraction (E) . Lane 5-7, GFP antibody did not detect any bands for
YFP-nyctalopin in the immunoprecipitation from TgYFPNYX membrane fractions.

Strep-YFP-Nyctalopin Expression
To overcome the problems of purifying nyctalopin from retinal tissue, I constructed a
recombinant nyctalopin to be expressed in HEK293T cells. A Strep-tag " (WSHPQFEK) was added
to YFP-nyctalopin to provide an additional purification option . The complete construct contains,
from N- to C-terminus, nyctalopin's signal sequence, Strep-tag ", YFP tag and full-length

nyctalopin with its LRR domain, conserved domain and transmembrane domain (Figure 26A).

90

This construct will be referred to as SYFP-NYX. SYFP-NYX was transfected into HEK293T cells and
its expression pattern examined by immunocytochemistry. Staining of the transfected cells with
a GFP antibody shows robust expression of SYFP-NYX (Figure 26). Double labeling experiments
were performed to examine sub-cellular localization of SYFP-NYX. The nucleus of the HEK293T
cells was stained with a mono-nucleic acid stain, ToPro3-iodide, their plasma membranes with
an antibody to Na/K-ATPase and their endoplasmic reticuli (ER) with an antibody to calnexin.
Figure 27B and 27C show the co-localization of these subcellular markers with GFP. The merged
images at the bottom show that SYFP-NYX does not co-localize with the nuclear marker, ToPro3
or with the plasma membrane marker, NA/K-ATPase. However, SYFP-NYX and calnexin display
strong co-localization as shown in the merged image (Figure 27D). These data suggest that the
majority of SYFP-NYX is restricted to the ER in HEK293T cells.
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Figure 27. SYFP-NYX expression in HEK293T cells. (A) Schematic of the SYFP-NYX construct transiently
expressed in HEK293T cells. Downstream of the signal sequence (purple) the Strep (blue) and YFP
(yellow) tags were added to the N-terminus of murine nyctalopin . The LRR regions (red) are flanked by
cysteine rich repeats (dark blue). The conserved region (pink) and transmembrane domain (green) are
at the ( -terminus. (8-0) Immunocytochemistry for SYFP-NYX was performed using a GFP antibody
(green) and double labeled with a nuclear dye, ToPro3 (red, 8) and antibodies to the plasma
membrane, Na-K ATPase (red, C) or the ER marker calnexin (red, D). SYFP-NYX co-localizes with calnexin
staining in the ER, shown by yellow in the merged image in (D) Scale bar is 10Ilm
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Purification of Strep-YFP-Nyctalopin

Isolation of recombinant SYFP-NYX from total HEK293T cell lysate is required to perform
interaction studies. SYFP-NYX can be purified by the Step-tag II or by the YFP tag, both methods
were tested.
Purification of the SYFP-NYX protein from HEK293T cell lysate can be achieved using
strep-tactin conjugated magnetic beads. The strep-tactin magnetic beads have a very high
affinity for the Strep-tag II tag (Kd = 11lM), which is nearly 100 times higher than to streptavidin
(Strep-tagged Protein Purification Handbook, Qiagen, Valencia, CA). Proteins can be eluted by
addition of a buffer containing 10 mM biotin. An western blot from a strep-tactin pull down
from a lysate prepared from SYFP-NYX transfected HEK293T cells is shown in Figure 28A.
Immunoblotting was done using a GFP antibody, which detects a band for SYFP-NYX at 90 kDa as
expected (lane 1). The elution fraction containing proteins bound to the strep-tactin beads and
is enriched with SYFP-NYX (lane 2, Figure 28A). The flow-through represents proteins that did
not bind to the strep-tactin beads and contains a small amount of SYFP-NYX (lane 3, Figure 28A).
This latter fraction contained SYFP-NYX because the strep-tactin beads were saturated. In
addition to the band at 90 kDa, the GFP antibody detected a band at 60 kDa in the elution
fraction. This band is also present in the elution fraction from mock transfected HEK293T cell
Iysates and represents non-specific labeling by the GFP antibody.
An alternative method to isolate SYFP-NYX protein from HEK293T cell lysate is to use a
GFP antibody. Complexes bound to the GFP antibody are precipitated using Protein-G agarose
beads. Figure 28B shows the immunoprecipitation fractions from mock transfected HEK293T
cells (mock, lanes 1-4) and HEK293T cells transfected with SYFP-NYX (lanes 5-8). Immunoblotting
shows the GFP antibody does not detect any bands in the mock transfected fractions (Figure
28B). However, a 90 kDa band, representing SYFP-NYX, is present in the total lysate from the
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transfected cells (L, lane 5, Figure 28B). Immunoprecipitation of SYFP-NYX with the monoclonal
GFP antibody shows enrichment for SYFP-NYX in the eluted fraction (E, lane 6, Figure 28B) . The
pre-clearing fraction (Pre) contains proteins that are bound non-specifically to the Protein-G
agarose beads (lane 7, Figure 28B) and this fraction contains a small amount of SYFP-NYX. This
shows that SYFP-NYX interacts non-specifically with the Protein-G beads, though the GFP
antibody does enrich for SYFP-NYX (E). The flow through (FT) fraction represents proteins that
did not bind the GFP antibody or Protein-G beads. A small amount of SYFP-NYX is present in this
fraction suggesting the GFP antibody was saturated with SYFP-NYX.
The above results demonstrate that recombinant SYFP-NYX protein expression in
HEK293T cells can be purified using strep-tactin magnetic beads or by immunoprecipitation with
a GFP antibody.
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Figure 28. Nyctalopin purification from transiently transfected HEK293T cells. (A) Strep-tactin pull
down. Immunoblott using a GFP antibody shows specific expression of SYFP-NYX in the Iysates (L) at
90KD, lane 1. SYFP-NYX is enriched when eluted off strep-tactin beads (lane 2, E) though a small
fraction remains in the flow-through (lane 3, FT). Mock transfected control is present in lane 4-6 and
shows a nonspecific band at 60KDa (B) Immunoprecipitation of SYFP-NYX using a monoclonal GFP
antibody (MBL). Negative control is loaded in lanes 1-4. SYFP-NYX is highly expressed in the lysate
(lane 5, L), but enriched by the immunoprecipitation (lane 6, E). A small fraction of SYFP-NYX nonspecifically interacts with the pre-clearing fraction (lane 7, pre) as well as remains in the flow-through
(lane 8, FT).
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Interactions between Nyctalopin and Grm6

Nyctalopin is required for the signal transduction between Grm6 and the TRPMl
channel in DBCs. To examine whether nyctalopin interacts with Grm6 a recombinant SYFP-NYX
column was made. To generate the SYFP-NYX column, total lysate from HEK293T cells
transfected with SYFP-NYX was harvested and immunoprecipitated with a monoclonal anti-GFP
antibody. Several washes were performed to remove unbound proteins from the Protein-GSYFP-NYX column before adding rabbit retina lysate to determine if Grm6 could bind SYFP-NYX.
Rabbit retina was used because the antibody to detect Grm6 was specific for rabbit Grm6.
Western blot shows a positive Grm6 band from total rabbit retina lysate (Ianel, Figure 29A).
There is no band detected by the GFP antibody in the rabbit retina lysate (lane 1, Figure 29B).
Protein fractions from generating the SYFP-NYX column and eluting off the column were
collected and analyzed by western blot. A GFP (Figure 29B) and rabbit-specific Grm6 (Figure
28A) antibody were used to follow the purification of SYFP-NYX and whether it interacted with
Grm6. Figure 28A shows the Grm6 antibody only detected a band for Grm6 in the flow through
fraction from the rabbit retina Iysates (Rab FT, lane 4). The GFP antibody detected SYFP-NYX in
the elution (E) fraction from the column (lane 5, Figure 29B). Detection of SYFP-NYX in the
elution (E) fraction indicates enrichment for SYFP-NYX on the column. Additionally, a small
fraction of SYFP-NYX was bound to the pre-clearing fraction, as described in the previous
section. These results show that I was unable to obtain any evidence for interactions between
Grm6 and SYFP-NYX in this in vitro system. This in vitro interaction study was attempted using
three different buffers with similar results. Buffers are described in the methods section (data
not shown).
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Figure 29: Western blot of in vitro binding study of SYFP-NYX and Grm6. SYFP-NYX column was
generated by immunoprecipitation with a GFP antibody. Upper panel is immunoblot with a GFP
antibody. SYFP-NYX is detected in pre-clearing fraction (pre) and enriched in the fraction eluted off
GFP antibody (E). Lower panel is an immunoblot with a rabbit Grm6 antibody. Grm6 is present in
rabbit retina lysate (Rab L) as well as the flow-through from the rabbit retinal lysate (Rab FT),
containing unbound proteins. Rabbit Grm6 does not interact with the SYFP-NYX bound protein.

Interactions between Nyctalopin and TRPMl

The TRPMl channel in Nyx"°b mice is predicted to be absent or closed (Gregg et 01.,
2007) and nyctalopin is required for TRPMl expression in the DBC dendritic tips (results from
Chapter III). Therefore, I examined whether nyctalopin interacted with TRPMl by doing coimmunoprecipitation experiments.
To perform interaction studies between TRPMl and nyctalopin I used a heterologous
expression system. A flag and GFP tag were added to the N-terminus of TRPM1-SS. The
complete construct contains, from N- to C-terminus, the flag and GFP tag linked to full-length
TRPMl with its TRPM homology region, six transmembrane domains (including the predicted
pore), TRP domain, coiled-coil domain and the C-terminus unique region (Figure 30A) . This
construct will be referred to as FG-TRPM1. HEK293T, CHO, and NG108-15 cell lines were tested
for expression of FG-TRPMl by immunocytochemistry, but all produced similar results so only
the data from HEK293T cells will be discussed in detail.
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FG-TRPMl was transiently transfected into HEK293T cells and expression was
determined by immunocytochemistry using a GFP antibody (Figure 30). FG-TRPMl was excluded
from the nucleus, which was labeled with ToPro3-iodide (Figure 30B). FG-TRPMl also did not colocalize with the plasma membrane marker, Na-K ATPase (Figure 30C). This result suggests that
the majority of FG-TRPMl is most likely located in the ER, although, if only a few channels are
expressed at the cell surface it may be difficult to detect. Double labeling for the ER marker
calnexin confirmed that FG-TRPMl is predominantly expressed in the ER (yellow in merged
image, Figure 300). These results are similar to the expression of SYFP-NYX in HEK293T cells
(refer to Figure 27). Localization of both FG-TRPMl and SYFP-NYX in the ER of HEK293T cells
suggests that DBC proteins are not being properly trafficked to the plasma membrane in this
heterologous system. Over expression of the protein by the CMV promoter may cause a
bottleneck effect in the ER, prevent proper folding the proteins or HEK293T cells might not
contain the proper trafficking machinery to deliver TRPMl to the plasma membrane. While the
intracellular localization of the two proteins was not as expected it is still possible they interact.
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Figure 30. Expression of FG-TRPMl in HEK293T cells. (A) Representation of the FG-TRPMl construct.
flag (purple) and GFP (green) were added to N-terminus of TRPMl followed by the TRPM homology
region (orange), 6 transmembrane domains (yellow) that contain the putative pore (red), TRP domain
(pink), coiled-coil domain (blue) and C-terminal unique region (aqua). (B-O) Immunocytochemistry for
FG-TRPMl was performed using a GFP antibody (green) and co-labeled with antibodies to the nucleus,
ToPro3 (red, B); the plasma membrane, Na/K-ATPase (red, C), or the ER, calnexin (red, 0). FG-TRPMl
only co-localizes with calnexin staining in the ER, shown by yellow in merged image (O) Scale bar is
10/lm
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To determine if FG-TRPM1 and SYFP-NYX do interact, I transiently transfected HEK293T
cells, prepared Iysates and performed pull-downs with step-tactin magnetic beads as described
previously. Four separate transfections were performed to include all the necessary controls.
HEK293T cells were mock transfected (lanes 1-2), transfected with either SYFP-NYX (lanes 3-5)
or FG-TRPM1 (lanes 6-8) or co-transfected with both SYFP-NYX and FG-TRPM1 (lanes 9-11,
Figure 31).
For each transfection I prepared fractions containing the total lysate (L), strep-tactin
bound proteins (E) and unbound proteins (FT) and analyzed then by western blot. Figure 31
shows the results of the western blot using a flag antibody for FG-TRPM1 (Figure 31A) and a GFP
antibody for SYFP-NYX (Figure 31B). To confirm the bound fractions were purified from the total
lysate the polyacrylamide gel was stained with coomassie blue (Figure 31C). Total HEK293T
lysate contains hundreds of bands, which are no longer present in the elution fractions.
In the mock lysate the flag antibody did not detect any bands. A non-specific band at 60
kDa can be seen with the GFP antibody in the bound fraction (lane 2, Figure 31B). This nonspecific band is in every fraction eluted from the strep-tactin beads and its identity is unknown.
The SYFP-NYX lysate contains a 90 kDa band representing SYFP-NYX (lane 3, Figure 31B). This
SYFP-NYX is greatly enriched in the elution fraction (E) as can be seen by the increase in band
intensity (lane 4, Figure 31B) and corresponding decrease in total protein as shown by
coomassie staining (Figure 31C). No bands are detected in the SYFP-NYX lysate with the flag
antibody (lane 3-5, Figure 31A). The FG-TRPM1Iysate (L) contains a 200 kDa band for FG-TRPM1
that is also present in the unbound fraction (lanes 6-8, Figure 31A). When FG-TRPM1 and SYFPNYX are co-transfected a fraction of FG-TRPM1 is detected in the bound fraction by the flag
antibody (lane 10, Figure 31A). This bound fraction is enriched with SYFP-NYX that is pulling
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down the FG-TRPMl (lane 10, Figure 31B). These results suggest that FG-TRPMl is interacting
with SYFP-NYX when purified from total lysate by the strep-tactin system .

SYFP-NYX+
A

SYFP-NYX

M OCK

L

E

L

FG-TRPM l

E

EFT
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IP: S rep-tadin (SYFP-NYX)
IB: Anti-Flag (FG-TRPMl)

IB: Anti-GFP (SYFP-NYX)
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Figure 31: Nyctalopin in vitro interactions with TRPMl. (A) Western blot using an anti-flag antibody
shows FG-TRPMl is not bound to the strep-tactin magnetic beads (E) when expressed alone. However,
a small fraction of FG-TRPMl does bind when co-transfected with SYFP-NYX. (8) Western blot with a
GFP antibody to identify SYFP-NYX elution off the strep-tactin magnetic beads (E) . (C) Coomassie
sta ined gel shows protein isolation from strep-tactin magnetic bead elution . Total Lysate (L), elution
(E) and flow through (FT) from strep-tactin magnetic beads.
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Functional Interactions of Nyctalopin and TRPMl
In the previous section I showed when nyctalopin and TRPMl are expressed in HEK293T

cells they interact. To examine if this interaction contributes to the function of the TRPMl
channel I performed patch clamp recordings of HEK293T cells. A stable cell line expressing HATRPMl was produced to reduce the variability of TRPMl expression levels observed in transient
transfection studies. The HA tag is 9aa (YPYDVPDYA) and should not interfere with normal
channel function.
The TRPMl channel in DBCs is opened by capsaicin and closed by capsazepine (Shen et

01., 2009). I used this agonist and antagonist to directly modulate the TRPMl channel in the HATRPMl stable cell lines. In rod BCs, recording of the TRPMl channel were done by holding the
cells at positive voltages (Snellman et 01., 2008; Shen et 01., 2009). When the channel opens and
outward current is generated. Therefore, whole-cell recordings from HEK293T cells were
performed at a holding potential of +50mV.
Initial patch clamp experiments were performed in mock transfected HEK293T cells to
confirm that capsaicin and capsazepine did not produce a current from an endogenous channel
(Figure 32A). Representative current recordings from a HEK293T cell exposed to a 3 sec puff of
20llM capsaicin (blue) and 20llM capsazepine (red) are shown in Figure 32A. Neither drug
elicited a current confirming HEK293T cells do not contain channels that respond to capsaicin or
capsazepine (n=8).
Whole-cell recordings from HA-TRPMl cells show that the capsaicin agonist did not
generate a current (blue trace, Figure 32B). However, application of the TRPMl antagonist,
capsazepine, elicited a small inward current in HA-TRPMl expressing cells (red trace Figure 32B).
For each condition 8 HEK239T control cells, 15 HA-TRPMl stable cells and 15 HA-TRPMl
expressing YFP-nyctalopin cells were tested. The mean and standard error of the peak response,
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time to peak and rise time are plotted in Figure 32D. The TRPM1 channel in HEK293T cells does
not respond to agonist, but responds with inward current to its antagonist. Inward currents
when holding at a positive potential suggests the antagonist is closing the channel. These results
imply that the TRPM1 channel is constitutively active in HEK293T cells.
To determine if nyctalopin affected TRPM1 currents SYFP-NYX was transfected into the HATRPM1 stable cells. SYFP-NYX expressing cells were identified by YFP fluorescence before wholecell recordings. Recordings from 13 cells were obtained and Figure 32C shows a representative
capsazepine response from SYFP-NYX transfected HA-TRPM1 stable cell. The capsazepine
current in the SYFP-NYX transfected HA-TRPM1 cells was indistinguishable from HA-TRPM1
alone. No significant difference was detected between peak responses, time to peak or rise time
between HA-TRPM1 and HA-TRPM1 with SYFP-NYX current (Figure 32D, E, F, respectively). This
suggests that either nyctalopin does not modulate TRPM1 channel currents or is not involved in
inserting TRPM1 into the plasma membrane in this heterologous system. T values for peak
response, time to peak and rise time are shown in Table 5.

Table 5: Capsazepine Response Statistics
Protocol

T Value

T Probability

Peak Response

0.53

0.60

Time to Peak

0.62

0.54

Rise Time

0.01

0.99
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Figure 32: Whole cell patch clamp recordings from HEK293T cells. Representative current response of
capsaicin (blue) and capsazepine (red) from a HEK293T cells (n=8) (A), HA-TRPMl stable cells (S) and HATRPMl stable cells transiently transfected with SYFP-NYX (C). TRPMl agonist, capsaicin, or antagonist,
capsazepine, were applied for a 3 second puff and currents recorded for 60 seconds. Traces represent an
average of 7 trials. HA-TRPMl and HA-TRPM1+SYFPNYX average current responses to capsazepine were
analyzed (D) . Average peak response, average time to peak or average time to rise from baseline to peak
for capsazepine responses were not significantly different between HA-TRPMl (n=15) and HATRPM1+SYFP-NYX (n =13) cells.
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Discussion
In DBCs, the Grm6 receptor uses an intracellular G-protein cascade to regulate the
TRPM1 channel. Nyctalopin is critical to maintain transduction of this signal, though it is an
extracellular protein. Structure-forming proteins bring receptors and channels into close vicinity
to help mediate signaling. The LRR domain of nyctalopin is primed for protein interactions, so it
could be involved in forming a macromolecular complex in the DBC dendritic tips. I tested
nyctalopin interactions to membrane bound proteins, Grm6 and TRPM1.
Purification of YFP-nyctalopin from TgYFPNYX retinas proved to be difficult. I attempted
to enrich for YFP-nyctalopin by isolating membrane fractions as well as performing
immunoprecipitation experiments. However, though the GFP antibody identified recombinant
SYFP-NYX, it was unable to detect YFP-nyctalopin from retina. Either further enrichment is
needed or YFP-nyctalopin is being bound by the extracellular matrix. Over expression of
recombinant SYFP-NYX in HEK293T cells, which do not contain extracellular matrix, may not
contain all the post-translational modifications added to nyctalopin in the DBCs. Nyctalopin has
been shown to be heavily glycosylated (O'Conner et 01., 2005). Computer-based predictions
show human nyctalopin contains six putative N-glycosylation sites and four O-glycosylation sites
(Pesch et 01., 2003; Zeitz et 01., 2003). These added modifications could lead to increased
molecular weight. Though I attempted to de-glycosylate YFP-nyctalopin using a variety of
deglycosylation enzymes, the lack of an internal control prevented me from determining if the
deglycosylation was working on retina lysate.
Patch clamp recordings from Nyx"°b DBCs show that Grm6 signaling to the TRPM1
channel is disrupted. Nyctalopin could be directly interacting with Grm6 to participate in signal
transduction. Interactions between rabbit Grm6 and a SYFP-NYX column could not be detected.
However, if the rabbit Grm6 is already bound to endogenous rabbit nyctalopin it may be unable
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to bind the recombinant SYFP-NYX column. In addition, the species differences between the
rabbit Grm6 and murine nyctalopin may prevent interaction between the two proteins. Despite
these issues, the result agrees with yeast-two hybrid analysis performed between full-length
nyctalopin and Grm6 (Bojang et 01., 2009). Therefore, it appears nyctalopin does not participate
in the DBC response by binding the Grm6 receptor.
On the other hand, nyctalopin could regulate channel opening by directly binding to the
TRPMl channel. Then in the absence of nyctalopin, TRPMl would be constitutively closed as
suggested by the patch clamp recordings (Gregg et 01., 2007). In vitro binding studies performed
resulted in interactions between nyctalopin and TRPMl. These results suggest that nyctalopin
interactions with TRPMl and could be regulating channel function or localization. Recombinant
forms of TRPMl and nyctalopin did not localize to the plasma membrane in HEK293T cells.
Therefore, interactions between the two proteins are likely to occur in the ER.
Nyctalopin interactions with the TRPMl channel were functionally investigated in a
heterologous system. The TRPMl antagonist, capsazepine, elicited small inward currents, while
no current was observed during application of the TRPMl agonist, capsaicin. These specific
TRPMl currents suggest that TRPMl is constitutively active in HEK293T cells, which is consistent
with a previous report that showed transient transfection of TRPMl into HEK293T cells
produced higher basal level of calcium (Xu et 01., 2001). Surprisingly, the addition of nyctalopin
in the TRPMl stable cells did not alter TRPMl capsazepine currents. Therefore, nyctalopin does
not modulate the TRPMl channel in this heterologous system.
Interdependence experiments from Chapter III suggest nyctalopin is required for proper
expression of TRPMl. From these results I hypothesized nyctalopin might be involved in
trafficking TRPMl to the plasma membrane. Therefore, I expected nyctalopin to increase TRPMl
membrane expression resulting in larger capsazepine currents. Nyctalopin and TRPMl are not
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properly localized in HEK293T cells. Both have high expression in the ER suggesting that the
machinery to traffic DBC proteins is absent from this heterologous system. On the other hand, if
nyctalopin expression did cause trafficking of the TRPMl channel to the membrane and the
channel is constitutively open in this system the cells could be dying from calcium overload.
Though this is a possibility, nyctalopin positive cells were identified and shown to have normal
TRPMl currents, so at least a population of cells does not cause cell death.
It is important to note that activation and regulation of TRP channels is likely a complex
process. For example, the TRP system in Drosophila requires a huge complex of proteins ranging
from kinases to G-proteins to maintain normal TRP channel responses (Popescu et al., 2006;
reviewed by Montell, 2005). These macromolecular complexes are difficult to study in
heterologous systems in which critical components are misSing or exist in an abnormal
stoichiometry. Therefore, determining functional interactions in the in vivo system would
provide the proper architecture to determine if nyctalopin affects TRPMl currents. Appendix"
describes initial in vivo electroporation experiments to transiently express YFP-nyctalopin in the
retina. Using this approach, TRPMl and nyctalopin could be manipulated in their native
environment. In addition, mutant mice are available and would provide a means to study the
proteins in a null background.
Collectively, my results suggest that nyctalopin and TRPMl interact and that this
interaction is required for proper expression of TRPMl to the dendritic tips of DBCs.
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CHAPTER V: METHODS

Animals: All experiments were performed using protocols approved by the Animal Care and Use
Committee at each institution and the guidelines of the National Institutes of Health. Mice were
housed in a 12:12 light:dark cycle. For all experimental manipulations, mice were killed by
anesthetic overdose or carbon dioxide exposure.
The NyJt°b mutation, originally discovered on the BALBc/ByJ strain (Pardue et 0/. 1998),
has been moved to a C57Bt/6J background by more than seven generations of backcrossing.
£S7B1/6J mice were provided by fheiackson Laboratory,'Sar -Harbor,ME The Grm6"°b4 mice

were obtained from Neuromice (www.neuromice.org). TRPMr/' mice were generated by
Lexicon Genetics (TRPMltmlLeX) and obtained from the European Mouse Mutant Archive.
Molecular details of the targeted allele are available at http://www.emmanet.org/.
The Tg(Gabrrl:EYFP-Nyxl g91 transgene was constructed using PCR based strategies as
previously described in Gregg et 0/., (2007). A promoter fragment, consisting of 8Kb of the
murine GABACp1 gene (Gabrr1, Accession NM_008075), was used to drive expression of the
fusion gene in BCs. The open reading frame (ORF) of EYFP was inserted in-frame after the
predicted nyctalopin signal sequence (amino acid 19, Gregg et 0/. 2003) followed by the ORF of i;l
cDNA representing the murine Nyx gene (Accession NM_173415). To improve expression, a
Kozak sequence (Kozak 1991) was added to the start codon and a rabbit l3-globin fragment
containing exon 2-intron 2-exon 3 and a polyadenylation Signal (Brinster et 0/., 1985) were
placed downstream of the EYFP-Nyx fusion construct. The final construct was verified by
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sequencing before transgenic mice were generated by standard pronuclear injection
procedures. Tg(Gabrrl:EYFP-Nyxl

gg1

will be referred to as TgYFPNYX mice.

Murine Genotyping: Genotypes were identified by PCR of DNA isolated from tail biopsies. All

primers are listed from the 5'- to 3' -end. PCR to identify the YFP-nyctalopin transgene was
performed with the following primers, XFPI: CACATGAAGCAGCACGACTICT and XFP2:
GGGTGTICTGCTGGTAGTGGTC

Nyx

nob

PCR

primers

were

as

follows,

Nob3:

CGGCCTICGACAATCTCTICC and m-Nyx31: TIACTACAGGCAGTIACTCA- TGGCAGTCAA. TRPMr/PCR

primers-- were

as

foltows,

neo-3k-

GCAGCGCATCGCCTICTATC,

GCATAGTCCATGGACCTAGC, Trp-OB2: TGCAGGTTIGATICACATCAT. Grm6

n0b4

Trp-081:

PCR primers were

as follows, Grm6Rev: AGAGGCCAGTGTAGACACGTAATI and Grm6Bio: 5'-bio/AGT GAC TCC ACA
CGC TAT GAC TI. The PCR products were then analyzed using the sequencing primer Grm6Seq:
GGAGGCACCACTCGG on a Biotage, Uppsala, Sweden pyro-sequencer following manufacturers
protocol.

eDNA Preparation: Retinas were collected at six separate developmental ages (PI, P7, P13, P21,

P26 and 3 Months) from C57BL/6J and Nyx"ob mice. For most experiments retinas from 2-3
animals were pooled for each age point. Tissue collection was repeated 4 times to provide
biological replicates at each developmental stage. RNA was extracted using the Ribo-pure kit
according to the manufacturers protocol (Ambion, Foster City, CAl. RNA was normalized to 50
ng/1l1 by measuring the absorbance at 260 nm using a Nanodrop Spectrophotometer (Thermo
Scientific, Waltham, MA). eDNA was then synthesized from total RNA using Superscript III
(Invitrogen, Carlsbad, CAl reverse transcriptase with 2.5 ng/1l1 random primers per
manufacturers protocol.

lOB

PCR Conditions: Full-length cDNAs representing the TRPMl were amplified from retina isolated

from adult C57BI/6J mice using Superscript III (Invitrogen, Carlsbad, CAl. PCR reactions were
performed using Accuprime DNA Taq polymerase (Invitrogen, Carlsbad, CAl. A 20 III PCR
reactionvolu~coFltained lX Accupflme Buffer, O.5iil

ef adult C57BJ/6J retiflal cDNA at a 1:10

dilution as template, 200llM of the each primer (refer to Table 1 in Chapter II) and 0.2 III
Accuprime Taq was run under the following conditions: denature at 94°C for 30sec, anneal at
55-65°C gradient for 30 sec, extend at 68°C for 4 minutes for 32 cycles. 10 III of the PCR
reactions were loaded on a 1% Agarose Gel and run at 90 Volts for 2 hours before Ethidium
Bromide (EtBr) staining. PCR bands were visualized under UV light.

Plasmid Constructs: PCR products were cloned into the pCR-Blunt II-TOPO plasmid following

manufaetureFs-protocol (Invitrogetr,- Carlsbad/CAt,- transfofl'lle6- into· One Shot TOPI0
chemically competent cells (Invitrogen, Carlsbad, CAl and plated onto Circlegrow (MP
Biomedicals, Solon, OH) agar plates containing 50 Il8IIlI Kanamycin (Sigma Aldrich, Saint louis,
MO). After overnight incubation at 37°C, clones were selected and grown in 2ml liquid
Circlegrow with 50 1lg/1l1 Kanamycin overnight at 37°C while shaking. Plasmid DNA was isolated
using a Wizard MiniPrep Kit (Promega, Madison, WI) per manufacturer's instructions and
restriction digested to identify positive insertion and digested with Xhol (Promega, Madison,
WI). Digested products were separated on an agarose gel (1% agarose in TBE) at 90V for 1.5
hours. Clones containing inserts of the expected size were sequenced in both directions using
the

following

primers

CAGGAAACAGCTATGAC;
CTTTGAGATACTCCAGGACGA,
ATGCTGGATGCTmGTCCT,

(shown

5'-3'):

mTRPMI-00s:

M13F:

TGCAAGGCTCACAATGTAGG,

mTRPM1-007:
mTRPMI-009:

GTAAAACGACGGCCAG;

M13R:

mTRPMI-0Q6:

TGCAGAAGATCAACACAAGG,

mTRPMI-0Q8:

TCGGGATGGTGAGGMATGC,

mTRPMI-01O:
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CGAGAGCGAGCTGGTGGATGA,

mTRPM1-011:

CTGCTCATCGTGCTIGTAAG,

mTRPM1-012:

TCTACGCCATGGAAATCAACC,

mTRPM 1-013:

TCAACAGTGCCGACGGCTAC,

mTRPM1-014:

AGACTIGGTGCAGCTICCGT,

mTRPM1-020:

CTIGGGCTACTIGCTGCTGT,

mTRPM1-026:

TGGCCCGAAACATCTICTAC and mTRPM1-027: AGCCTCTIGCCTICCTCATC. Sequences were
aligned to murine Ensembl TRPM1 sequence (TRPM1; NM_018752) and analyzed using Seqm~n
software (DNAStar).
Strep-tag II (5'-TGGAGCCACCCGCAGTICGAAAAG-3') tag inserted between the nyctalopin signal
Seq-UeACe-

ami ¥FP-nyctalopin. For mammHtan expre55ian, strep-¥fP-flyctaktpin

(SYFP-NYX}~was

inserted into pcDNA3.1 + vector (Invitrogen, Carlsbad, CAl at the EcoR1 site using infusion
cloning techniques (Clonetech, Mountain View, CAl. For expression of TRPM1 into HEK293T cells
a flag-probe (5'-GACTACAAGGACGACGAC-3') was fused to the 5' end of full length TRPM1 cDNA.
For

stable

expression

of

TRPM1

into

HEK293T

cells

aHA-probe

(5'-

TACCCATACGATGTICCAGATIACGCT-3') was fused to the 5' end of full length TRPMl.

Final

constructs were verified by sequencing.

Quantitative Real-Time peR: Taqman primers and probes were designed to identify three forms

of TRPMl (TabIe-6). All isoforms of:mf1Ml contain e*6fl3and exon4, so to-t~ TRPM1 (TRPM1T) primers were generated to the 3 and 4 exon junction. The assay for the long forms of TRPM1
(TRPM1-lF) were designed to the 20 and 21 exon junction. The assay for the TRPM1-SV isofor.m
was designed to the 19 and 21 exon junction. Each sample represents an average of three qRTPCR reactions. qRT-PCR was performed in a 10

~I

reaction volume with 0.5

~I

of cDNA and the

Taqman Master Mix 2.0 according to manufacturer's protocol (Applied Biosystems, Foster City,
CAl. Thermal cycling and fluorescent detection was performed on a 7900HT Fast Real-Time P,CR
System (Applied Biosystems, Foster City, CAl.
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Table 6. qRT-PCR Taqman primers and probes for TRPMl splice varfants In murine retina
PeR

forwiIrd Primer

Probe

Reverse Primer

TRf'Ml-T

CCTTCMGCGTGGTTCAATCA

AGCTCC~ATCAGGGTCCCAGAAGG

TGTCTTCTCTATCCATGCmCTGA

TRf'Ml-lF

CATTGGAACAAAG./\TCTGTGAATTCT

CGCCCATTGTCAAGTTCTGGTTTTN:.ACA

ACAGCAGCAAGTAGCCCAAGTAG

TRf'Ml-SV

GATGN:.TTCTCCTATCAAACATCCAA

AAGATGGCAAAGAAAAGGA.AGAAGAGAATGTGAm

ACAGCAGCAAGTAGCCCAAGTAG

The concentration of TRPMl variant in each sample was determined using a standard
curve generated by serial dilutions of TOPO-TRPM1-LF and TOPO-TRPM1-SV plasmid. TRPM1-T
slope of the curve was calculated as y

= -3.5288x + 21.311, TRPM1-LF was y =-3.2997x + 22.37

and TRPM1-SV was y =-3.6381x + 21.796 where y is the c',cle-numbef: (Ct)-and x is the log of the
pg of RNA (log[pgJ). The concentration for each variant was normalized to adjust for input cDNA
using a Taqman assay for 18S RNA (Applied Biosystems, Foster City, CAl.

Retinal Preparation: Normal human eyes were obtained from Kentucky Lions Eye Bank. For

transverse retina sections: freshly dissected retinas were fixed for 10 minutes in 4% (w/v)
paraformaldehyde (Sigma Aldrich, Saint Louis, MO) in 0.1 M phosphate buffer (PB). They were
then washed in O.lM PB before being cryoprotected through a graded sucrose series (5%, 10%,
15%,20% sucre5e in O.lM PB) and-embeddecHn OCT:2B% StICf"-6Se {2:1).-5ections (16j.tffi) were
cut on a cryostat (Leica Microsystems, Bannockburn, IL), and mounted onto superfrost glass
slides (Fisher, Waltham, MA). For whole mount retinas: freshly dissected retinas were fixed for 5
minutes in 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer (PB). They were then washed
in O.lM PB before being cut into quarters. Retinal quarters were mounted photoreceptor sioe
down on nitrocellulose membrane.
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Immunohistochemistry: Frozen sections were brought to room temperature (RT), washed in P~S
for 5 min, 0.5% (v/v) Triton X-100 in PBS for 5 minutes and then incubated in blocking solution
containing: 5% (v/v) normal goat serum, 0.5% (v/v) Triton X-loo in PBS for 1 h. Primary
antibodies were diluted in blocking solution and incubated at RT overnight. Antibodies and their
dilutions are listed in Table 7. After incubation with the primary antibody, sections were wash~~
in PBS 3X for 5 minutes each, sections then were incubated in fluorescent secondary antibodies
(1:1000 in blocking solution) at RT for 1 h. Secondary antibodies were Alexa 488 goat anti-rabbit;
Alexa 555 goat itAti-mouse; Alexa 568-donkey anti-Fabbit (Invitrogen, Carl5bad, CAl. Alexa-643labeled PNA (Invitrogen, Carlsbad, CA, at 1:1000) was added with secondary antibodies. Slides
were then washed 3X in PBS and coverslipped with Immunomount (ThermoShandon, Waltham,
MA). Immunostained sections were imaged on an Olympus FV300 confocal microscope, using a
60x oil objective (1.45 NA). Images shown are maximum projections of confocal stacks, adjusted
for contrast and brightness with Fluoview software.

latHe 7. Primary antibodies used for immunohistochemistry.
Antmody

Dilution

Company

Species

Antigen

TRPM1
TRPM1

1:100
1:100

Sigma (HPA014785)
Osaka Bioscience Institute

Rabbit
Rabbit

Synthetic peptide from C-termlnus of human TRPM 1 (1449-1567aa)
Synthetic peptide from C-termlnus of mouse TRPM1 (1SS4-1622aa)

RIBEYE
Goa
Grm6

1:1(0)
1:1(0)
1:1(0)

BD Biasciences (612044)
Chemlcon (MAB3073)
Neuromics (RA1310S)

Mouse
Mouse
Rabbit

Synthetic peptide from mouseQBP2 (361445aa)
Purified bovine brain GOa
Synthetic peptide from C-termlnus of rat mGluR6 (AAPPQNENAEDAK)

GFP
GFP

1:1(0)
1:1(0)

Invitrogen (A11120)
Invitrogen (A21311)

Mouse
Rabbit

Full length GFP
Full length GFP antibodv conjugated to Alexa-488

Quantitative analYSis of immunohisochemistry from confocal images was performed

usmg.-ilie Fluovtew-software package-{Qlymf*Js, Ceffie.F-Valtey"PAtr TRPMl
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images co labeled

with RIBEYE, PNA, or YFP-nyctalopin were selected for further analysis. The region of interest,
the OPl, was determined by the positive staining for the marker protein and used as a reference
for the normalization of the recorded fluorescence intensity in the channel containing protein
being measured. The fluorescence intensity within synaptic puncta was analyzed using line-scan
mode. A 2Jlm long line was placed across individual punctum using PNA as a reference or
2.5Jlm-long line was placed across the ribbon using RIBEYE as a reference. The distribution of
the maximal intensities along this line was determined in both channels and averaged across 1q
individual lines. In human retina, the fluorescence intensity between the two channels was
equal, so reported as pixel versus distance. In mouse retina, the TRPM1 intensity was decreased
compared to the markers, so the fluorescence was normalized to the peak and reported as
normalized versus distance. The intensity distribution in each channel was plotted and analyzed
using Microsoft Excel software.

Cell Culture: HEK293T (human embryonic kidney cells; ATCC, Manassas, VA) cells were grown in
high glucose DMEM supplemented with 10% fetal bovine serum, l-glutamine (2 mM), penicillin
(50 IU/ml) and streptomycin (50 Jlg/ml). Transient transfections were performed using CalPhos
Mammalian Transfection Kit (Clonetech, Mountain View, CA) according to the manufacturers
protocol.
The pcDNA3.1:HA-TRPM1 vector was linearized with Mfel and purified using the QIAQuick PCR
Purification Kit (Qiagen, Valencia, CA). Stable cell lines expressing HA-TRPM1 were produced by
transfecting cells using the CalPhos Mammalian Transfection Kit (Clonetech, Mountain View, CA)
according to the manufacturers protocol. Next day, HA-TRPM1 transfected HEK293T cells were
diluted 1:100 and grown under G418 (1 mg/ml) selection for four weeks. Single colonies were
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picked, grown to confluence and then screened for TRPM1 activity by whole-cell patch clamp
recordings.

Strep-tactin Magnetic Bead Pull Dawn: Two 10 cm plates of transiently transfected HEK2~3T

cells were lysed by sonicating in 400 III NP-T lysis buffer (NaH2P04, NaCl, Tween-20, pH to S.O
with 1M NaOH). The homogenate was cleared by centrifuging at 15,000 X g for 10 minutes at
4°C, 40 III of total lysate was

save&;wh~e

the remaifl-iflg was incubated wkh 200 III of strep-

tactin magnetic beads (Qiagen, Valencia, CA) on a rocker at 4°C for 2-3 hrs. 40 III from the flow
through fraction was collected and saved. After three washes with the NP-T lysis buffer, the
proteins were eluted from the beads with 10 mM O-Biotin (Sigma Aldrich, Saint louis, MO), in
the same NP-T lysis buffer. SOS sample buffer (62 mM Tris, 10% glycerol, 2% SOS, and 5%

~

mercaptoethanol) was added and samples were incubated for 10 minutes at 70°C before
loading the 4-12% NuPAGE gel (Invitrogen, Carlsbad, CA).

Membrane Fractionation: Three 10 cm plates HEK293T cells or retinas from 4 mice (Nyx"ob and

TgYFPNyx) were collected and washed in 1X PBS before resuspeAding tn- hypotonic swelling

buffer (10 mM Tris, 15 mM KCI, 1 mM MgCI2, pH7.5 with 1X Complete Protease Inhibitor,
Roche, Basel, Schweiz). The homogenate was incubated on ice for 15 minutes before adjusting
the buffer to contain 250 mM Mannitol and 1 mM EOTA. Cells were homogenized with a glass
pestle and dounce before clearing by centrifugation at 600 X g for 10 minutes. Membrane
fractions were collected at 100,000 X g for 20 minutes at 4°C. The fraction of the supernatant
was saved as the cytosolic fraction. The pelleted membranes were then resuspended in 100 III
Protein-G buffer (250 mM Tris-HCI, 150 mM NaCl, 1% Non-indet P-40, 0.5% sodium
deoxycholate, pH 7.5).
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GFP Antibody Immunoprecipitation: For immunoprecipitation retinas from 1 rabbit or at te(lst 3

mice were homogenized in 500 \11 extraction buffer. Three separate buffers were tested.
Protein-G buffer (50 mM Tris-HCI, pH 7.5, 150 mM NaCl, 0.1% Nonidet P-40, 0.05% sodium
deoxycholate, lX complete protease inhibitor, Roche, Basel, Schweiz); Brandstatter Buffer (50
mM Tris-HCI, pH 7.5, 150 mM NaCl, 1% Triton X-I00, 0.5% sodium deoxycholate, IX complete
protease inhibitor; tom Dieck et ai, 2005);

Morgans Buffer (1% NP-40, 0.5% sodil,lm

aeoxychofiite, 0.:1:% SOS, 1 mM fOTA,-150 mM ~act, SO-mM Tfis j pH8.D, lXcomplete protease
inhibitor; Morgans et aI., 2005). The homogenates were subjected to centrifugation at 14,000 X

9 for 10 minutes at 4°C to remove insoluble material.
For cO-immunoprecipitation experiments from transfected cells, HEK293T cells from two
10 em plates were lysed by sonicating in 400 \11 Protein-G Buffer (50 mM Tris-HCI, pH 7.5, IS0
mM NaCl, 0.1% Nonidet P-40, 0.05% sodium deoxycholate, lX complete protease inhibitor,
Roche, Basel, Sehweiz). The homogenate was centrifuged at 14,000 X 9 for 10 minutes at 4°C.
Total lysate (40 \11) from either retina or HEK293T cells was saved, while the remaining
was incubated with l\1g GFP antibody (MBL International, Woburn, MA) rotating at 4°C
overnight. Next day, 40 \11 Protein-G agarose beads (Roche, Basel, Schweiz) were added and
incubated for 2 hours at 4°C. 40 \11 from the flow through fraction was collected and saved.
Beads were washed 2 X in wash buffer 2 (50 mM Tris-HCI, pH 7.5, 500 mM NaCl, 0.1% Nonidet P40 and 0.05% sodium deoxycholate) and 2X in wash buffer 3 (10 mM Tris-HCI, pH 7.5, 0.1%
Nonidet P-40 and 0.05% sodium deoxycholate). Elution off the GFP antibody was preformed in
40 \11 Protein-G buffer with 5 X SOS sample buffer at 70°C for 10 min.
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Deglycosylation: Retina protein was extracted into 4M guanidine HCl, 10 mM Sodium Acetate
and 10 mM EDTA. lysates were then concentrated using Centricon YM-3 filters and diluted into
the appropriate-glycoslyation buffer (Table 8). After the-reaction; protein was TCA precipitated,
resuspended in SOS sample buffer and loaded onto an SOS-PAGE gel. 10Ilg Bovine Fetuin (Sigma,
Saint louis, MO) was used as a control in Neurominidase experiments. Fetuin control samples
were resolved on SOS-PAGE and visualized by coomassie blue staining.

Table 8. Glycosidase buffers and reaction conditions
Glycosidase

COfJl)any

BufferjProtocol

Reaction

O-GI'l'tositiase

Si"V3 (G 1163)

5X Reaction Buffer -2SOmM Sodium Phosphate, pH 5.0

3 hours at 370(

Neurominidase

Sigma (N3786)

50 mM Sodium Phosphate, pH 6.0

3 hours at 37°C

Chondrotinase ABC

Sigma (C2905)

2SOmM Tris, pHS.o, 300mM Sodium Jlcetate, 05% BSA

3 hours at 37°C

Hyaluroni dase

Atlanta
Biochemicals

500mM Sodium Phosphate ~~th lSOmM Sodium Chloride, pH 5.3

3 hours at 37°e

Collagenase Type 2

Worthington
Biochemical

O.05M rES with O.36mM Calcium Chloride, pH 7.5

5 hours at 370(

PNGase F

Sigma (P 7367)

50mM Sodium Phosphate, pH 75

3 hours at 37°C

Endoglycosidase F1

Sigma (E9762)

2SOmM Sodium Phosphate, pH 5.5

1 hour at 37°e

Endoglycosidase F2

Sigma (E 0639)

2SOmM Sodium Jlcetate, pH 45

1 hour at 37°C

Endoglycosidase F3

Sigma (E2264)

2SOmM Sodium Jlcetate, pH 45

1 hour at 370(
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Western Blotting: Protein fractions were analyzed on 4-12% NuPAGE gels (Invitrogen, Carlsbad,
CAl following the manufacturers protocol. Protein bands were transferred onto PVDF
membranes (GE Healthcare, Piscataway, NJ). Immunoblot analysis was performed using primary
antibodies at the specific dilutions as listed in Table 9. Anti-mouse (Sigma Aldrich, Saint lo~is,
MO) and anti-Rabbit (Pierce, Rockford, Il) HRP-conjugated secondary antibodies were used to
detect bands with the advanced ECl (Pierce, Rockford, Il) detection system.

Table 9. Primary antibodies used for immunoprecipitatiOn and western blot.
Dilution

Species

Method

Sigma (sc-7392)

1:500

Rabbit

WB

Hemagglutinin amino acids 90-115

Flag

Sigma (F31GS)

1:2a:l>

Mouse

WB

Flag M2 (DVI<DOODK)

GFP

MBl (M048-3)

1~

Mouse

lP

GFP

Cell Signaling (2555)

1:2a:l>

Rabbit

WB

Synthetic GFP peptide coupled to KlH

Grm6

Giftfrom Dr. Massey

1:1a:l>

Rabbit

WB

Synthetic peptide from C-Terminus of Rabbit Grm6

AntiKKty

Company

HA-probe F-7

Antieen

Full length GFP protein

Immunocytochemistry: HEK293T cells (4 X 105 cells) were plated onto poly-lysine coated
coverslips. The next day cells were transiently transfected using the CalPhos transfection system
per the manufacturer's protocol (Clonetech, Mountain View, CAl with 1 J.tg of pcDNA3.1:SYFPNYX, pCDNA3.1:F-Grm6, or pcDNA3.1:FG-TRPM1 per coverslip. After 24 hours, cells were fixed
for 5 minutes in 100% Methanol at -20°C then for 5 minutes in 1:1 Methanol/Acetone at -20°C
followed by three washes in 1 X PBS. Fixed cells were then incubated with primary antibody
. tif1uted to l:S00ifl a 3% BSA blocK-ingsmutionin lX-PBST (0.1% ffleen-2G in lX PBS) for 1 hour
at room temperature. A list of primary antibodies is shown in Table 10. The coverslips were
washed in 1 X PBST before incubating with secondary Alexa-488 goat anti~rabbit, Alexa-555 goat
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anti-mouse, Alexa-5G8 donkey anti-rabbit (Invitrogen, Carlsbad, CAl at a 1:500 dilution in
blocking solution (3% BSA blocking in lXPBST) for 1 hour at room temperature. Coverslips were
washed

with

1 X PBST and

mounted onto permafrost slides using Immunomount

(ThermoShandon, Waltham, MA) then sealed with nail polish. Immunostained cells were imaged
on an Olympus FV300 confocal microscope, using a GO X oil objective. Images shown are
maximum projections of ten 0.5 11m confocal stacks, adjusted for contrast and brightness with
Fluoview software.

Table 10. Primary antibodies used for immunocytochemistry.
Antix>dy

Company

Species

Antigen -

Na/K ATPase

Sigma

Mouse

Synthetic ~tide from 646-652aa of Sheep kidney asubunit

Ca!nexin

SD Biosciences

Mouse

Synthetic ~tide from 116-301aa of Human cal nexi n

Flag

Sigma

Mouse

Synthetic ~tide DVKDDDDKC

GFP

Invitrogen (A21311)

Rabbit

GFP antibody conjugated to Aiexa-488

Patch Clamp Recordings: For whole-cell recordings, HEK293T or HA-TRPMl stable cells were

grown on coverslips then transferred to standard external solution. Patch pipettes were
fabricated from borosilicate glass (WPI, Sarasota, FI) and filled with a K+-based solution with 5.5
mM EGTA, 10 mM HEPES and 4 mM ATP (pH 7.25 by KOH). The TRP channel agonist Capsaicin
(20 11M, Sigma Aldrich, Saint Louis, MO) and antagonist Capsazepine (20 11M, Sigma Aldrich,
Saint Louis, MO}-were delivered to tbe cells from a pipette using positive pressure (2-4 PSI) with
a computer-controlled solenoid valve (Picospritzer, General Valve Corp). The holding potential
for all recordings was +50 mV.
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Recording and analysis: Whole-cell recordings were obtained with an Axopatch 1D amplif;er
(Molecular Devices, Sunnyvale, CAl. Currents were acquired at a sampling rate of 2 kHz with
Axograph X software and an Apple G5 computer, low pass filtered at 50 Hz (Frequency Devices,
Ottawa; Il) and~igitized with an ITC-18 interface (Heka,- Bellmore, NY}. Holding potentials were
corrected for the liquid junction potential, which was measured to be 10 mV with the standard
K+ gluconate pipette solution. Recordings were discarded if the series resistance exceeded 20
MO. Data were analyzed offline with Axograph X and Kaleidagraph (Synergy Software, Reading,
PAl. The student t-Test was used to analyze the data.
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CHAPTER VI: DISCUSSION

My data show that the TRPM1 channel is expressed in the DBCs where it co-localizes
with nyctalopin at the dendritic tips. Proper localization of TRPM1 to the dendritic tips requires
expression of nyctalopin and Grm6. In addition, using a heterologous expression system I found
that TRPM1 interacts with nyctalopin. I interpret these results to indicate that nyctalopin plays a
role in localizing the TRPM1 channel in the dendritic tips of the DBCs. Whether nyctalopin is
required for trafficking to the membrane, stabilizing or clustering the channel in the membrane
or assembling channel subunits remains to be determined.
Why are there Multiple TRPMl Splice Variants in the Retina?

Alternative splicing occurs in all eukaryotes, and in humans over 80% of genes are
believed to be alternatively spliced, thus greatly increasing the diversity of proteins encoded by
the genome (Matlin et 01.,2005). I identified five splice variants of TRPM1 from retina cDNA.
In the retina, splice variants can have functions in the same cell or be expressed in
different cells. The splice variants of the G-protein heterotrimer subunits Gao: Gam and Ga02
(Goldsmith et 01., 1988; Strathmann et aI., 1990), are present in the DBCs (Dhingra et 01., 2000,
2002). The highly abundant Gam variant is required for the light-evoked activity of the DBCs
(Dhingra et 01., 2002); however, a recent report also showed that Ga02 plays a role in generating
the DBC response though lO-fold less sensitive than Gam (Pahlberg et 01., 2009). The Gao splice
variants work together to improve the light sensitivity in the DBCs.
The ~-subunit of the trimeric G-protein involved in Grm6 function also exists as two
splice variants, G~5-L and G~5-S, which are found in two different cell types within the retina.
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Both splice variants interact with and stabilize the RGS proteins: RGS6, RGS7, RGS9, and RGS11.
The photoreceptor-specific long form, G~5-L, interacts with RGS9 and R9AP to confer
intracellular stability, membrane affinity, and outer segment targeting modality to the G~5-L,
RGS9, R9AP complex (Chen et 01., 2003; Martemyanov et 01., 2003; Keresztes et 01., 2004). This
complex regulates the intrinsic GTPase activity of transducin, Gat (He et 01., 1998; Makino et 01.,
1999). The short form, G~5-S, is found in the DBCs where it co-localizes with RGS7 and RGSll
and is required for proper DBC responses (Morgans et 01., 2007; Rao et 01., 2007). The

G~5

splice

variants are involved in terminating the G-protein cascade in both photoreceptors and DBCs
(Rao et 01., 2007).
My analyses of the TRPM1 splice variant expression profile during development
suggests the variants with all six transmembrane domains are expressed in bipolar cells.
Morphological classification of DBCs have identified 6-8 cell types in the mammalian retina
(Boycott & Wassle, 1991; Euler & Wassle, 1995; Ghosh et 01., 2004); however, little is known
about the functional difference between each type. Each DBCs type could be expressing a
different TRPM1 variant that might contribute to different kinetics in their light-evoked
responses. Furthermore, my analysis showed that the TRPM1 variant lacking transmembrane
domain 2 (TRPM1-SV) had a temporal pattern during development more similar to PR
expression. Therefore this variant could have a function in the PRs.
Apart from each TRPM1 isoform being expressed to a specific DBC type they could work
in combination in all DBCs. Endogenous TRPM1 expressed in B16-F10 epidermal melanocytes or
human melanoma cells have high outward rectification (Oancea et 01., 2009). In comparison the
current-voltage relationship in DBCs exhibits a moderate outward rectification (Shen et 01.,
2009). The difference in the biophysical properties of the TRPM1 channel between these
separate systems may reflect differences in the TRPM1 splice variant composition. Furthermore,
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TRP channels are known to be hetero-tetrameric channels with other TRP members. The
moderate outwardly rectifying current seen in OBCs could also reflect a heterotetrameric
channel between TRPM1 and another TRP channel.
Further analysis of the retinal TRPM1 splice variants could be determined in a
heterologous system. Recombinant expression of each variant followed by calcium imaging or
patch clamp recordings could be used to determine if they form a functional cation channel.
Studies were performed for TRPM1 variants identified in human melanocytes (Oancea et al.,
2009). Of the four N-terminal TRPM1 variants they identified, all contained six transmembrane
domains, yet only two of the variants displayed currents similar to full-length TRPM1 when
expressed in a heterologous system. This suggests that some of the retinal splice variants may
not even form a functional cation channel.
TRPMllnstability in the DBC Dendritic Tips

The first TRP channel identified was found in Drosophila and is required for
phototransduction (Montell & Rubin 1989). This finding has served as a standard model of
macromolecular organization of TRP channels. The Drosophila TRP channel associates with other
signaling proteins to form a large macromolecular complex, the signalplex. INAO (Inactivation
No After Potential 0) is a POZ scaffold protein that is a central player in the signalplex.
Interactions between TRP and INAO are required to target the complex to the rhabdomere
membrane (Chevesich et al. 1997). To determine if a similar signaling complex was formed in
OBCs, I investigated the interdependence of TRPM1, Grm6 and nyctalopin expression. A
summary of the immunohistochemical results from wildtype and three knockout mice, TRPM/·,
Grm6

nob4

and Nyx"°b are displayed in Table 11 and Figure 33.
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Tab le 11. Expression of PR and OBC pro eins in he OPl of CSNB I mu an mice
Genotype
Protein

C57BI/6J

ycta l'o pin

Ny]("ob

TRPM1-i -

Grrnf1t<>b4

*

+

+

b

TRPMl
Grm6

+~

(al Gregg er al., 2003; (bl Morgans er al., 2009; leI Pi ntoeral., 2001
• No antibody for nyctal opin

Wildtype

TRPMri ·

Grrn~

Figure 33. Summary of immunohistochemical staining of DBC membrane proteins from three CSNBl
mutant mice compared to wildtype . Antigen sta ined is indicated in each panel. *Not determined
antibody for nyctalopin.

In the Nyx"ob mice TRPM1 is absent from the OPL; however, TRPM1 remains in the cell
bodies of the OBCs in the INL. Th is suggests that TRPM1 is still expressed but is not being
properly transported or clustered to the tips of the dendrites. To further determ ine if TRPM1 is
in the membrane our collaborator, Dr. Nawy, performed patch clamp recordings from Nyx"°b rod
BCs.
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Figure 34 shows the responses from wildtype and Nyx"ob rod BCs to application of
agonists. LY341495 inhibits Grm6 and generates an outward current (Figure 34A, Snellman et

01., 2008) . The application of LY341495 does not elicit a current in the Nyx"°b mice (Figure 34A).
To directly stimulate TRPM1 channels in the membrane the TRPM1 agonist, capsaicin, was
puffed onto rod BCs. In wildtype rod BCs capsaicin elicits an outward current similar to
LY341495. However, capsaicin was unable to elicit a current in Nyx"°b rod BCs (Figure 34A).
These data support that the TRPM1 channel is not present in the membrane of rod BCs in the
absence of nyctalopin . I postulate that nyctalopin is likely involved in trafficking or inserting the
TRPM1 channel in the DBC dendrites or assembling the tetrameric TRPM1 channel.
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Figure 34. Rod BC patch clamp recordings . (A) Wildtype responds to the Grm6 receptor antagonist,
LY341495, with an outward current. This outward current is also elicited by direct stimulation of
nOb
TRPM1, using the agonist, Capsaicin. Nyx
rod BCs do not respond to either LY341495 or capsaicin .
The Grm6 cascade is unable to act on TRPMl because TRPMl is not in the membrane. (B) Histogram
of the peak response for each condition . Patch clamp recordings from Dr. Nawy unpublished data .

In TRPMr/- retina nyctalopin remains expressed in the dendritic tips of the DBCs,
suggesting that nyctalopin localization and stability is not dependent on TRPM1 expression. One
possibility for nyctalopin' s stability is if it is acting as a scaffold protein . Then nyctalopin could be
independently transported to the DBC dendrites where it interacts with extracellular matrix
proteins to maintain stability.
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In both TRPMl and nyctalopin mutants, the Grm6 receptor is properly expressed in the
DBC dendrites. These results suggest that Grm6 has an independent means of transport or
stabilization in the DBC dendritic membrane.
The Grm6 mutants have nyctalopin present in the DBC dendrites; however, TRPMl
expression in the DBC dendrites decreases though it is expressed in cell bodies in the INL.
Interestingly, patch clamp recordings suggest that the TRPMl channel is constitutively active in
the absence of Grm6. Though the DBCs have no response to the TRPMl channel agonist,
capsaicin, the TRPMl antagonist, capsazepine, is able to produce a small inward current (Figure
36). This suggests the TRPMl channel is still in the membrane, but at very low levels and this
may explain why it is not detected by Immunohistochemistry.
Presumably in the absence of Grm6 the TRPMl channel is no longer closed by the
activation of the G-protein cascade. The unregulated influx of cations through the channel could
cause morphological abnormalities, which have been observed in Grm6nob4 and Grm61- mice
(Cao et 01., 2009; Ishii et 01., 2009). The loss of TRPMl from the dendrites of the Grm6 mutants
might be a secondary mechanism to help prevent cell death.
In contrast, YFP-nyctalopin is normally expressed in the Grm6 mutants at the light
microscopy level. Therefore, nyctalopin maybe expressed in the abnormal dendrites, while
TRPMl is not. These results can be interpreted two ways. First, nyctalopin may require an
intermediary protein that is part of the Grm6 cascade to direct insertion of TRPMl into the
membrane. Therefore, in the absence of Grm6 signaling, nyctalopin is trafficked to the
membrane but not bringing TRPMl. Alternatively, TRPMl may interact directly with Grm6 and
require complex interactions between both nyctalopin and Grm6 to maintain stability. Initial
yeast-two hybrid experiments to examine interactions between TRPMl and Grm6 were negative
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(Pearring et 01., 2009); however, further analysis of protein interactions in an alternative system
will be required to confirm this result.
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Figure 35. TRPMl (purple), Nyctalopin (green), and Grm6 (red) protein localization and TRPMl
nob
channel response properties in CSNBl mouse models: CS7Bt/6J (wildtype), Nyx , TRPMrl · and Grm61- . Currents are from Dr. Nawy unpublished data .

Collectively, these data show that TRPM1 is dependent on both Grm6 and nyctalopin for
proper localization. However, nyctalopin and Grm6 expression are not dependent on each other
or on TRPM1 (summarized in Figure 35). These results suggest that the three proteins are not
forming one large interdependent membrane complex. Furthermore, the instability of TRPM1 in
nyctalopin and Grm6 mutants suggests that its expression in the membrane may be activity
dependent. Signal-induced translocation to the plasma membrane is a common property of TRP
channels {Van Buren et 01., 2005; Zhang et 01., 2005b; Mehta et 01., 2003; Bezzerides et 01., 2004;

126

Odell et 01., 2005; Smyth et 01., 2006). Therefore, perhaps signaling through the Grm6 cascade is
required for TRPM1 insertion into the membrane. This insertion is not likely to be the gating
mechanism for the channel, but could be acting as a secondary means of regulating the amount
of TRPM1 in the membrane. Further analysis of TRPM1 expression in the DBC dendrites of other
no b-wave mutant mice, such as Gaor/ - or G65-5-1-, or CACNA1F"°b2, would help determine if
disrupting Grm6 activity or specific downstream members of the cascade lead to loss of TRPM1
from the DBC dendrites.
Nyctalopin maintains TRPMl Channel Integrity in the Membrane

A recent study provided new evidence that TRPM1 may function as an intracellular TRP
channel in melanocytes (Oancea et 01., 2009). Similar to my own results, localization studies of
GFP-tagged TRPM1 isoforms showed they were all localized to intracellular structures (Oancea

et 01., 2009). This unexpected intracellular location is consistent with the relatively modest
magnitude of the whole-cell currents that I recorded from HA-TRPM1 stable cell lines (Chapter
IV) and reported in melanocytes (Oancea et 01., 2009). In the DBCs, TRPM1 is expressed in the
cell bodies as well as the dendritic tips and patch clamp recordings show higher TRPM1 currents
suggesting that more TRPM1 channels are expressed in the membrane of these cells (Nawy,
1999; Gregg et 01., 2007; Shen et aI., 2009). TRPM1 expression in the plasma membrane might
require specialized trafficking mechanisms restricted to DBCs. Nyctalopin could be acting to
target the TRPM1 channel to the membrane, since it is not expressed in HEK293T cells or
melanocytes but restricted to DBCs dendritic tips (Gregg et 01., 2007). Both proteins are
processed through the ER, so nyctalopin could bind a fraction of the TRPM1 channels to ensure
they are placed into specific vesicles bound for the dendritic tips (see trafficking model in Figure
36). Surprisingly, when I transfected nyctalopin into HEK293T cells that stably express TRPM1
the expression of TRPM1 in the membrane was unaltered (Chapter IV). Likely specific neuronal
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proteins or properties are required for TRPM1 and nyctalopin targeting to the plasma
membrane.
Another possible role for nyctalopin would be to assemble the TRPM1 channel into
tetramers. Interestingly, the structure of nyctalopin is similar to the structure of the ankyrin
repeat domain found in many TRP channels (Phelps et al., 2007, 2008). Both are curved
structures with ~-sheets on the concave side and helixes on the convex side (Bech-Hansen et al.,
2000; Pusch et al., 2000; Gregg et al., 2003; Mosavi et al., 2004; Sedgwick & Smerdon 1999).
Ankyrin repeats are involved in trafficking and assembly of TRP channels in the membrane (Jung

et al., 2002; Chang et al., 2004; Erler et al., 2004). Nyctalopin could be acting as an auxiliary
ankyrin domain for the TRPM1 channel to ensure it is properly assembled into its tetrameric
structure (see assembling model in Figure 36).
Nyctalopin was shown to remain expressed in the DBC dendrites in the absence of both
TRPM1 and Grm6. The stability of nyctalopin suggests it maybe binding other proteins, likely
extracellular in nature. Nyctalopin interactions maybe providing the proper structure to hold the
TRPM1 channel in the membrane and prevent lysosomal degradation of the channel (see
stabilizing model in Figure 36).
I showed that nyctalopin interacts with TRPM1 in a heterologous system. Further
analysis of nyctalopin's structure could help determine its function with TRPMl. Nyctalopin is an
extracellular protein, so it must interact with an extracellular region of TRPMl. To determine
where these proteins are interacting, constructs lacking critical protein domains, such as the LRR
or TM domain of nyctalopin or specific extracellular loop regions ofTRPM1, could be individually
tested in the heterologous binding system. In addition, CSNB mutations for nyctalopin could be
tested to determine if they interfere with binding. Identifying the specific interacting regions
would help to further elucidate the function of nyctalopin.
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Figure 36. Models for nyctalopin and TRPMl interactions in DBCs. Nyctalopin could be playing a role in
trafficking TRPMl to the DBC dendritic tips by helping to sequester it into vesicles targeted for
dendritic expression. Nyctalopin could be helping maintain TRPMl stability in the dendritic membrane
by being involved in assembly and insertion or by stabilizing it in the membrane to prevent lysosomal
degredation .

Since nyctalopin was first identified in 1998, its role in generating the DBC response has
remained elusive. My data show that nyctalopin is required for TRPM1 expression in the
dendritic tips of DBCs and that it directly interacts with TRPM1. In addition, I characterized how
Grm6 impacts TRPM1 localization and provide evidence that nyctalopin is not interacting with
Grm6. Collectively my results are the first to revec;ll the function of nyctalopin in DBCs.
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APPENDICES
Appendix I: Transient expression of YFP-nyctalopin using in vivo Electroporation
A major limitation in my ability to characterize nyctalopin functional interactions with
TRPM1 is that there is no good in vitro model to study these structure function relationships. As
described in Chapter IV, nyctalopin and TRPM1 were not properly localized in the plasma
membrane when recombinantly expressed in HEK293T cells. Making modified nyctalopin or
TRPM1 constructs and generating transgenic mouse lines is a costly and time consuming. To
overcome this limitation I begun initial experiments to implement in vivo electroporation of
plasmid constructs into the retina at PO of the mouse, as first described by Matsuda and Cepko
(2004). A solution of DNA plasmid is directly injected into the subretinal space of neonatal
mouse pups (PO), and electric pulses applied by using tweezer-type electrodes. The genes of
interest are then transiently expressed in a variable number of cells in a pattern that is dictated
mostly by the promoter being used.
Initial in vivo electroporation experiments were performed to determine if I could obtain
sufficient expression of YFP-nyctalopin in DBCs of the Nyx"°b mice. At post-natal day 30 (P30) an
electroretinogram (ERG) were performed to assess visual function and at P45 the expression of
YFP-nyctalopin in the retina was determined by immunohistochemical analysis using a GFP
antibody.
I tested several promoters to determine which gave the most abundant expression of
YFP-nyctalopin in the bipolar cells. The promoters I tested were either ubiquitously expressed,
Humari ubiquitin-3, or bipolar cell specific, GABAc pI and Calcium Binding Protein S (CABPS).

154

Examples ofthe staining patterns are shown in Figure 37A-C. Human ubiquitin-3 promoter drove
expression into all cell types, Figure 37 A. Immunohistochemistry using a GFP antibody shows the
region near the injection site has expression of YFP-nyctalopin, while the remaining retina,
shown with the nuclear stain ToPro3, does not have staining for YFP-nyctalopin (Figure 37A). I
observed GFP positive puncta in the OPL when YFP-nyctalopin was being driven by either of the
two bipolar cell specific promoters, GABAc pi or CABP5 (Figure 37B,C) . This OPL puncta
represents the expression of YFP-nyctalopin on the dendrites of DBCs, which is consistent with
YFP-nyctalopin expression in the transgenic mice . In addition, there is occasionally a cell that is
completely stained (Figure 37C) . I do not know the cause of this but suspect it is because of the
transient nature of the expression .

nob

Figure 37. Immunohistochemical analysis of Nyx
retina at post-natal day 45 (P45) after in vivo
electroporation of YFP-nyctalopin plasmids at PO. (A) Human-Ubiquitin3 promoter dives expression of
YFP-nyctalopin (green) in all cell types. Double labeling with nucleic acid stain, TOPR03, shows
boundaries of YFP-nyctalopin expression in retina . (B) GABAcpl promoter drives expression in of YFPnyctalopin to the dendritic tips of BCs. (C) CABP5 promoter also shows bipolar cells positively
expressing GFP in their dendritic arbors. In addition, some cells do not properly express YFPnyctalopin.
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ERGs were performed at P45 to test whether transient expression of YFP-nyctalopin was
sufficient to rescue the no b-wave ERG phenotype of Nyx"°b mice. ERGs were normalized to the
peak of the a-wave trough in the uninjected eye. Normalization accounts for the difference in
amplitude of the a-wave in the injected verses uninjected eyes. A representative ERG from each
injected plasmid is shown in Figure 38. Each graph plots the normalized ERG for the non-injected
(pink, left) and the injected (blue, right) eyes as well as the difference trace (green, left-right)
between the two eyes (Figure 38). In every mouse the uninjected control eye (pink) has a Nyx"°b
ERG phenotype, a large a-wave and no b-wave (Figure 38A-D). In the YFP-nyctalopin injected
eye, there is a shoulder present at the bottom of the a-wave that was initially thought to be a
small b-wave (Figure 38A-C). This difference can be seen when subtracting the control ERG from
the injected ERG (difference trace, green). However, when the negative control Hanks Balanced
Salt Solution (HBSS) was electroporated the injected ERG showed the same shoulder present in
YFP-nyctalopin injections (Figure 38D). The injection is causing a retinal damage that affects the
ERG a-wave. This ERG difference is not dependent on YFP-nyctalopin expression.
Collectively, this data showed that transient expression of YFP-nyctalopin can target
YFP-nyctalopin to DBC dendrites, but is not abundant enough to restore function to the DBCs.
This technique could be used to transiently express nyctalopin or TRPM1 constructs and
determine if they have the ability to properly locate to the DBC dendrites.
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Figure 38. Normalized ERG from YFP-nyctalopin in vivo electroporated into Nyx
mice. ERG's were
performed on the non-injected control eye (pink, left) and injected (blue, right) eye for each mouse.
The control ERG was subtracted from the injected ERG and the difference plotted (green) to
determine if the injection of YFP-nyctalopin rescued the ERG b-wave. Mice were injected with
plasmids driving YFP-nyctalopin expression by a GABAcpl (A), Ubiquitin3 (B) or CABPS (e) promoters.
Normalized ERGs of injected eye were indistinguishable from the HBSS injected control animals (D).

in vivo Electroporation: Newborn pups are anesthetized on ice, a cut made to open the eyelid
and a small incision in the sclera near the cornea made with a 30-gauge needle. 0.5
containing 2.5

~g

~I

of PBS

of plasmid DNA will be injected into the subretinal using a Hamilton syringe

with a 33-gauge blunt-ended needle . After plasmid injection, tweezer-type electrodes (7 mm
diameter, Nepa Gene Co, Japan) briefly soaked in PBS were placed so that a current is passed
across the head of the animal. Five 90V square pulses of 50-ms duration with 950-ms intervals
are applied by using a pulse generator (Nepa Gene Co, Japan). DNA was transfected only into
the right eye and the left eye will be used as non-injected control.
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Appendix II: Thrombin Digest of YFP-nyctalopin

Nyctalopin is predicted to be highly glycosylated, so the exact molecular weight of YFPnyctalopin from retinal tissue remains unknown. In an attempt to reduce the size of YFPnyctalopin, the protein was screened for protease cleavage sites. Thrombin cleaves YFPnyctalopin at two sites, at amino acid 344 and 657 (Figure 39A). This digest is predicted to
liberate the YFP tag from nyctalopin, which could be identified by immunoblotting with the GFP
antibody. The predicted YFP would have a molecular mass of 36 kDa. Though this method will
not identify full length YFP-nyctalopin it will help to determine if problems trying to detect YFPnyctalopin are due to glycosylation.
Membrane prepared fractions from Nyx"ob and TgYFPNYX retinas were digested with
restriction grade thrombin (Novagen) for 0, 2 and 4 hours before analysis by western blot.
Figure 39B shows that the GFP antibody did not detect a band in either the Nyx"°b or TgYFPNYX
fractions before or after thrombin digestion. RIBEYE also contains a thrombin cleavage site,
which was used as an internal control for the thrombin digest. The membrane was stripped and
re-probed with a RIBEYE antibody, which detects two bands from the retina (90 and 110 kDa,
tom Dieck & BrandstiHter, 2005). Figure 39C shows that after a 2 or 4 hour digestion with
thrombin the RIBEYE antibody detected two new bands at half the molecular weight of normal
RIBEYE (60 and 50 kDa). These cleavage products were not present before digesting with
thrombin. This data suggests that thrombin is digesting retina membrane proteins; however, a
YFP fragment could not be detected.
To determine if the thrombin digest actually cleaved the predicted sites in YFPnyctalopin it was tested on the recombinant SYFP-NYX. HEK293T cell membrane fractions from
transfections with mock or SYFP-NYX were subjected to the thrombin digest. Figure 39D shows
the results from the western blot using a GFP antibody. A non-specific band at 65 kDa is

158

detected by the GFP antibody in every lane. The recombinant SYFP-NYX is detected only in SYFPNYX transfected cells; however, thrombin does not cleave the SYFP-NYX into a smaller 36 kDa
band as expected. The thrombin assay does not work on SYFP-NYX, which suggests it is also
probably not working on YFP-nyctalopin from retina preparations.
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Figure 39: Thrombin digest of YFP-nyctalopin. (A) Schematic diagram of the predicted thrombin
cleavage sites on YFP-nyctalopin. (8) Immunoblot with GFP antibody shows no cleavage of the SYFPNYX at 90KOa from TgYFPNYX membrane preparation . (C) Immunoblot with RI8EYE antibody shows
cleavage with thrombin after 2 and 4 hours digestion. (0) Thrombin digests on HEK293T cell lysate
from mock or SYFP-NYX transfections. Recombinant SYFP-NYX is not cleaved by thrombin . A nonspecific band is present in every lane at 65KOa.
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Thrombin Digest Protocol: The membrane fraction from HEK293T cell and retinal Iysates were

used in the thrombin digest. 1 X Cleavage Buffer (Novagen, Gibbstown, NJ) 30 ul Protein, 1 III of
1:25 dilution of Recombinant Grade Thrombin (Novagen, Gibbstown, NJ) up to final volume of
75 Ill. The reactions were incubated at room temperature for 0, 2 or 4 hours. 6 III of 5 X Sample
Buffer was added to stop the reaction. Samples denatured at 85°C for 7 minutes before loading
onto a 10% polyacrylamide gel.
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